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ABSTRACT 
Charge transport and catalysis in enzymes often rely on amino acid radicals as intermediates. 
The generation and transport of these radicals are synonymous with proton-coupled electron 
transfer (PCET), which intrinsically is a quantum mechanical effect as both the electron and 
proton tunnel. The caveat to PCET is that proton transfer (PT) is fundamentally limited to 
short distances relative to electron transfer (ET). This predicament is resolved in biology by 
the evolution of enzymes to control PT and ET coordinates on very different length scales. In 
doing so, the enzyme imparts exquisite thermodynamic and kinetic control over radical 
transport and radical-based catalysis at cofactor active sites.  
New tools are needed to study PCET reactions of amino acid radical in biology. This thesis 
describes methods for photogeneration of amino acid radicals, with particular emphasis on 
tyrosine. Unnatural fluorotyrosine amino acids are developed to vary the driving force for 
proton and electron transfer in PCET reactions of tyrosyl radical (Y•), and to provide unique 
spectroscopic handles to study enzymes utilizing multiple Y•s. These tools allow for an in-
depth study of the PCET mechanism of tyrosyl radical generation, both in solution and within 
the ribonucleotide reductase enzyme.  
Enzymatic acitivity of class I E. coli ribonucleotide reductase requires the transport of charge 
from an assembled diiron-tyrosyl radical cofactor to the enzyme active site over 35 Å away 
via an amino acid radical hopping pathway spanning two protein subunits. To study the 
mechanism of this radical transport, we have developed photochemical RNRs wherein radical 
generation, transport, and enzymatic turnover can be initiated by UV-vis excitation of a 
peptide bound to the subunit containing the enzyme active site. This method allows us to 
observe Y•s competent for initiating turnover on the peptide bound to the protein subunit. 
Turnover assays with the wild-type and mutant proteins show that both the electron and 
proton move along a unidirectional pathway to affect radical transport in this subunit. 
Thesis Supervisor: Daniel G. Nocera 
Title: W. M. Keck Professor of Energy and Professor of Chemistry 
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flash. . Left and right insets for each panel correspond to single 
wavelength absorbance kinetics data (○) and exponential fit (▬) 
monitored at 396 and 455 nm, respectively. 
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Figure 9.2 Emission spectra of [Re]-3,5-F2Y-R2C19 as a function of pH, which 
was titrated from 4.5 to 11.5. Inset: pH Titration curve of integrated 
emission intensity. 
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following a 355 nm laser pulse. Insets: Single wavelength kinetics traces 
(○) with single exponential fit (▬) recorded at 480 nm. 
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Figure 9.4 (Left) TA spectra of 100 μM [Re]-3,5-F2Y-R2C19 obtained 65 and 215 
ns after a 355 ns flash. (Right) TA spectrum of 100 μM [Re]-3,5-F2Y-
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355 nm laser flash. Conditions: 50 mM Tris buffer (pH 8.5), 20% 
glycerol, 1 mM CDP, 3 mM ATP, and 15 mM MgSO4. Insets: Single 
wavelength kinetics traces (○) with single exponential fit (▬) recorded 
at the wavelength indicated. 
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215, and 415 ns (left) and at 115, 215, and 415 ns (right).  Insets: Single 
wavelength absorbance kinetics data measured at 480 nm. 
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Single wavelength absorbance kinetics recorded at 395 nm. 
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Figure 9.13 TA spectra of a 100 μM solution of [Re]-3,5-F2Y-R2C19 with 10 mM 
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Figure 10.1 Proposed photochemistry for [Re]-3,5-F2Y356-β2. 215 
Figure 10.2 TA spectra recorded after  photolysis of 100 μM solutions of 4-Ac-BP 
in the absence (left) and presence (right) of 10 mM L-tyrosine methyl 
ester with 320 nm pulsed laser light. Spectra in the left panel were 
recorded 100, 200 ns, 1, 2, and 5 μs after the laser pulse (top to bottom). 
Spectra in the right panel were recorded 200 ns, 1, and 5 μs after the 
laser pulse (top to bottom). 
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50 μM Y356C(BP)-β2 with 70 μM α2 (C). Spectra were recorded 150, 
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mM Tris (pH 7.5), 15 mM MgSO4, 1 mM CDP, and 3 mM ATP. 
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1.1 Fundamentals and Nomenclature 
Proton-coupled electron transfer (PCET)1,2 steps beyond simple electron transfer (ET) in 
the complexity associated with the two particle nature of this reaction. In a chemical context, 
ET is associated with redox events that are oftentimes influenced by the surrounding medium, 
while PCET is extended to combine redox and acid/base chemistry and encompasses charge 
transfer and bond-making/bond-breaking reactions. The electron and proton may be 
transferred together or separately in a concerted or stepwise fashion and the term PCET 
generally encompasses all of these reactions. Figure 1.1 presents an illustration of two 
fundamentally distinct types of PCET commonly encountered in chemistry and biology.3 The 
first type, termed unidirectional PCET, 
involves the transfer of both a proton and an 
electron from a single donor to a single 
acceptor. The proton and electron may be 
transferred together as a hydrogen atom, or 
separately involving electronic orbitals for 
ET and PT of different symmetry. In 
contrast, bidirectional PCET reactions invoke 
a single donor and two separate acceptors, one for ET and one for PT. Mechanistically, these 
PCET reactions have been treated within the context of “square schemes” as illustrated in 
Figure 1.2. The electron and proton may be transferred in a stepwise (ETPT or PTET) fashion 
 
Figure 1.1. Fundamentally distinct types of PCET. 
 
Figure 1.2. Square scheme for PCET. X is the 
ET and PT donor and Y is the acceptor.
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along the outside of the square, or in a concerted electron-proton transfer (CEP) along the 
diagonal. Importantly, CEP is defined as occurring with a single transition state. Genuine 
hydrogen atom transfer, HAT, can thus be classified as a type of CEP reaction.  
Conflicting use of nomenclature by several authors has muddied the dissemination of 
mechanistic insight obtained through recent investigations into PCET reactions. Table 1.1 
presents a summary of the various nomenclatures used by prominent authors in this field. A 
general agreement has been reached for the stepwise reactions, ETPT (electron transfer 
followed by proton transfer) or PTET; both of which may be classified as a general PCET 
reaction since both the electron and proton are transferred. The nomenclature for concerted 
reactions (those occurring with a single transition state) is a bit more ambiguous.  
Table 1.1 Various Nomenclatures Used to Describe PCET. 
Concerted Unidirectional PCET3 
Concerted Electron-
Proton Transfer (CEP)4  
Electron-Proton 
Transfer (EPT)5,36 
  
Concerted Proton-
Electron Transfer 
(CPET)6,7
Concerted Electron 
Transfer Proton 
Transfer (ETPT)8
Concerted Bidirectional PCET3 
Bidirectional Concerted Electron-Proton 
Transfer (CEP)4
Enzymes often rely on the coupling of electrons and protons to affect primary metabolic 
steps involving charge transport and catalysis.9 Amino acid radical generation and transport is 
synonymous with PCET10 as is the activation of most substrate bonds at enzyme active 
sites.11 PCET is especially prevalent at metallo-cofactors that activate substrates at carbon, 
oxygen, nitrogen, and sulfur atoms. PCET charge transport and activation events in enzymes 
embody “quantum catalysis” inasmuch as PCET is intrinsically a quantum mechanical effect 
because both the electron and proton tunnel.12 The caveat to PCET is that the transfer of the 
proton, as the heavier particle, is fundamentally limited to short distances whereas the 
electron, as the lighter particle, may transfer over very long distances.13,14 When transport 
distances are short, the electron and proton may transfer together. When they are long, 
however, the predicament of the disparate transfer distances is resolved by the evolution of 
enzymes to control proton-transfer (PT) and electron-transfer (ET) coordinates on very 
 
 Multi-Site Electron Proton Transfer (MS-EPT)5
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different length scales. Adding to the challenge of effecting PCET over long distances with 
appreciable rates are the requirements that charge transport occur under physiological 
conditions, with minimal thermodynamic driving-force, with low over-potentials, and with 
specificity. To do so, enzymes impart exquisite thermodynamic and kinetic control over the 
electron and proton during radical transport and catalysis events. By discovering and 
understanding functional PCET mechanisms in these systems, we can begin to develop and 
test predictive theories for PCET reactions, in much the same way the ET field has 
1.2 
er this 
theo
 
nuc
this model, the expression for the rate and activation energy for ET was derived by 
Marcus:15 
 
developed.15 
Theory of ET and PCET 
In 1956, a theory was developed by Marcus to treat the potential energy of the transition 
state of a fixed distance electron transfer reaction.16 ET occurs as a Franck-Condon transition 
with the nuclear coordinates frozen as the electron is transferred from donor to acceptor. 
Marcus’ theory addressed the electrostatic contribution associated with reorientation of 
solvent molecules to the free energy of formation of the transition state for ET. Lat
ry was discussed in terms of potential energy surfaces and statistical mechanics.17  
Figure 1.3 presents examples of these potential energy surfaces as previously 
described.15,18 With the nuclear coordinates at the equilibrium position of the reactants 
(Figure 1.3, top), poor electronic overlap exists between the reactant and product electronic 
wavefunctions due to their offset in energy. The transition state occurs at the intersection of 
the reactant and product potential energy wells (Figure 1.3, middle), and, at this nuclear 
position, the reactant and product electronic wavefunctions are degenerate providing optimal 
overlap for electron tunneling through the barrier. Once the electron has been transferred, the
lear coordinates relax to the equilibrium position of the product well (Figure 1.3, bottom). 
Cast in 
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Figure 1.3. Electronic (left) and nuclear (right) potential energy wells for 
an ET reaction. 
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where A is a prefactor that defines the frequency of the barrier crossing, ΔG‡ is the activation 
energy, ΔG° is the free energy of the reaction, and λ is the reorganization energy with 
contributions from both the inner sphere reactants and outer sphere solvent. Quantum 
mechanical treatments of the nuclear coordinates19,20 have resulted in the modified Marcus-
Levich equation for ET reactions with very weak electronic coupling: 
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where HAB is the donor-acceptor electronic coupling.  
Figure 1.4 presents a modified potential energy surface incorporating the quantum 
mechanical effect of electronic coupling.21 The 
reactant and product diabatic surfaces split near the 
intersection, often referred to as the “avoided 
crossing”, with the magnitude of the splitting equal 
to twice the electronic coupling. For an adiabatic ET 
reaction, 2HAB is large, significantly decreasing the 
activation energy, and electron transfer occurs every 
time the reactants reach the transition state. For the 
nonadiabatic case, the electronic coupling is small 
and the reactants cross the transition state many 
imes before the electron is transferred to the 
product energy well.
t
 
Figure 1.4. Potential energy well for 
an ET reaction treated quantum 
mechanically. 
21  
Marcus’ theory predicts a parabolic dependence of the ln(kET) vs. –ΔG°: the rate increases 
to a maximum value where –ΔG° = λ and decreases with further increase in driving force. The 
latter region is often referred to as the “inverted region” for electron transfer and has been 
experimentally observed many times.22- 29 However, the decrease in rate with driving force is 
often less than parabolic.30 Nuclear tunneling through vibrational wavefunction overlap is 
usually coupled to inverted region ET, as illustrated in Figure 1.5. For inverted region ET, the 
equilibrium position of the reactant well is situated inside the product well, affording optimal 
overlap between the ground state reactant and excited state product vibrational wavefunctions 
(red region in Figure 1.5). Inverted region ET mediated by vibrational wavefunction overlap 
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has been treated as a form of nonradiative decay in a modified version of the “energy gap 
law”:31- 33 
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where ħω is the averaged energy of the accepting 
vibrational modes, λo is the outer sphere (solvent) 
reorganization energy, and S is the electron-
vibrational coupling constant or Huang-Rhys 
factor34 which gives the extent to which the final 
and initial states coincide along the normal 
coordinate. Equation 4 is valid in the limit that –
ΔG° >>S ħω and ħω >> kBT (low temperature 
and/or high energy acceptor mode) and predicts that 
ln(kET) should vary linearly with –ΔG°, rather than 
the parabolic dependence predicted by Marcus.  
 
Figure 1.5. Inverted region electron 
transfer. Area in red illustrates 
vibrational wavefunction overlap. 
Theoretical treatments of PCET1,35- 37 have more recently been developed and are based 
on the quantum mechanical results obtained for ET (eq. 3 and 4). These equations rely on the 
application of the Born–Oppenheimer and Condon approximations that allow for separation 
of the nuclear and electronic parts of the overall wavefunction. The validity of this 
approximation for PCET has yet to be verified.  
Hammes-Schiffer has developed a PCET theory that treats potential energy surfaces as a 
pair of paraboloids, which are functions of the solvent response to changes in both electron 
(ze) and proton (zp) position as shown in Figure 1.6.36 In the limit of electronically adiabatic 
PT and electronically nonadiabatic ET, the following expression was derived:38 
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where Σμ and Σν indicate a sum over vibrational states 
associated with ET states I and II, respectively and PIμ 
is the Boltzmann factor for state Iμ. In this formalism, 
each vibrational mode or channel in the reactant well 
couples to the product well with a different electronic 
coupling, Vμν, and the overall rate for each vibrational 
mode is weighted by the Boltzmann factor for thermal 
population of that channel. Thus at extremely low 
temperatures or for high energy vibrations, only the 
ground state reactant vibrational mode is populated 
and contributes to the rate. An important difference 
between eqs. 3 and 6 is that the reorganization 
energies, equilibrium free energy difference, and 
couplings are defined in terms of the two-dimensional 
paraboloids for eq. 6 and depend on both the electron and proton position, as changes in both 
are coupled to solvent response.36 Through knowledge of the experimental rate constant and 
overall reaction driving force, the reorganization energies, electronic couplings, and percent 
contribution to the rate for each reactant-product vibrational channel can be computed 
theoretically. Although not predictive, this theory provides a framework with which to begin 
analysis of PCET reactions. 
 
Figure 1.6. Two dimensional 
vibronic free energy surfaces for 
reactants (I, μ, blue) and products 
(II, ν, red) of a PCET reaction. 
Taken from ref [12]. 
1.3 PCET of Amino Acid Radicals in Biological Systems 
Enzymes often utilize PCET to effect bond making/breaking reactions and charge 
transport over long distances, therefore these biological systems serve as excellent mediums 
to discover, develop, and test PCET reaction mechanisms and theory. Amino acid radicals, in 
particular, have emerged prominently as vehicles for charge transport and cofactors for 
substrate activation.39,40 Oxidation of amino acids at physiological pH usually involves the 
loss of both a proton and electron, implicating PCET10 as the redox mechanism. Free amino 
acid radicals in solution typically have a micro-millisecond lifetime, yet Nature has evolved 
enzymes to manage both the proton and electron equivalents in harnessing the oxidative 
power of these intermediates for chemical transformations. Understanding these control 
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mechanisms may lead to the discovery of new reactivity as well as the development of drugs 
targeting specific enzymatic PCET steps. 
1.3.1 Amino Acid Radicals as Redox Active Cofactors 
1.3.1.1 Galactose Oxidase 
Galactose oxidase (GAO) is a 68 kDa monomeric fungal copper metalloenzyme that is 
secreted by Fusarium spp. into the extracellular 
environment and functions as a broad-spectrum 
alcohol oxidation catalyst and a source of 
hydrogen peroxide.41 The two-electron nature of 
the substrate oxidation chemistry is interesting in 
that it occurs at a mononuclear copper active site, 
which typically functions as a one-electron redox 
agent. This quandary has been explained by the 
direct participation of the protein,42 in particular a 
tyrosine residue,43 in the redox steps. The X-ray 
crystal structure of GAO44 reveals that the Cu-
atom in the active site is coordinated by two His residues, a Tyr residue, a water molecule, 
and a Cys-crosslinked-Tyr residue, as shown in Figure 1.7. Oxygen becomes reduced to 
hydrogen peroxide at the cuprous active site resulting in a cupric ion bound to a •Y272–C228 
radical.45 In this way, the Y272–C228 residue serves as a redox active ligand allowing a 
single Cu center to perform multielectron redox chemistry.46 Substrate alcohol is believed to 
bind in place of the active site water molecule. No intermediates have been observed in the 
substrate oxidation process; however a mechanism has been proposed in which PT from the 
substrate hydroxyl group to Y495 activates the substrate for oxidation. Product formation 
involves the loss of two electrons and the cleavage of one Cα–H bond.45 The mechanism for 
this transformation is a subject of current debate, but may involve ET to Cu(II) followed by 
PCET/HAT from the alkoxyl radical to •Y272–C228.45 
 
Figure 1.7. Crystal structure of the 
active site of GAO from ref [44]. 
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1.3.1.2 Cytochrome c Peroxidase 
Cytochrome c peroxidase (CcP) is a Class I plant peroxidase whose main role is to remove 
hydrogen peroxide from the cell.47 Hydrogen peroxide is 
reduced to water at a heme active site in CcP using 
electrons from the cytochrome c redox substrate. 
Reduction of H2O2 to water requires two electrons; 
however, cytochrome c is a one electron redox reagent. 
ENDOR studies have shown that H2O2 binds to and 
oxidizes the ferric heme of CcP to an Fe(IV)=O, ferryl 
intermediate and a protein amino acid radical, most likely 
[•W191]+.48 The high resolution crystal structure of CcP49 
(Figure 1.8) reveals that this residue resides in the 
proximal pocket of the CcP heme. Electrons are therefore 
transferred to the [•W191]+ and ferryl intermediate from 
two separate cytochrome c substrates in two separate 
steps, primarily along a CCP(heme)–Trp191–Gly192–
Ala193–Ala194–Cyt. c (heme) ET pathway.50 Trp191 
thus serves as a redox reservoir in the reduction of hydrogen peroxide to water.  
 
Figure 1.8. Crystal structure of 
yeast cyt. c peroxidase active site 
from ref [49]. 
1.3.1.3 Cytochrome c Oxidase 
Cytochrome c oxidase (CcO) comprises the terminal component of the respiratory chain 
in aerobic organisms that couples NADPH oxidation to the reduction of oxygen to water.51 
This process creates the necessary proton gradient across the membrane to drive the synthesis 
of ATP, the energy currency of biology.52,53 Reduction of oxygen to water at heme is a 
remarkably complicated process requiring precise timing of electrons and protons to prevent 
hydrogen peroxide formation.11 In CcO, oxygen reduction occurs at the CuB–heme a3 site of 
CcO and is mediated by electron transfer from a bound cytochrome c redox cofactor through a 
binuclear CuA cofactor. Cyt. c binds near CuA and electrons are transferred along a cyt c → 
CuA → heme a → CuB–heme a3 pathway.54,55 Oxygen binds to and is activated by the fully 
reduced ferrous heme a3–cuprous CuB site. This process induces heterolytic O–O bond 
cleavage with the formation of an Cu(II), Fe(IV)=O  intermediate56,57 and a protein derived 
radical.58 EPR experiments of the isotopically labeled enzyme reveal that the radical resides 
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on a tyrosine residue.59 Reaction of the radical 
with radioactive 125I– followed by peptide 
mapping resulted in iodide labeling at Y244, 
although yields of the labeled protein were 
small.60 The crystal structure of the heme a3–
CuB site in CcO (Figure 1.9) reveals the 
location of this residue in the distal pocket of 
heme a3 and crosslinked to H240, a ligand to 
CuB.61 Thus Y244 may serve as a redox 
reservoir in the reduction of oxygen to water 
in CcO in much the same as W191 in the 
reduction of hydrogen peroxide to water in CcP. •Y244 is characterized as a deprotonated, 
neutral tyrosyl radical implicating PCET in the radical forming step; however, mechanistic 
details remain to be uncovered. 
 
Figure 1.9. Crystal structure of bovine heart 
CCox heme a3–CuB site from ref [61]. 
1.3.2 Amino Acid Radicals as Charge Transport Intermediates 
1.3.2.1 Pyruvate Formate Lyase 
As a participant in anaerobic glucose 
fermentation, pyruvate formate lyase (PFL) 
catalyzes the reversible conversion of 
pyruvate and coenzyme A to acetylCoA and 
formate. The enzyme relies on the formation 
of a stable glycyl radical at position 734 for 
activity,62 which is formed via a radical SAM 
mechanism63 utilizing a pyruvate formate 
lyase activating enzyme.64 The mechanism of 
action proposed for PFL is incredibly 
complicated involving radical transport from 
•G734 to a pair of redox active cysteine residues, C418 and C419. The crystal structure of 
PFL with pyruvate substrate bound in the active site (Figure 1.10) reveals that these three 
 
Figure 1.10. Crystal structure of PFL active 
site from ref [65]. Distances are in Å. 
 35
residues are within hydrogen bond contact.65 Thus hydrogen atom transfer (HAT) could 
operate as the radical transport mechanism. 
Based on the work of Knappe66- 69 and Kozarich,70- 72 the conversion of pyruvate to 
formate and coenzyme A to acetylCoA can occur in two steps. In the first step, •C418 attacks 
the acetyl group of pyruvate, forming acylated C418, formate, and •C419, which relaxes back 
to •G734. In the second step, a transiently formed •C419 abstracts an H-atom from the thiol 
group of coenzyme A. The thiyl radical on coenzyme A then attacks the acetyl group of C418, 
forming acetylCoA and •C418, which relaxes back to •G734.65 When [14C]-pyruvate was 
incubated with C419S-PFL, acylated protein was not observed, consistent with the notion that 
radical transport from •G734→C419→C418 is required for the formation of the putative 
•C418 radical.69 Thiyl radical intermediates remain to be observed experimentally, inhibiting 
investigations into the mechanism of radical transport in PFL. 
1.3.2.2 DNA Photolyase 
Photolyases are monomeric proteins containing a 
flavin adenine dinucleotide (FAD) cofactor that is 
responsible for the photochemical repair of pyrimidine 
dimers in DNA.73  Upon cell lysis and isolation from E. 
coli, the FADH– cofactor is oxidized to the FADH• 
radical redox state. Exposure of this form of the enzyme 
to light in the presence of a reducing agent regenerates 
FADH– cofactor and reactivates the enzyme.74 Transient 
absorption spectroscopy revealed that the initially 
excited doublet state of FADH• converts to the lowest 
excited quartet state via intersystem crossing.75 This 
state then abstracts an electron from the apoenzyme, 
forming a neutral W• radical.76,77 Site directed 
mutagenesis studies revealed that the W306F mutant 
failed to be photochemically reactivated, suggesting that 
W306 was the site of the observed W•.78 The X-ray 
crystal structure of the enzyme79 (Figure 1.11), however, revealed that W306 was near the 
surface of the protein and remote from the FADH• cofactor. Picosecond transient absorption 
 
Figure 1.11. Crystal structure of 
DNA photolyase from ref [79] with 
the potential ET hopping pathway 
denoted by dashed lines. 
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studies produced a model wherein the excited FADH• chromophore initially oxidizes the 
proximate W382 residue; the radical then hops to the protein surface along a 
•W382+→W359→W306 pathway and the subsequently formed •W306+ radical deprotonates 
on the 300 ns timescale.80 Direct electron tunneling (superexchange) pathways from W306 to 
the excited FADH• chromophore have also been proposed.81 While interesting in its own 
right, this photochemical enzyme reactivation reaction likely has little physiological 
significance, as the necessary FADH– cofactor is stable in vivo.73 
1.3.2.3 Photosystem II 
Photosystem II (PS II) is an integral 
component of photosynthesis, the process in 
plants that uses sunlight and water to drive 
NADPH and ATP production (which are then 
used to fix CO2 in the form of carbohydrates) 
with O2 released as a byproduct.82 
Chromophores in PS II harvest light and 
generate a charge separated state that is a 
weak reductant but a powerful oxidant 
capable of oxidizing H2O to O2. Light is 
harvested by various reaction center 
chromophores (antenna chlorophylls and 
carotenoids) that are electronically coupled to 
a chlorophyl a component termed P680.83 The 
excited P680* then transfers an electron to a 
pheophytin a cofactor and ultimately to a pair 
of quinone molecules termed QA and QB, the 
latter of which diffuses into the membrane 
toward the cytochrome b6f complex. The oxidized P680+ transfers the electron-hole to the 
inorganic oxygen evolving complex (OEC) of PSII, which is responsible for water oxidation. 
Four flashes of light are required for O2 evolution, and each flash steps the OEC through a 
different redox state, S0 through S4, with the S4 to S0 transition occurring in the dark with 
 
Figure 1.12. Crystal structure of PSII 
oxidizing cofactors from ref [99]. Purple 
and green spheres represent a model for 
electron density corresponding to Mn and 
Ca, respectively, in the OEC. Orange sphere 
represents Mg and distances are in Å. 
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thermal release of O2.84- 86 Time resolved X-ray absorption spectroscopy experiments have 
recently modified and enriched this S-state cycle.87 
In 1973, a dark-stable organic radical, denoted D, was observed in PSII by EPR 
experiments.88 Later, a light induced reversible phase of this EPR signal was also identified,89 
denoted cofactor Z, and assigned to the physiological donor to P680+.90 In 1987, EPR 
experiments identified the existence of a tyrosyl radical, •YD, in PS II in dark adapted samples 
and suggested that the Z radical was also a tyrosyl radical, •YZ.91 Site directed mutagenesis 
experiments isolated the radical to Y160 on the D2 polypeptide and suggested, by the pseudo-
C2 symmetry of the complex, that the Z radical corresponded to Y161 of the D1 
polypeptide,92 which was later confirmed by mutagenesis studies of the D1 polypeptide.93 
More site directed mutagenesis studies revealed that the presence of H190 facilitated 
oxidation of YZ by P680+ by a factor of at least 200 in rate, implicating hydrogen bonding 
between these residues.94- 96 PCET was then identified as the mechanism for YZ oxidation 
with electron transfer to P680+ and proton transfer to H190.97,98 One of the more recent 
crystal structures of PS II99 is presented in Figure 1.12 and clearly illustrates the hydrogen 
bond between YZ and H190, along with the electron transfer tunneling distances along the 
P680→YZ→OEC (Mn4Ca) pathway. Thus, PS II is a clear example of bidirectional PCET in 
a biological system.9 The electron, as the lighter particle, can tunnel over much longer 
distances between the redox active cofactors, while proton tunneling is restricted to within the 
short distance provided by the H-bond between H190 and YZ. 
1.4 Class I Ribonucleotide Reductase 
Class I E. coli ribonucleotide reductase (RNR) plays a crucial role in DNA replication and 
repair by catalyzing the reduction of nucleoside diphosphates (NDPs) to deoxynucleoside 
diphosphates (dNDPs).40,100 The enzyme is composed of two homodimeric subunits 
designated α2 and β2, and a complex between the two is required for activity.101 α2 houses 
the NDP binding sites and the binding sites for the effectors that control the specificity and 
rate of nucleotide reduction.101- 103 β2 harbors a diferric tyrosyl radical (•Y122) cofactor 
proposed to initiate nucleotide reduction by oxidizing a cysteine residue (C439) in the active 
site of α2.104  
The mechanism of deoxynucleotide formation has been the subject of intense 
investigation. Biochemical studies with radio-labeled substrates and mechanism based 
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inhibitors have resulted in Scheme 1.1 as the model for this chemical transformation.40 The 
transient •C439 generated in the active site of α2 abstracts the 3′-H atom from the ribose ring 
to initiate the reaction.105 The radical then migrates to the 2′-carbon with concomitant loss of 
water; E441 serves as a base to deprotonate the 3′-hydroxyl group forming the 3′-ketone. An 
active site cysteine residue (C462/C225) then reduces the 2′-radical with an H-atom, forming 
the disulfide radical anion. At this point, a PCET event may ensue with ET from the disulfide 
radical anion and PT to the 3′-ketone from E441, thereby regenerating the 3′-carbon centered 
radical. This radical then oxidizes C439 to complete the transformation and reform the thiyl 
radical in the active site of α2. Following dNDP production, •C439 is reformed in the active 
site and the radical is transferred back to Y122 in β2; thus one β2 subunit can turnover 
multiple α2 subunits.106 Transport of the radical out of the active site of α2 prevents reaction 
of the sulfur centered th
 
Scheme 1.1. Proposed mechanism of deoxynucleotide formation in E. coli class I RNR. 
iyl radical with oxygen, which is known to generate thiol peroxyl107 
and sulfinyl radicals.108 
The crystal structures of both subunits have been solved independently,109- 111 and a 
docking model of the two proteins in a 1:1 complex has been generated based on their 
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complementary shapes and on knowledge of conserved residues.109 In this model, more than 
35 Å separates the •Y122 on β2 from C439 in α2; this long distance has recently been verified 
by PELDOR studies of the mechanistically inhibited α2:β2 complex.112 Superexchange 
electron tunneling between •Y122 and C439 based on Marcus theory (kET = 10-6 s–1 for β = 
1.2 Å–1 under activationless conditions) is too slow to account for a kcat of ~ 2 to10 s–1.15 Thus, 
the radical generation process has been proposed to occur via a hopping mechanism involving 
conserved amino acid residues •Y122→W48→Y356→Y731→Y730→C43910,109 as shown in 
Figure 1.13. Site directed mutagenesis studies confirm that these residues are required for 
activity,113- 116 however they do
 
Figure 1.13. Conserved residues of class I RNR that compose the putative 
PCET pathway for radical transport from •Y122 in β2 to C439 in the α2 
active site. Distances are from the separate crystal structures of the α2109 
and β2111 subunit from the E. coli enzyme. Residues where the radical has 
been directly observed or trapped via site-specific replacement with non-
natural amino acid analogues are highlighted in green. Y356 is not located 
in either the β2 or α2 crystal structures, hence its distance from W48 and 
Y731 is unknown. 
 not provide additional information regarding the precise 
mec
d in the α2:β2 complex for 
radical transport and subsequent active site chemistry to occur.106  
hanism of radical transport. 
Pre-steady state stopped flow experiments have been performed to probe the mechanism 
of radical transport in RNR. No changes in the •Y122 concentration could be detected upon 
mixing the α2 and β2 subunits under a variety of conditions. These data supported a model in 
which a rate-limiting physical or conformational step was require
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Using intein protein ligation methods, semi-synthetic β2 subunits were generated with 
unnatural amino acids at position 356.117- 119 In particular, a series of fluorinated tyrosine 
derivatives were generated with reduction potentials that vary from –50 mV to +270 mV 
relative to tyrosine over the accessible pH range for RNR and pKas that range from 5.6 to 9.9 
(See Chapter VI).120 The pH rate profiles of deoxynucleotide production by these FnY356-β2s 
were reported, and the results suggested that the rate-determining step in RNR activity could 
be changed from the physical step to the radical propagation step, by altering the reduction 
potential of •Y356 with these analogues. These studies supported the model that Y356 is a 
redox active amino acid on the radical propagation pathway. Furthermore, several of the 
FnY356-β2s are deprotonated at pH > 7.5 and efficiently initiate nucleotide reduction. Thus a 
proton is not obligated to the pathway between W48 and Y356 of β2 and Y731 of α2, nor is 
H-atom transfer between these residues obligatory for radical propagation.  
By incorporating 3,4-dihydroxyphenylalanine (DOPA) into position 356 in β2, the •Y122 
radical can be trapped along the radical transport pathway at •DOPA356, but only in the 
presence of α2 and RNR substrate and effector.121 Further studies revealed the presence of 
back radical transport (•DOPA356→Y122) and an analysis of these reactions led to a new 
model for radical transport in RNR that questions the symmetry of the docking model.122 
However, in all these studies catalytically competent radical intermediates have not been 
observed, preventing a detailed analysis of the PCET mechanism of radical transport along 
this conserved pathway. 
1.5 Photochemical RNR 
To address the challenge of kinetically resolving radical transport, we have developed 
photochemical RNRs: simplified RNR constructs utilizing the α2 subunit and the 19-mer C-
terminal peptide tail (R2C19) of β2 as depicted in Figure 1.14. R2C19 contains the binding 
determinant of β2 to α2123,124 and the redox active Y356 residue. Using solid-phase peptide 
synthesis, we can append a photo-oxidant proximate to Y356 (Figure 1.14, red circle) that, 
upon excitation, can produce •Y356, which can then be translated into the C439 active site of 
α2. The first experiments with this construct were performed using tryptophan as the photo-
trigger of •Y356.125 Excitation of the peptide-α2 complex in the presence of CDP substrate 
and ATP effector resulted in dCDP formation, demonstrating enzymatic activity was retained 
when the entire β2 subunit was replaced by a photoactive peptide.125 However a drawback 
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with tryptophan-based peptide constructs arose from the need for UV-light to excite 
tryptophan. Deep UV excitation profiles fall within the absorption envelope of RNR, thus 
presenting a significant problem for the direct kinetic analysis of α2-bound peptides owing to 
inner-filter optical effects and protein instability. Therefore, new photo-oxidants of tyrosine 
need to be developed. 
 
Figure 1.14. Experimental design for studying the kinetics of radical 
transport along the •Y356 → Y731 → Y730 → C439 pathway. •Y356 is 
generated photochemically by a proximal photo-oxidant (red circle) on the 
R2C19 peptide. NDP, nucleoside diphosphate substrate; dNDP, 
deoxynucleoside diphosphate product; R2C19, 19-mer C-terminal peptide 
tail of β2. 
1.6 Scope of the Thesis 
This thesis explores the mechanisms of proton-coupled electron transfer (PCET) within 
the context of amino acid radical generation, with application to radical transport in the 
ribonucleotide reductase (RNR) enzyme. Figure 1.15 summarizes the thesis organization with 
regard to the study of photochemical RNR. Chapter II describes transient absorption (TA) 
studies of photochemical amino acid radical generation and transport in dipeptides containing 
W and Y, providing insight into the mechanism of radical generation in the W-based 
photochemical RNR125 and the mechanism of radical transport in the β2 subunit of RNR. In 
Chapter III, we explore a host of other organic and inorganic photochemical oxidants for the 
production of Y•. Chapter IV describes the design, synthesis, and photophysical 
characterization of new Re(I), MLCT excited states for photochemical Y• generation. Chapter 
V explores the mechanistic complexity of the PCET of Y• generation with one of these Re(I) 
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systems, and through comparison to other Ru(II) systems in the literature, presents a general 
scheme for the PCET of Y oxidation in aqueous solution. In Chapter VI, we develop the 
redox, acid-base, and spectroscopic characterization of a series of fluorotyrosine unnatural 
amino acids and their corresponding radicals as useful probes for the study of PCET in 
biological systems that utilize Y•. In Chapter VII, we characterize photochemical RNRs 
containing benzophenone and anthraquinone chromophores, and in Chapter VIII we show that 
Y356 is not required for activity of the photochemical RNRs. Chapter IX describes extensive 
work with Re(I) based photochemical RNRs in an attempt to characterize radical 
intermediates in α2, and Chapter X presents initial synthetic work towards developing 
photochemical β2 subunits, and preliminary TA experiments with benzophenone-labeled β2 
to characterize radical transport in the full α2:β2 complex. The work in the first half of the 
thesis has general application to the study of PCET in enzymes that utilize amino acid 
radicals, while the latter half more specifically targets an understanding of the mechanism of 
radical transport in RNR. 
 
Figure 1.15. Layout of the thesis designed towards the generation and study of 
photochemical RNRs. 
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Trp as a Photochemical Radical Initiator & pH 
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2.1 Motivation 
We wish to characterize the products of W and Y UV photolysis, as it has been used as a 
radical generator in the initial experiments with photochemical RNRs. We also wish to gain 
insight into the mechanism for radical transport in the β2 subunit of class I RNR. This chapter 
describes characterization of radicals produced upon UV excitation of W-Y and N-terminal 
acetylated, Ac-W-Y, dipeptides using transient absorption spectroscopy. The pH dependence 
of the kinetics of radical transport between W and Y is also determined and provides a model 
for the mechanism of radical transport through W48 in β2. 
2.2 Background 
Radical initiated electron transfer between tryptophan and tyrosine residues in proteins has 
been extensively studied,1,2 with particular focus on lysozyme enzymes.3- 5 The observation 
of these two amino acids interacting with each other as part of a natural enzymatic electron 
transfer (ET) pathway, however, has been limited to only a few systems. A. nidulans 
photolyases possess a triad of Ws (W390, W367, and W314) through which a flavin 
generated electron hole passes to generate a tyrosine radical located at the surface of the 
protein.6 In the absence of exogenous reductants, Y• is generated in <500 ns, and reverse ET 
regenerates Y, suggesting regulated radical transport between Y and W.7,8 Y• hole transfer in 
the reverse direction is slowed in D2O, suggesting the role of a proton in mediating the ET, 
though the basis for the increase in Y• lifetime has yet to be determined. Electron transfer 
between cytochrome c and cytochrome c peroxidase modified with a K+ binding site is also 
believed to be modulated by an equilibrium between tryptophan cation and tyrosyl radicals.9 
Population of the K+ binding site shifts the equilibrium from [•WH]+ towards the Y•, which in 
turn retards the rate of cytochrome c oxidation by the Compound I intermediate of 
cytochrome c peroxidase. 
Focusing on the redox interplay between Y and W in class I RNRs, oxidized W48 is 
proposed to be a key intermediate along the PCET radical hopping pathway from •Y122 in β2 
to C439 in α2 (see Chapter I).10 This residue is positioned between Y122, the initial site of 
radical generation in β2, and Y356, the conduit for radical transport between α2 and β2.11 Site 
directed mutagenesis studies suggest that W48 is needed for the forward propagation of the 
radical into the active site.12 This implicates oxidation of W48 by •Y122 to produce a radical, 
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which in turn is proposed to oxidize Y356. Moreover, studies of the assembly of the diiron 
cofactor of β2 provide direct spectroscopic evidence for a [•W48H]+ radical13- 17and suggest 
it to be directly involved in Y122 oxidation.14 Together these studies suggest that W↔Y 
electron transfer is needed for radical propagation in RNR and that the protonation state of 
W48 may be important in controlling the direction of radical propagation. 
Tryptophan has also been used as a radical photoinitiater in turning on ribonucleotide 
reductase activity.18 In these experiments, the 20-residue, C-terminal peptide tail of β2, which 
contains the binding determinant of β2 to α219,20 and the redox active Y356 residue, was 
generated by solid phase peptide synthesis. W was appended immediately after the Y356 
residue, the peptide bound to α2, and protein-peptide complex excited with light of λ > 285 
nm in the presence of RNR substrate and effector. This construct resulted in ~20 % turnover, 
which decreased to ~2% upon omission of W from the peptide.18  
To gain insight into radical photo-generation and transport in systems containing W and 
Y, we have undertaken detailed time-resolved laser spectroscopy studies of the pH 
dependence of the rates of radical transfer between tryptophan and tyrosine in W–Y and Ac-
W–Y dipeptides. The kinetics of W•–Y → W–Y• have previously been examined in 
dipeptides using either flash photolysis or pulsed radiolysis as the radical generator. At or near 
pH 7, the reaction rate is observed to occur with a rate constant of 9 ± 5 × 104 s–1.21- 27 Studies 
of the intermolecular reaction of L-tryptophan and L-tyrosine in solution show that tyrosine 
radicals can oxidize tryptophan at pH 1.1 and possibly at 12.5, but, between these values, 
tryptophan radicals oxidize tyrosine.28 The pH dependence for radical transport through 
proline has been found to be constant between pH 6.5 and 11 and increase linearly below pH 
6.29 We now show that the directionality of radical transport in W–Y is controlled by pH and 
suggest the importance of the W protonation state on the directionality of PCET in RNRs 
2.3 Results and Discussion 
The transient absorption spectrum of laser excited (λexc = 266 nm) solutions of W–Y at pH 
7.8 is dominated by the dynamics of the decay of the 3W* excited state (λmax = 450 nm30) at 
short times (10 ns -1 μs). After 2 μs, all triplet states have decayed to the ground state or 
reacted with dissolved O2 to reveal the transient absorption spectrum shown in Figure 2.1. 
Two prominent transient signals are observed with λmax = 410 and 510 nm; these maxima 
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coincide with the maxima for Y• and W• radicals, 
respectively (ε410nm(Y•)31 = 2750 ± 200 M–1cm–1; 
ε510nm(W•)32 = 1800 ± 50 M–1cm–1). The time 
evolution of the absorption spectrum is revealed 
with single wavelength kinetics measurements. As 
shown in the inset, the W• radical decays with a rate 
constant of 8.6 × 104 s–1 and Y• appears on a 
commensurate time scale (kX• = 1.1 × 105 s–1).  
Other intra- and intermolecular radical decay 
process of Y and W were examined by measuring 
the kinetics of control peptides Ac-F–Y and W–F, 
respectively. We find that the decay processes of 
photogenerated radicals in the control dipeptides are 
slow and do not contribute significantly to transient 
signals shown in Figure 2.1. 
 The rate constants for radical transport agree 
well with the rates previously observed for W•–Y → W–Y• transfer at neutral pH.21-27 A 
similar result is obtained for Ac-W•–Y → Ac-W–Y• with a slightly attenuated rate for radical 
transfer (kX• = 1.8 × 104 s–1). Because radical transport is slower in the acetylated peptide, 
other radical decay processes become competitive for Y• decay but not W• decay as 
determined from the control peptides. For this reason, the kinetics of the Ac-W•–Y → Ac-W–
Y• reaction (over all pH ranges) were determined from monitoring the 510-nm transient 
signal corresponding to the W•. In the case of the native W–Y dipeptide, the N-terminus is 
protonated and thus electron transport occurs across a favorable dipole. Ab initio calculations 
show that the removal of the positive charge at the N-terminus of dipeptides significantly 
reduces the dipole moment33; we therefore expect the electron transfer rate to be reduced, as 
observed, in the Ac-W–Y peptide. These observations are consistent with electron transfer in 
model peptides, which have been shown to exhibit enhanced rates for charge transfer when 
the direction of electron movement coincides favorably with the peptide dipole.34,35 
 
Figure 2.1. Transient absorption 
spectrum following 266-nm laser 
excitation (fwhm = 3 ns) of W–Y solution 
at pH 7.8 at 2 (▬) and 20 (▬) μs. 
Insets: Single wavelength kinetics traces 
for the appearance of the 410 nm (Y•) 
signal and the disappearance of the 510 
nm (W•) signal.
The overall profile of the transient absorption spectrum and the kinetics for radical 
transport are maintained over a pH range of 6 to 10. Below pH 6, the transient signal for 
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tryptophan radical red-shifts from 510 nm to 560 
nm as shown in Figure 2.2. At pH 3.1, the transient 
absorption spectrum is dominated by the 560-nm 
feature, which is consistent with the production of a 
protonated tryptophan radical, [•WH]+ (ε560nm = 
3000 ± 150 M–1 cm–1, pKa = 4.3) 36. At intermediate 
pH, a signal is observed with a maximum that lies 
between the 510 and 560 nm signals for W• and 
[•WH]+, respectively. The transient signal at pH = 
4.3 = pKa ([•WH]+) is shown in Figure 2.2 and is 
the superposition of nearly 1:1 contributions of the 
[•WH]+ and W• transient signals.  
The rate for radical transport from W to Y in 
both W–Y and Ac-W–Y steadily increases as the 
pH is lowered from 6 to 2. However, below pH ~4, the radical transport in W–Y becomes fast 
enough to be convoluted and masked by the decay of 3W*. Owing to the slower radical 
transport in Ac–W–Y (vide supra), rate constants could be measured to pH ~2.  At pH 2.35, 
Ac–[•WH]+–Y → Ac–W–Y• proceeds with rate constant of 1.5 × 105 s–1 as measured by the 
disappearance of the 560 nm component. For the control W–F peptide, the W decay is 
invariant with pH and slow with respect to this time scale. Thus specious radical decays do 
not interfere with these measurements. The observed steady increase in the rate of radical 
transport from W to Y with decreasing pH is consistent with similar previous studies in the 
Trp–Pro–Tyr peptide probed by pulse radiolysis.29 
 
Figure 2.2. Transient absorption 
spectrum 2 μs after 266-nm laser 
excitation (fwhm = 3 ns) of Ac–W–Y 
solution at pH: 7.2 (▬), 4.3 (▬) and 
3.1 (▬). 
At the other end of the pH scale, the radical transport rate constant decreases over the 
range 10 < pH < 11.6 for W–Y and 10 < pH < 12.2 for Ac-W–Y. The rate for radical transport 
becomes sufficiently slow that other first and second order radical decay processes, as 
measured for the control peptides, prevent extraction of an electron rate constant from the 
decay trace of the 510-nm transient. A further increase in pH beyond 12 is accompanied by 
opposite behavior in the time evolution of the transient absorption spectrum of W–Y. Namely, 
the 510-nm transient signal of W• appears with the concomitant disappearance of the 410 nm 
signal of Y•, indicating the reverse reaction, W–Y• → W•–Y–, where Y– represents the 
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deprotonated tyrosinate anion. The 
rate constant for this reverse reaction 
is kX•rev = 1.2 × 105 s–1.  
Figure 2.3 summarizes the pH 
dependence of the rates of the radical 
transport reactions of W–Y and Ac-
W–Y. For both peptides, radical 
transport from W to Y is preferred 
for pH = 6- 10 and the rate constant 
for the reaction is invariant over this 
pH range. At the endpoints of the pH 
plateau, the rate constant 
monotonically increases as the pH is 
lowered below 6 and decreases as 
the pH is raised above 10.  For pH > 
12, the reaction reverses and radical transport from Y to W is favored. This reversal of radical 
transport in W–Y dipeptides has escaped detection by laser photolysis and only been observed 
previously by pulse radiolysis at pH 13.28 
 
Figure 2.3. Rates of radical transport vs. pH for 
dipeptides: W•/[•WH]+–Y → W–Y• (○); Ac-W•/[Ac-
•WH]+–Y → Ac-W–Y• (□); and W–Y• → W•–Y– (●). 
The solid line is the ∆E = Ep(W•/W) – Ep(Y•/Y), 
calculated from the differential pulse voltammetry 
measurements shown in Figure 2.4. 
Insight into the rates and direction of radical transport between W and Y dipeptides is 
provided by analysis of the W•/W and Y•/Y reduction potentials. The solid line in Figure 2.3 
is the difference in these reduction potentials, ΔE = Ep(W•/W) – Ep(Y•/Y), as calculated from 
the differential pulse voltammetry measurements of Tommos et al that are summarized in 
Figure 2.3.37 For pH > 6, the rate constants are approximated well by the driving force 
dependence of the radical transport. We ascribe the invariance of the rate constant for pH = 6 
- 10 to the constant value of ΔE over this pH range. For pH > 10, the hydroxyl group of Y is 
deprotonated and Ep(Y•/Y) becomes constant with pH whereas Ep(W•/W) continues to 
decrease monotonically (see Figure 2.4). The confluence of these two trends causes the 
driving force for radical transfer between W• and Y to decrease in this pH range. The rate 
constant for radical transfer is expected to reflect this decrease until Ep(Y•/Y) = Ep(W•/W) at 
pH 10.9; this is observed in Figure 2.3. For pHs > 10.9, the direction of radical transport 
reverses, as oxidation of W by Y• is preferred. 
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A perplexing increase in rate is observed 
for pH = 2 - 6. Over this pH range, protonation 
of W• to produce [•WH]+ is favorable and the 
reduction potential accordingly becomes pH 
independent (see Figure 2.4). The increased 
oxidizing power of the [•WH]+ radical, 
however, is offset by the increased difficulty in 
oxidizing Y, leading to a mild reduction in the 
driving force over this pH range. On this basis, 
the rate for Y oxidation by W•/[•WH]+ should 
slowly decrease, but this expectation is not 
met. The rate of Y oxidation increases with 
decreasing pH to pH = 2. We ascribe the rate 
enhancement in part to the further augmentation of the peptide dipole upon protonation of the 
tryptophan residue. The convergence of the Y•/Y and [•WH]+/W reduction potentials at pH 
2.8 causes the driving force for radical transport to decrease to the point that the reaction 
becomes thermoneutral. A further decrease in the pH should shift the energetics to favor the 
W–Y• → W•–Y reaction. Indeed, radical transport from Y to W in at very acidic pH (=1) has 
been observed for the intermolecular reaction between W and Y in pulse radiolysis 
experiments.28 
  
Figure 2.4. Ep(W•/W) and Ep(Y•/Y) 
reduction potentials vs. pH as measured by 
differential pulse voltammetry37 of aqueous 
solutions of Ac-W–NH2 and Ac-Y–NH2.  
2.4 Conclusions 
The results reported herein reveal that W• can be effectively generated upon UV 
photolysis and that W• is capable of oxidizing Y under physiological pH. Thus W• generated 
in the W-based photochemical RNR18 is capable of oxidizing Y356 on the peptide or Y731 in 
α2. The data also have mechanistic implications in the radical-induced cofactor assembly and 
nucleotide reduction processes of RNR. Figure 2.5 shows the diiron cofactor and selected 
amino acid residues that comprise the beginning of the 35 Å radical transport pathway that 
spans β2 and α2 subunits of class I RNRs. The figure highlights the location of W48 between 
Y122 and Y356 and the proximity of W48 to D237.  
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The potential importance of W48 
and [•W48H]+ was first noted by 
Nordlund and Eklund39,40 who proposed 
that the Fe1→H118→D237→W48 
pathway in β2 could be mechanistically 
important in cofactor assembly and 
nucleotide reduction, based on the 
structurally analogous and 
spectroscopically well-characterized 
Fe(heme)→ H→ D→ W ET pathway in 
cytochrome c peroxidase. Subsequent 
studies have suggested that the PCET 
pathway in the assembly process is 
shared with part of the ET pathway in 
the nucleotide reduction process.10 
Additionally, radical initiation at C439 
is thought to occur reversibly between the two subunits on every enzymatic turnover.41 The 
studies reported herein show that the protonation state of W48 can control the rate and 
direction of radical transport by modulating the Y122→W48→Y356 interactions. D237 
provides a site to establish PCET by coupling electron transfer along the radical transport 
pathway to proton transfer to or from W48. As has been recently noted,42 a conserved residue, 
R236, may also influence local pKa by interacting directly with D237 or other redox active 
residues along the pathway. 
 
Figure 2.5. The Y122↔W48↔Y356 pathway of 
β2 proposed to be important for the assembly of 
the diiron cofactor and radical transport leading 
to nucleotide reduction. The radical transfer 
pathway and distances are from the crystal 
structure of oxidized β2 at 1.4-Å resolution.38 The 
last 35 amino acids of the C-terminal tail of β2, in 
which Y356 resides, are thermally labile and 
undetectable in available crystal structures. 
By implicating D237 in radical transport, a PCET pathway is constructed whereby proton 
transfer is orthogonal to the electron transfer pathway. Modulation of electron transport by a 
proton along an orthogonal path appears to be an emerging trend in the PCET events of 
biology. As described in Chapter I, YZ (Y161) in Photosystem II (PSII) is the linchpin that 
manages electron and proton flow in the conversion of the primary light absorption event at 
the P680 chlorophylls into the multielectron activation of water at the oxygen-evolving 
complex (OEC).43,44 Histidine H190 positioned off of the ET pathway, provides a base 
function that is essential for effective oxidation of YZ by P680+. The neutral radical, •YZ, 
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which forms is the primary oxidant that steps the tetranuclear manganese cluster through each 
of the four S states of the Kok cycle.45,46 In RNR, PCET involves tyrosyl radicals produced 
from orthogonal proton and electron pathways; but unlike PS II the tyrosyl radical 
participation is not direct. Instead, W48 sandwiched between tyrosines provides the necessary 
coupling between the proton and electron. By enforcing the appropriate pKa on W48, the 
protein can control the direction of radical transport among tyrosines, which are proposed to 
be involved in radical initiation of nucleotide reduction and di-iron tyrosyl radical assembly.  
2.5 Experimental Section 
Materials. L-Tryptophanyl-tyrosine (W–Y), L-tryptophanyl-phenylalanine (W–F) 
(Sigma), N-α-acetyl-L-tryptophan (Ac-Trp-OH), N-α-acetyl-L-phenylalanine (Ac-F-OH), L-
tyrosine tert-butyl ester (H-Tyr-O-t-Bu), 1-Hydroxybenzotriazole (HOBt) (NovaBiochem), 1-
(3-Dimethylamino-propyl)-3-ethylcarbodiimide hydrochloride (WSC·HCl), and N-
methylmorpholine (NMM) (Aldrich) and trifluoroacetic acid (TFA, 99.9%) (J. T. Baker) were 
used as received.  
N-α-Acetyl-L-tryptophanyl-L-tyrosine (Ac-W–Y). Ac-Trp-OH (301 mg, 1.22 mmol, 
1.0 eq), H-Tyr-OtBu ( 290 mg, 1.22 mmol, 1.0 eq), WSC·HCl (258 mg, 1.34 mmol, 1.1 eq), 
HOBt (182 mg, 1.34 mmol, 1.1 eq) and NMM (550 μL, 4.88 mmol, 4.0 eq) were combined in 
a round bottom flask with 100 mL of chloroform and stirred overnight. The reaction solution 
was extracted in a separatory funnel with 2 × 50 mL 10 % citric acid, 1.0 M sodium 
bicarbonate, and water. The organic layer was dried over magnesium sulfate and the solvent 
removed in vacuo to yield a clear oil. The oil was dissolved in a minimal amount of ethyl 
acetate, loaded onto a chromatotron plate (silica gel, 2mm), and eluted with ethyl acetate. 
Three bands were observed under a UV lamp (254 nm). The first band to elute was collected 
and the solvent removed in vacuo to yield a clear oil. The oil was dissolved in 1% 
MeOH/10%TFA/CH2Cl2 (100 mL) and stirred for one hour during which time the solution 
turned pink. Solvent was removed in vacuo resulting in a tan oil that was placed under high 
vacuum overnight. It was then dissolved in a minimal amount of ethyl acetate and loaded onto 
another chromatotron plate (silica gel, 2 mm). The plate was allowed to dry to remove the 
ethyl acetate and was then eluted with 5 - 6% MeOH/CH2Cl2 (1% acetic acid). The most 
intense band was collected and solvent removed under high vacuum. The tan oil was 
dissolved in 150 mL ethyl acetate, washed with 2 × 75 mL water to remove any remaining 
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acetic acid, dried over MgSO4, and the solvent removed in vacuo to yield a tan oil that 
solidified over a few days (205 mg, 0.500 mmol, 41 %). 1H NMR (300 MHz, CD3OD, 25 oC) 
δ = 7.93 (d, 1H, N-H), 7.57 (d, 1H, indole-H), 7.30 (d, 1H, ind-H), 7.15 - 6.61 (m, 7H, ind-H 
and phenol-H), 4.67 (m, 1H, W-CH), 4.56 (m, 1H, Y-CH), 3.28 - 2.80 (m, 4H, W-CH2 and Y-
CH2), 1.86 (s, 3H, Ac-CH3). Anal. Calcd for C22H23N3O5: C, 64.54; H, 5.66; N, 10.26. Found: 
C, 64.47; H, 5.71; N, 10.15. 
N-α-Acetyl-L-phenylalanyl-L-tyrosine.   Ac-Phe-OH (291 mg, 1.40 mmol, 1.0 eq), H-
Y-O-t-Bu (333 mg, 1.40 mmol, 1.0eq), WSC·HCl (296 mg, 1.54 mmol, 1.1 eq), HOBt (208 
mg, 1.54 mmol, 1.0 eq) and NMM (631 μL, 5.60 mmol, 4.0 eq) were dissolved in chloroform 
(125 mL) and stirred overnight in a round bottom flask. The reaction solution was extracted in 
a separatory funnel with 2 × 50 mL 10 % citric acid, 1.0 M sodium bicarbonate, and water. 
The organic layer was dried over magnesium sulfate and the solvent removed under rotary 
evaporation to yield a clear oil that eluted as one spot by TLC (Si gel, ethyl acetate).  The oil 
was dissolved in 1% MeOH / 10 % TFA / CH2Cl2 (100 mL) and stirred for one hour.  The 
solvents were removed in vacuo and the remaining residue was placed under high vacuum 
overnight to yield a clear oil which crystallized from ethyl acetate as a white solid (450 mg, 
1.26 mmol, 90 %).  1H NMR (300 MHz, CD3OD, 25 oC) δ = 8.08 (d, 1H, N-H), 7.21 (m, 5H, 
F-C6H5), 7.02 (m, 2H, Phenol-H), 6.67 (m, 2H, Phenol-H), 4.58 (m, 2H, F-CH and Y-CH), 
3.16-2.71 (m, 4H, F-CH2 and F-CH2), 1.84 (s, 3H, Ac-CH3).  Anal. Calcd for C19H20N2O5: C, 
64.04; H, 5.66; N, 7.86. Found: C, 64.15; H, 5.61; N, 7.76. 
Physical Measurements. 1H NMR spectra were recorded on a Varian 300 MHz NMR at 
the MIT Department of Chemistry Instrumentation Facility (DCIF). UV-vis absorption 
spectra were recorded on a Cary 17D spectrophotometer. Pump light for transient absorption 
(TA) measurements was provided by an Infinity Nd:YAG laser (Coherent) running at 20 Hz. 
The set-up of the instrument was slightly modified from that previously described.47 The 
second harmonic was frequency doubled with an XPO-UV frequency doubling crystal 
(Coherent) to produce a 266 nm laser pulse with beam diameter of 4 mm, 2.5 ns pulse width, 
and pulse energy of ~500 μJ. A 75-W Xe arc lamp (unpulsed, PTI) provided the probe light. 
For photochemical measurements, a sample ground state absorbance of 1 at 266 nm in a 1 cm 
cuvette (~0.3 mM) was used in order to maximize signal and minimize first and second order 
radical reactions. Aqueous samples were prepared in deionized water with 10 mM phosphate, 
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pH adjusted with 1 M NaOH or 1 M HCl, and flowed through a 1-cm cell with continual 
oxygen bubbling. 
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3.1 Motivation 
To study the light initiated, amino acid radical hopping in the photochemical RNRs 
described in Chapter I, photo-oxidants that absorb light of wavelengths outside of the protein 
absorption envelope (λ > 290 nm) need to be synthetically incorporated into peptides and 
their competence for photochemical tyrosine oxidation demonstrated. The excited states of 
these oxidants should react with tyrosine rapidly (ideally sub-nanosecond) to avoid 
convolution of the initial, •Y356-forming step with radical hopping into R1. The •Y356-
reduced-oxidant charge separated state should also persist for long times (μs to ms) to allow 
for charge injection from •Y356 on the peptide into R1 to occur. Finally, the reduced oxidant 
needs to be spectrally distinguished from •Y356 to allow for spectroscopic characterization of 
the radical formation and propagation steps. Two basic types of photo-oxidants have been 
explored: (1) organic and inorganic compounds known to undergo electron transfer reactions 
from their excited states, and (2) organic photo-oxidants that are capable of accepting both an 
electron and a proton in their excited state. This chapter describes the synthesis and 
photophysical characterization of these excited state oxidants covalently appended to tyrosine 
in model systems designed for photochemical tyrosine radical generation. 
3.2 Ru(bpy)32+  
3.2.1 Background 
Metal-to-ligand charge transfer (MLCT) excited states of metal complexes can be used to 
initiate biological redox processes using visible light.1 The MLCT excited state of RuII 
bipyridyl (bpy) and its derivatives have been especially useful for redox processes involving 
metallo-cofactors.2 The excited state reduction and oxidation potentials for Ru(bpy)32+ are 
modest: E°(RuII*/I) = 1.1 V and E°(RuII*/III) = 0.7 V vs. NHE. Therefore, application of the 
RuII polypyridyl MLCT excited states is best-suited for the study of ET reactions involving 
metal containing cofactors with mild reduction potentials such as hemes,3 iron-sulfur 
clusters,4 and blue copper proteins.5 Extension of this methodology to oxidation of protein 
derived organic cofactors, such as amino acids, is more difficult; for example the MLCT 
excited state of Ru(bpy)32+ is not kinetically capable of direct tyrosine oxidation at neutral 
pH.6  The utility of the RuII polypyridyl MLCT excited state may be expanded when 
implemented as part of the flash quench method.7,8 With this technique, the more powerfully 
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reducing RuI or oxidizing RuIII centers are photogenerated by bimolecularly quenching the 
MLCT excited state with an external reductant or oxidant, respectively. The RuI or RuIII 
complex persists with sufficient lifetime, owing to a slow bimolecular back-reaction or 
irreversible quenching step, to enable it to initiate a subsequent redox process on timescales 
longer than that for the decay of the corresponding MLCT excited state. Owing to the greater 
oxidizing and reducing power of the flash-quenched products, as compared to that of the RuII 
MLCT excited state, redox processes of non-metal based cofactors may be initiated. The 
approach has been extended to amino acid radicals by Hammarström and co-workers6 who, 
using the flash-quench generated RuIII(bpy)33+, observed oxidation of a tyrosine residue 
covalently bound to one of the bpy ligands. The overall reaction is depicted in the reaction 
Scheme below.  
RuII(bpy)2(bpy–Y)2+
hν 3[RuIII(bpy)2(bpy•––Y)2+]*MLCT Ru
III(bpy)2(bpy–Y)2+
Ox Red
RuIII(bpy)2(bpy–Y)2+ RuII(bpy)2(bpy–Y•)2+
kPCET
(1)
(2)
 
The rate of charge transport, kPCET, is 5 × 104 s–1 at neutral pH and tyrosyl radical formation 
occurs by a PCET mechanism with proton loss to bulk solvent (see Chapter V for a detailed 
discussion of the PCET mechanism of Y oxidation in this system).9 The rate of tyrosine 
oxidation in this system relatively slow, owing to the PCET nature of the reaction and the 
significant driving force required for Y oxidation (E°(Y–OH•+/Y–OH) = 1.35 V vs. NHE10). 
Application of this system to PCET studies with RNR would likely be inhibited by 
convolution of the initial rate of radical formation with the rate of radical hopping into R1. 
Radical generation can be accelerated by increasing the oxidizing strength of the flash-
quenched, RuIII, product. When two of the bipyridine ligands are substituted with ethyl esters 
(2,2’-bipyridine-4,4´-diethyl ester), the RuIII/II reduction potential is increased by 0.24 mV, 
thereby increasing the driving force for tyrosine oxidation upon flash quench generation of the 
RuIII intermediate.11 This increase in driving force results in an increase in the rate for 
intramolecular tyrosine oxidation to 5 × 105 s–1 at pH 7, corresponding to a 2 μs lifetime for 
radical generation.11 To make this system amenable for application to PCET studies in RNR, 
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we decided to further increase the electron-withdrawing nature of the bipyridine ligands using 
the 4,4′-bis(trifluoromethyl)-2,2′-bipyridine (BTFMB) ligand in hopes that a more strongly 
oxidizing RuIII flash-quenched product would expedite tyrosine oxidation. 
3.2.2 Results and Discussion 
The [Ru(BTFMB)2(bpy-(Y/F))](PF6)2 complexes could be synthesized from the 
Ru(BTFMB)2Cl2 starting material by coordination of bpy-COOH, followed by coupling of the 
appropriate tert-butyl protected amino acid to the free carboxylic acid of the bpy ligand. 
Deprotection of the tert-butyl group in TFA affords the free carboxylic acid compound which 
is soluble in water.   
Figure 3.1 plots the cyclic voltammograms obtained for the Ru(bpy)2(bpy-COOH)(PF6)2 
and Ru(BTFMB)2(bpy-COOH)(PF6)2 compounds. Standard reduction potentials (E°) were 
obtained from the half-wave potential values (E1/2)13 and are listed in Table 3.1, along with 
the corresponding values for the amino acid conjugated Ru(BTFMB)2(bpy-F)(PF6)2 complex. 
Each reduction or oxidation wave was either reversible or quasi-reversible under the 
conditions used with anodic and cathodic peak currents separated by less than 100 mV. 
Oxidation of the RuII complex occurs upon scanning to positive potentials (Figure 3.1, left 
panel). The electron is removed from the highest occupied molecular orbital (HOMO), which 
is mainly comprised of metal-centered d-orbitals.14 Substitution of bpy at the 4,4′ positions 
 
Figure 3.1. Cyclic voltammograms of (▬) Ru(bpy)2(bpy–COOH)(PF6)2 and (▬) 
Ru(BTFMB)2(bpy–COOH)(PF6)2 in MeCN with 0.1 M tetrabutylammonium 
hexafluorophosphate supporting electrolyte. The scan rate was 100 mV/s and the 
potentials are referenced to the Fc+/Fc couple (0.65 V vs. NHE).12 The red 
voltammogram in the right panel was shifted to positive current values for illustration. 
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Table 3.1. Electrochemical Reduction and Oxidation Potentials of Ru Complexes.a
Complexes E°(RuI I / I) E°(RuI / 0) E°(Ru0/–1) Eo(RuI I I / II)  
Ru(bpy)2(bpy-COOH)(PF6)2 -1.75 -1.96 -2.24 0.89 
Ru(BTFMB)2(bpy-COOH)(PF6)2 -1.28 -1.49 -2.07 1.17 
Ru(BTFMB)2(bpy-F)(PF6)2 -1.29 -1.47 -1.91 1.17 
aReported in V vs. Fc+/Fc with 0.1 M (Bu4N)PF6 supporting electrolyte in CH3CN.  
with trifluoromethyl groups results in a 280 mV increase in the RuIII/II redox couple, reflecting 
the electron-withdrawing nature of the BTFMB ligands. Three reduction events are observed 
upon scanning to negative potentials (Figure 3.1, right panel), and these events are assigned to 
the RuII/I, RuI/0, and Ru0/–1 redox couples. Reduction occurs primarily to orbitals of π*-
symmetry centered on the bpy ligands.14 The 
RuII/I and RuI/0 couples increase by 470 mV 
upon bpy fluorination, while the Ru0/–1 
exhibits a more moderate increase (170 mV). 
Importantly, the RuIII/II couple is unaffected 
by coupling of F to bpy-COOH, thereby 
showing that we have effectively increased 
the driving force for tyrosine oxidation in the 
flash quench generated RuIII(BTFMB)2(bpy-
Y)3+ compared to RuIII(bpy)2(bpy-Y)3+.  
Figure 3.2 shows the absorption and 
emission spectra of the [Ru(BTFMB)2(bpy-
F)](PF6)2 control complex in 20 mM Tris 
buffer at pH 7.5. The absorption spectrum exhibits several broad, overlapping peaks from 
400-500 nm corresponding to the MLCT transitions and a sharp, intense transition with λmax = 
295 nm corresponding to the π → π* transitions  of the bipyridine ligands. The emission band 
is broad and featureless with λmax = 655 nm, typical of room temperature 3MLCT emission. 
The emission band was fit with a standard Franck-Condon analysis15- 17 to yield the energy of 
 
Figure 3.2. Absorption and emission spectra 
of Ru(BTFMB)2(bpy-F)(PF6)2 in 20 mM Tris 
buffer at pH 7.5 
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the 3MLCT excited state (ΔG°MLCT) as 2.1 eV. 
The room temperature emission lifetimes of the 
Ru(BTFMB)2(bpy-(F/Y))2+ complexes were also 
measured under the same conditions yielding 
values of 424 ns and 410 ns for the F and Y-
containing complexes, respectively.  These 
values are virtually identical, within 5% 
experimental uncertainty; therefore tyrosine does 
not substantially quench the 3MLCT excited 
state directly under these conditions. 
A sacrificial oxidant is required in solution 
for bimolecular oxidation of the 3MLCT excited 
state to form the RuIII intermediate in the flash 
quench reaction. [RuIII(NH3)6]Cl3 was chosen as the bimolecular oxidant due to its relatively 
high reduction potential (0.214 V vs. NHE)18 and its prevalence in the flash quench literature. 
Figure 3.3 plots the emission quenching rate, kq, versus the concentration of the 
[RuIII(NH3)6]Cl3 quencher in solution for both Ru(bpy)2(bpy-(Y))2+ and Ru(BTFMB)2(bpy-
(Y))2+ complexes. The slope of the linear fits to these data provides the bimolecular 
quenching rate constants. The rate constant for [RuIII(NH3)6]Cl3 quenching of the 
3[Ru(bpy)2(bpy-(Y))2+]* excited state (1.5 × 109 M–1s—1) is a factor of 22 larger than for the 
3[Ru(BTFMB)2(bpy-(Y))2+]* excited state (6.8 × 107 M–1s–1). Since both complexes have 
similar excited state lifetimes under these conditions, we obtain 22 times more RuIII flash 
quenched product per laser flash with the bpy complex vs. the BTFMB complex.  The slow 
bimolecular quenching rate for the BTFMB complex necessitates using high concentrations of 
the RuIII(NH3)63+ quencher for an appreciable yield of the RuIII(bpy-Y)3+ flash quenched 
product.  
 
Figure 3.3. Plot of kq vs. concentration of 
[RuIII(NH3)6]Cl3 quencher with linear fit 
for Ru(bpy)2(bpy-(Y))2+ (●,▬) and 
Ru(BTFMB)2 (bpy-(Y))2+ (○,▬) in 20 mM 
Tris buffer at pH 7.5 in the presence of air. 
We undertook transient absorption (TA) studies to characterize any tyrosine oxidation in 
the RuIII(BTFMB)2(bpy-Y)3+ complex. Figure 3.4 (left) plots the TA spectra obtained upon 
photolysis of a solution of the Ru(BTFMB)2(bpy-F)2+ control complex in the presence of 50 
mM RuIII(NH3)63+ quencher at  115 ns, 1 and  10 μs after the laser flash. The spectrum at 115 
ns contains a strong peak with λmas = 375 nm and a broad ground state absorbance bleach with 
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Figure 3.4. (Left) TA spectra of a solution of Ru(BTFMB)2(bpy-F)2+ obtained (▬) 115 ns, 
(▬) 1 and (▬) 10 μs after the laser flash. The * denotes scatter from the 355 nm laser. 
(Left Inset) Blow-up of the spectrum at 1 μs corresponding to the RuIII(bpy-F)3+  flash 
quench product. (Right) TA spectra of a solution of Ru(BTFMB)2(bpy-Y)2+ obtained (▬) 
115, (▬) 500 ns, (▬) 1, and (▬) 10 μs after the laser flash. (Right Inset) Blow-up of the 
spectrum at 1 μs showing the Y• product. Spectra obtained in 20 mM Tris buffer at pH 7.5 
in the presence of 50 mM RuIII(NH3)63+ quencher. 
λmax ~ 465 nm. This spectrum corresponds to the unquenched 3MLCT excited state of the 
RuII(bpy-F)2+ complex which has a lifetime of 140 ns from time resolved emission studies. By 
1 μs, the peak at 375 nm has decayed, leaving a spectrum with only the ground state 
absorbance bleach (expanded in the left inset of Figure 3.4). This spectrum can been 
attributed to the RuIII(bpy-F)3+ flash quench product. At 10 μs, we observe a spectrum with a 
broad absorbance at λmas ~ 463 nm and bleach at 540 nm. We attribute this spectrum at long 
times to a product of photo-induced ligand exchange reactions of the 50 mM RuIII(NH3)63+ 
quencher. 
Figure 3.4 (right) plots the TA spectra obtained after photolysis of a solution of the 
Ru(BTFMB)2(bpy-Y)2+ complex in the presence of 50 mM RuIII(NH3)63+ quencher at 115, 
500 ns, 1 and  10 μs after the laser flash. The spectrum at 115 ns again resembles the 
unquenched 3MLCT excited. Some of the unquenched 3MLCT absorbance remains in the 
spectrum recorded at 500 ns, however a new feature appears with λmax = 410 nm. By 1 μs, all 
of the 3MLCT has decayed and only the feature at 410 nm remains, shown in the blow-up in 
the right inset of Figure 3.4.  We attribute this feature to Y• (ε410 = 2750 ± 200. M–1cm–1),19 
which is the result of tyrosine oxidation by the flash quench RuIII(bpy-Y)3+ intermediate. 
Unfortunately, the kinetics of Y• formation (and RuIII(bpy-Y) decay) are masked by the decay 
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of the unquenched 3MLCT excited state.  However, we note that in none of the spectra is the 
RuIII(bpy-Y) intermediate clearly visible (the bleach at 463 nm is always accompanied by the 
absorbance at 375 nm, corresponding to the unquenched 3MLCT state). Therefore, tyrosine 
oxidation must occur concomitant with or faster than the decay of the 3MLCT state (τ = 140 
ns). 
Ineffective quenching of the RuII excited state by RuIII(NH3)63+ masks the kinetics of Y• 
formation due to the dynamics of the unquenched excited state and ultimately results in a 
reduced quantum yield of Y• production. The low quantum yield of the RuIII(BTFMB)2(bpy-
(Y))3+ flash quenched product arises from the lower driving force for electron transfer from 
the excited state to the quencher, due to the higher RuIII/II reduction potential for the BTFMB 
ligated complex vs. bpy. This presents an inherent downfall to this approach, as it is this 
higher RuIII/II reduction potential that we initially sought for increased driving force for Y 
oxidation. In an effort to circumvent this problem, we searched for other quenchers that could 
more effectively oxidize the 3MLCT excited state. These oxidants should be transparent 
between 355-420 nm to prevent absorption of the probe light by quencher in the region for 
tyrosyl radical detection. The quenchers we did investigate included methyl viologen, 
CoIII(NH3)63+, RuIII(tris-ethylenediamine)33+, RuIII(EDTA)Cl,  and decamethylferrocinium 
tetrafluoroborate. In all cases, the quenching was either less effective than for 
[RuIII(NH3)6]Cl3, or the RuIII(bpy-F)3+ flash quench product was not observed following decay 
of the quenched excited state owing to fast back electron transfer. Tropylium tetrafluoroborate 
proved an effective irreversible quencher, however the reduced product (presumably ditropyl, 
C14H14) precipitated from the solution hampering data acquisition in the absence of a flow 
cell. 
3.3 Pyrene 
3.3.1 Background 
Pyrene, Py, is a highly fluorescent, blue emitting organic chromophore that exhibits 
marked vibronic spectral structure, which is sensitive to the polarity of the environment.20 As 
such it has found application as a fluorescent probe in biological media and as a dynamic 
probe of protein interactions and conformations. In addition, the emissive ππ* singlet excited 
state of pyrene is a powerful one-electron oxidant and reductant. Of relevance to light initiated 
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amino acid radical generation, this 1ππ* excited state was found to oxidize indole 
bimolecularly in solution21 and was used as an oxidant of tryptophan, forming the [WH•]+ 
radical cation and the Py•– radical anion, for the study of electron transfer in peptides.22-  24 
Additional reactivity can be achieved via the flash quench method, in which the singlet 
excited state of pyrene is irreversibly quenched by a sacrificial oxidant in solution forming the 
Py•+ radical cation. This procedure has been used to study the oxidation of Y25 and W25- 27 in 
peptides.  
The ground state of pyrene exhibits a large absorption cross section to the red of the 
protein absorption envelope (εmax ~30,000 M–1cm–1) and the absorption spectra of both the 
radical cation and radical anion28 do not significantly overlap that of Y•. Given these 
characteristics and the previously observed photochemistry with amino acid radical 
generation, we therefore thought that pyrene would be a prime candidate for initiating and 
probing the radical hopping chemistry in RNR upon excitation with light. The synthesis and 
photophysical characterization of pyrene incorporated into “dipeptides” with alanine and 
tyrosine are now described.  
3.3.2 Results and Discussion 
Pyrene was incorporated into 
dipeptides, Py-A and Py-Y, by coupling 
the commercially available 1-
pyrenecarboxylic acid with the tert-butyl 
protected amino acids (alanine and 
tyrosine), followed by deprotection of the 
protecting group with TFA to afford the 
free carboxylic acid.  Figure 3.5 plots the 
ground state absorption spectrum of Py-A 
in 10 mM KPi buffer at pH 7.5. As 
previously observed for other pyrene 
derivatives,20,29 the absorption spectrum of 
Py-A exhibits three bands with ε(375 nm) 
= 1600 M–1s–1,  ε(340 nm) = 29,000 M–1s–
 
Figure 3.5. Plot of the absorption and emission 
spectra of Py-A and emission spectrum of Py-Y. 
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1, and ε(275 nm) = 35,000 M–1s–1 corresponding to excitation to the first, second, and third 
excited singlet state, respectively, with the second and third bands exhibiting marked vibronic 
fine structure. The first band has a low extinction coefficient because the corresponding 
transition is symmetry forbidden.20  
Pyrene fluorescence typically occurs from the lowest excited singlet state.20 Figure 3.5 
plots the emission spectra of Py-A and Py-Y in 10 mM KPi buffer at pH 7.5. The spectra of 
both the Y and A derivatives are similar, exhibiting vibronic fine structure with λmax = 384 
and 398 nm.  However, the fluorescence of Py-Y (ΦFl = 0.097) is 87% quenched compared to 
that of the A derivative (ΦFl = 0.73).  The lifetimes of the Py-A and Py-Y derivatives were 
measured as 24.7 + 0.5 and 3.4 + 0.1 ns, respectively, confirming that the pyrene singlet 
excited state is 87% quenched when appended to tyrosine and revealing the dynamic nature of 
this emission quenching.  
We next measured the excited state reduction and oxidation potential of the pyrene 
chromophore in the “dipeptide” for thermodynamic considerations of the mechanism of 
pyrene fluorescence quenching in the Py-Y system. Table 3.2 presents the ground state 
reduction potentials for the Py•+/Py and Py/Py•– redox couples in the Py-A control compound. 
Both pyrene reduction and oxidation events occur as irreversible waves in cyclic 
voltammetry, CV, experiments with 100 mV/s scan rate; the peak potential for these events 
was more accurately measured using differential pulse voltammetry, DPV. The potentials 
match closely those previously observed for the quasi-reversible Py•+/Py and Py/Py•– redox 
couples measured for 1-pyrenebutanoic acid ethyl ester using CV at higher scan rates.30 Table 
3.2 also presents the measured singlet excited state energy, E00(1Py*), and the calculated 
excited state reduction and oxidation potentials. These data confirm that 1Py* is both a 
powerful one electron reductant and oxidant, owing primarily to the high energy of the singlet 
excited state.  
Experiments with nanosecond transient absorption spectroscopy were carried out to 
characterize the nature of the emission quenching in Py-Y. We first wished to characterize the 
absorption spectra of the pyrene excited states and radical anions with our TA setup. Figure 
3.6 plots the TA spectra obtained after flashing a solution of Py-A in 10 mM KPi buffer at pH 
7.5.  The black spectrum was obtained 1 μs after the laser flash and contains a peak with λmax 
~ 420 nm with a shoulder to the red at 510 nm. This spectrum corresponds to the triplet 
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excited state of pyrene, 3Py*, (ε(414 nm) 
= 16700 + 4500 M–1cm–1 for triplet 1-
pyrenebutanoic acid in water)31 which 
has a previously measured lifetime of 31 
μs25 in aqueous solution in the absence 
of triplet-triplet annihilation (i.e. at low 
concentrations).  
The red spectrum in Figure 3.6 was 
obtained under the same conditions but 
in the presence of 10 mM 
CoIII(NH3)6Cl3, which serves as an 
irreversible flash-quench oxidant. This 
spectrum exhibits a sharp peak with λmax 
= 456 nm, consistent with that 
previously observed for Py•+ (ε(457 nm) 
= 13000 + 3000 M–1cm–1 for the radical cation of 1-pyrenebutanoic acid in water).31 The 
radical anion of pyrene is expected to have a peak at 490 nm (ε ~ 49,000 M–1cm–1).28 
 
Figure 3.6. Transient absorption spectra of a 
solution of Py-A in 10 mM KPi buffer at pH 7.5 
obtained 1 μs after the laser flash in the 
presence (▬) and absence (▬) of 10 mM 
Co(III)(NH3)6 Cl3. 
Upon flashing a solution of Py-Y, only very weak signals corresponding to 3Py were 
observed on the nanosecond timescale. The decreased intensity of these signals, compared to 
that observed for Py-A, is a result of the previously described quenching of the singlet excited 
Table 3.2. Ground and Excited State Reduction and Oxidation Potentials 
of Py-A. 
Ep(Py/Py•–)a Ep(Py•+/Py)a E00(1Py*)b E°(1Py/Py•–)c E°(1Py/Py•+)d 
-2.16 0.92 3.28 1.77 1.71 
aPeak potential from DPV reported in V vs. Fc+/Fc with 0.1 M (Bu4N)PF6 
supporting electrolyte in CH3CN. bReported in eV from the intersection of the 
normalized absorption and emission bands. cE°(1Py/Py•–) = E00(1Py*) + 
Ep(Py/Py•–) and reported vs. NHE. dE°(1Py/Py•+) = E00(1Py*) – Ep(Py/Py•–) 
and reported vs. NHE. 
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state (and thus lower quantum yield for triplet formation). Importantly, no transients 
corresponding to Y• or Py•– could be detected. Therefore, if tyrosine oxidation is occurring 
from the pyrene singlet excited state, then back electron transfer must be very rapid to deplete 
the charge transfer state on the < 10 ns timescale. Nanosecond TA experiments with Py-Y 
were also carried out with 10 mM CoIII(NH3)6Cl in an effort to generate Py-Y• via the flash 
quench method, however the short fluorescence lifetime of this compound inhibited buildup 
of the critical Py•+-Y intermediate. 
3.4 Benzophenone and Anthraquinone 
3.4.1 Background 
The preceding sections described oxidants which only manage the electron transfer part of 
tyrosine oxidation. Recent work has shown, however, that tyrosine oxidation can be expedited 
by forming a hydrogen bond between the phenol and a base32- 34 (see also Chapter V), thus 
switching the photo-oxidation from ET to PCET.35 Following this lead, we sought to develop 
photo-oxidants that could fulfill the dual role of electron and proton acceptor in the rapid 
tyrosine oxidation required for phototriggering RNR and at the same time could be excited by 
light outside the RNR absorption manifold. 
Both benzophenone (BP)36- 38 and anthraquinone (Anq)39 - 44 are strong triplet nπ* excited 
state oxidants with the ability to oxidize amines, aliphatic alcohols, and even water, though 
sluggishly. Studies on the mechanism of phenol oxidation by carbonyl triplet excited states 
have resulted in a model wherein PCET occurs within a hydrogen-bonded exciplex.45 In this 
model, electron transfer from the phenol to the electronically excited carbonyl is kinetically 
coupled to proton transfer between the oxygen atoms of phenol and the photo-oxidant. In fact, 
3BP* has been shown to be a competent, bimolecular oxidant of tyrosine46 with a bimolecular 
rate constant of 2.6 ± 0.2 × 109 M–1s–1. The triplet excited state of Anq was used to create 
organic radicals upon oxidation of the nucleo-base of guanine and, as such, was used to study 
long distance hole transport in DNA.47 We therefore thought that BP and Anq would serve as 
a prime candidates for rapid formation of •Y356 on the R2C20 peptide. We sought to first 
demonstrate this in dipeptides containing the BP and Anq chromophores and tyrosine. 
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3.4.2 Results and Discussion 
Figure 3.7 shows the low energy region of the absorption spectra of BPA-Y-OMe•TFA 
and Anq-Y-OH for 
wavelengths to the red 
of the protein 
absorption envelope (λ 
> 300 nm). The BPA 
chromophore exhibits 
a weak low energy 
feature for λ > 300 nm 
corresponding to the 
nπ* transition of the 
BPA chromophore, 
while the Anq chromopore has a much larger absorption cross section for λ > 300 nm. 
Therefore, in the transient absorption experiments, BPA must be excited with the 300 nm, 
frequency-doubled OPO laser output, to afford enough excited state for a good signal-to-noise 
ratio while Anq can be more conveniently 
excited with the third harmonic of our 
Nd:YAG laser (355 nm).  
 
Figure 3.7. Ground state UV-Vis absorbance spectra of BPA-Y-
OMe•TFA and Anq-Y-OH.
Excitation of a solution of BPA-Y-
OMe at pH 4.0 with a 300 nm nanosecond 
laser pulse produces a species with the 
transient absorption spectrum shown in Figure 
3.8 at 100 ns. The strong, sharp peak with λmax 
= 334 nm and broad peak at λmax = 547 nm 
with a shoulder to the blue are the spectral 
signatures of the reduced benzophenone ketyl 
radical48 (ε550 nm(BPK•) = 3300 ± 700 M–1cm–1 
exane),in cycloh 49 whereas the absorption 
bands at λmax = 390 and 407 nm are 
 
Figure 3.8. Transient absorption spectra 
recorded at (▬) 100 ns, (▬) 400 ns, and 
(▬ ▬) 1 μs following 300 nm, 5 ns 
excitation of a 500 μM solution of BPA-Y-
OMe buffered to pH 4.0 with 20 mM 
succinic acid. Inset: Single wavelength 
kinetics of the 547 nm absorption (○) and 
the single exponential decay fit (▬) to the 
data. 
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characteristic of Y• (ε410(Y•) = 2750 ± 200).19 The Y• peak is slightly blue-shifted from that of 
free Y• owing to their overlap with the tailing absorption of the 334 nm band of the ketyl 
radical of BPA (BPA•). The subsequent gray traces recorded at 400 ns and 1 μs show that the 
overall profile shape does not change with time. The transient signals decayed concomitantly 
with a rate constant of 5.6 × 106 s–1; single wavelength kinetics data recorded at 547 nm is 
shown in the inset of Figure 3.8. This unimolecular decay is consistent with charge 
recombination between BPA• and Y•. The kinetics were unaffected by the presence or 
absence of oxygen in solution. A minor residual absorbance (<10%), which persists for tens 
of microseconds, is likely due to a small fraction of product formed in the bimolecular 
reaction between 3BPA-Y-OMe and ground state BPA-Y-OMe. This reaction is favored at the 
high concentrations of dipeptide required for the TA experiment. 
Figure 3.9 (left) shows the absorption spectrum obtained 50 ns after excitation of the 
control “dipeptide” Anq-F-OH with a 355 nm nanosecond laser pulse. The transient contains 
a broad feature with λmax ≈ 417 nm and an even broader and weaker shoulder with λmax ≈ 530 
nm. Additional spectra obtained at 100 ns, 1, and 10 μs show that the overall profile remains 
fairly constant with time. Single wavelength kinetics obtained at 410 nm revealed that the 
spectrum has a non-exponential decay, and does not decay to baseline on the μs-ms 
 
Figure 3.9. Left panel: Transient absorption spectra of Anq-F-OH obtained 65 (▬), 115 ns, 
1, and 10 μs (▬) following 355 nm excitation. Right: Transient absorption spectra of Anq-Y-
OH obtained 15 (▬), 115 ns, 1, and 10 μs (▬) following 355 nm excitation. Insets: Time-
evolved absorbance data (○) with bi-exponential decay fit (▬) obtained at 410 and 520 nm. 
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timescales. These spectra are not the result of a reaction of a photoreaction with the buffer, as 
similar spectra and kinetics were recorded in Tris buffer (pH 7.6) and in neat water. The 
triplet excited state of 9,10-anthraquinone-2-sulfonate, 3AQS, was previously shown to react 
with water and/or OH–, although the exact photoproducts and reaction mechanism remain 
unclear.44 Given this information, along with the lack of any observable triplet 
phosphorescence which is normally observed for 3Anq in organic solvents, it is likely that the 
spectrum in the top panel of Figure 3.9 is due to an unidentified photoproduct of the reaction 
between 3Anq and water.  
The right panel of Figure 3.9 displays the results for the same experiment performed 
on Anq-Y-OH. The first transient (50 ns) is markedly different from that obtained for Anq-F-
OH and contains features with λmax ~ 520 nm and 410 nm and a shoulder at 395 nm. We 
ascribe the 520-nm absorption to the anthraquinone semiquinone radical anion, Anq•–, based 
on the similarity to absorption spectra of the native 9,10-anthraquinone semiquinone radical 
anion (ε395 = 7800 M–1cm–1 and ε480 = 7300 M–1cm–1 at pKa = 5.3)40 and anthraquinone-2-
sulfonate semiquinone radical anion (ε400 = 8000 M–1cm–1, ε500 = 8000 M–1cm–1 at pKa = 
3.25).50 The higher energy TA band is a superposition of two absorptions at 394 nm and 408 
nm; these wavelengths are commensurate with the absorptions of Y• (ε410 nm = 2750 ± 200)19 
and Anq•– of the diradical, Anq•–-Y•-OH, which we propose to result from Y oxidation by the 
triplet nπ* excited state of Anq, 3Anq. This photochemistry is consistent with the known 
reactivity of 3Anq with alcohols.39,41 The concomitant disappearance of the 410 and 520 nm 
transient absorptions (Figure 3.9, right insets) are indicative of radical recombination. A small 
residual absorbance, evident at times >10 μs, is similar to the transient features observed with 
Anq-F-OH (Figure 3.9, left panel). Single wavelength kinetics obtained at 410 nm and 520 
nm are best fit to a bi-exponential decay function with a short (τ1 = 370 ± 20 ns, 80%) and 
long (τ2 > 10 μs, 20%) components. The major, short component of the decay is assigned to 
the radical recombination between Anq•– and Y• in Anq•–-Y•-OH, proceeding at 2.7 ± 0.1 × 
106 s–1. The minor, long component is assigned to the decay of the Anq-solvent photoproduct 
identified in the TA spectrum of the Anq-F-OH dipeptide (vide supra). 
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3.5 Flavins 
3.5.1 Background 
Flavins have a rich excited state photochemistry51 with lumiflavin (LF) and riboflavin 
(RF) (Chart 3.1) being particularly well characterized owing to the role of riboflavin as a 
redox active cofactor in biological enzymes. Both LF and RF can exhibit redox activity from 
their singlet and triplet excited states.  The singlet excited state is highly fluorescent (Φfl = 
0.26),51 thus steady-state and time-resolved emission spectroscopy can be used as a probe for 
its reactivity. On the other hand, flash photolysis or flash EPR methods must be used to probe 
reactions with the dark (at room temperature) triplet excited state. The singlet excited state 
converts to the triplet on the order of nanoseconds,51 therefore most of the redox activity 
reported in the literature deal with the triplet excited state of LF or RF. 
The triplet excited state of LF/RF can act as a strong oxidant52,53 and reductant.54,55 The 
photochemistry is complicated by the observation of different protonation states of the 
oxidized,55 reduced,56 and even triplet excited state (pKa = 4.45),57 as well as bimolecular 
reactivity of the triplet excited state with itself (triplet-triplet quenching) and with another 
ground state molecule.53,58 The redox and acid/base equilibria of the ground state flavin and 
flavin radicals described here are presented in Chart 3.2. From these data, two protonation 
forms of the oxidized radical, Flox+ and Flox(-H), and reduced radical, FlredH• and Flred•–, could 
play a role near neutral pH. Bimolecular oxidation of tryptophan and tyrosine with the triplet 
excited state of flavins was reported to forming the reduced FlH•.51,59 We sought to extend 
this photochemistry to dipeptides containing the Fl unnatural amino acid shown in Chart 3.1  
 
Chart 3.1. Chemical structures of flavins discussed herein. 
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Chart 3.2. Redox and acid/base equilibria of flavin and flavin radicals. aRef 55 bRef 51 cRef 56. 
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and tyrosine.  The synthesis of Fl was 
accomplished using the method of Carrel and 
et al,60 and dipeptides with tyrosine and 
alanine were synthesized using standard 
peptide coupling methods.  The photophysics 
and photochemistry of these dipeptides is now 
described. 
3.5.2 Results and Discussion 
Figure 3.10 shows the ground state UV-vis 
absorption and fluorescence emission spectra 
of Fl-A. The Fl chromophore exhibits a strong 
absorption feature in the visible with λmax = 
370, 442 (ε445 nm = 10930 M–1cm–1 for LF)61 and a strong emission peak with λmax = 530 nm.  
Time-resolved fluorescence (λexc = 400 nm) was measured in 10 mM phosphate buffer at pH 7 
for both Fl-A and Fl-Y dipeptides, yielding fluorescence lifetimes of 5.25 and 2.95 ns, 
respectively. The quenched fluorescence lifetime for Fl-Y compared to the Fl-A control 
compound could be due to oxidation of tyrosine from the singlet excited state, although other 
mechanisms such as stacking of the aromatic phenol with the isoalloxazine ring or hydrogen 
bonding from the phenol cannot be ruled out.51 
 
Figure 3.10. Ground state UV-Vis absorbance 
and steady state emission spectra (450 nm 
excitation) of Fl-A in 10 mM KPi buffer (pH 7). 
Nanosecond transient absorption spectroscopy was employed to probe the mechanism of the 
 
Figure 3.11. Transient absorption spectra obtained (▬) 115ns, (▬) 2μs, and (▬) 
20μs following 355 nm ns-laser excitation of a solution of Fl-A in 10 mM KPi at 
pH 7. 
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Figure 3.12. Transient absorption spectra obtained (▬) 65ns, (▬) 115 ns, and 
(▬) 1 μs following 355 nm ns-laser excitation of a solution of Fl-Y in 10 mM KPi 
at pH 7. 
fluorescence quenching, as well potential reactions of the dark triplet excited state. Figure 3.11 
shows the transients observed following 355 nm, ns laser excitation of Fl-A in 10 mM phosphate 
buffer at pH 7. At the earliest time point (115 ns) the spectrum contains peaks at 395, 660 and 
~715 nm and a ground state bleach at 450 nm, resembling that of the triplet excited state, 3LF.58 
The low energy region of the spectrum with the peak at 715 nm is particularly informative in 
distinguishing 3LF from the reduced and oxidized radical forms of Fl. The spectrum at 115 ns 
decays on the microsecond timescale to another transient with a broad ground state bleach for 
450 nm < λ < 500 nm and a broad absorption between 500 and 650 nm that persists into the 
hundreds of microseconds timescale. This spectrum resembles that of FlredH•56  superimposed on 
the ground state bleach. From the literature, the decay of 3LF is complex with rates for first-order 
nonradiative decay and concentration dependent triplet-triplet and triplet-ground state quenching, 
in some cases yielding FlredH• and Flox(-H) or Flox+.53,58 
In contrast to the spectra observed for Fl-A, the transient observed 65 ns following excitation 
of Fl-Y (Figure 3.12) does not contain the low energy absorption feature at 715 nm. Instead this 
spectrum features a broad ground state bleach at λ = 450 nm and a broad, tailing absorption for λ 
> 500 nm that decays on the nanosecond timescale. This spectrum also resembles that of FlredH• 
superimposed on the ground state bleach and could be due to reduction of the 3Fl by Y to form 
the •HFlred-Y• charge separated state. However, we would also expect to see an absorption 
feature near 410 nm due to Y•. Unfortunately, the ground state of Fl absorbs strongly in this 
region, thus the ground state bleach of FlredH• in the TA spectra inhibits direct detection of the 
Y• signal. Owing to the fact that the Y• signal is obscured and that the Fl photophysics are so 
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complex, we abandoned Fl early on as a potential excited state oxidant of Y for the proposed 
studies with RNR. 
3.6 Conclusions 
A Ru(bpy)32+ derivative, pyrene, benzophenone, anthraquinone, and flavin were 
investigated as excited state oxidants of tyrosine in model “dipeptides.” All chromophores show 
some evidence for tyrosine oxidation from their excited states, however each has a drawback 
with regard to application to the RNR system. For the Ru(BTFMB)2(bpy)2+ system, the high 
RuIII/II potential inhibited significant buildup of the flash-quench RuIII product required for Y 
oxidation. In the pyrene dipeptides, tyrosine oxidation may occur from the singlet excited state, 
however no buildup of the charge separated state could be observed on the nanosecond 
timescale. For benzophenone, the ketyl radical is clearly distinguished from the tyrosyl radical in 
the TA spectrum of the •BPA-Y•-OMe diradical state. However, the low absorption cross section 
of the benzophenone chromopore necessitates excitation at λ < 300 nm. There is some overlap 
with the tailing absorption of RNR in this region, creating difficulties in obtaining good signal-
to-noise ratios at the peptide concentrations required for peptide:α2 experiments. The 
benzophenone aromatic ring could be substituted with electron donating groups to shift the 
absorption spectrum farther to the red,62 which we investigate in Chapter X. Both the Anq and Fl 
chromophores overcome this absorption cross section problem with higher molar absorptivities 
in the near UV and visible regions of the spectrum, respectively. Both chromophores are 
competent for Y• generation, but the reduced Anq•– and FlredH• TA signals significantly overlap 
that of Y•, thereby obscuring any potential reactivity of •Y356 with α2. Nonetheless, since BPA 
and Anq exhibited the cleanest photochemistry with regard to Y oxidation that could be 
characterized with nanosecond TA, these chromophores were incorporated into Y-R2C19, the C-
terminal peptide tail of β2, for light initiated activation of α2. Characterization of the ensuing 
photochemistry of the chromophore on the peptide and light-initiated turnover assays of these 
peptides bound to α2 is discussed in Chapter VII. 
3.7 Experimental Section 
Materials. L-Tyrosine tert-butyl ester (Y–OtBu), 4-benzoyl-N-[(1,1-dimethylethoxy) 
carbonyl]-L-phenylalanine (Boc-BPA-OH), 1-hydroxybenzotriazole (HOBt) (NovaBiochem), L-
alanine tert-butyl ester hydrochloride (A–OtBu•HCl), L-phenylalanine tert-butyl ester 
 84
hydrochloride (F–OtBu•HCl), 2-(6-chloro-1H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium 
hexafluorophosphate (HCTU) (Advanced ChemTech), magnesium sulfate (MgSO4) (EMD), 
Anthraquinone-2-carboxylic acid (Anq-COOH), 4-dimethylaminopyridine (DMAP), 1-
pyrenecarboxylic acid (Py-COOH), 1-(3-dimethylamino-propyl)-3-ethylcarbodiimide hydro-
chloride (EDC•HCl), N-methylmorpholine (NMM), 60 % hexafluorophosphoric acid (HPF6), 
hexaaminecobalt(III)chloride (CoIII(NH3)6Cl3) (Aldrich) and trifluoroacetic acid (TFA, 99.9%) 
(J. T. Baker) were used as received. 4´-Methyl-2,2´-bipyridine-4-carboxylic acid (bpy–COOH) 
was prepared as described.63 Bis(4,4′-bis(trifluoromethyl)-2,2′-bipyridine)rutheniumII dichloride 
(Ru(BTFMB)2Cl2) was a gift from Prof. Masaoki Furue.64 Bis(bipyridine)(4-methyl-2,2′-
bipyrdine-4′-carboxylic acid)rutheniumII hexafluorophosphate ([Ru(bpy)2(bpy-COOH)](PF6)2) 
was prepared as previously described.65 The flavin-containing unnatural amino acid, (S)-2-
amino-Nα-(tert-butyloxycarbonyl)-6-(7’,8’-dimethylisoalloxazin-10’-yl)hexanoic Acid (Boc-Fl-
OH), was synthesized by the method of Carell et al.60 
[Ru(BTFMB)2(bpy-COOH)](PF6)2. Ru(BTFMB)2Cl2 (200 mg, 0.264 mmol, 1 eq) and bpy-
COOH (60 mg, 1.06 eq) were combined in a 100 mL round bottom flask along with 50 mL of 
70% ethanol.  The mixture was heated at reflux for one hour, at which point 60 mg more of the 
bpy-COOH ligand was added. The mixture was heated at reflux for seven more hours and the 
solvent removed in vacuo. The residue was dissolved in ~30 mL of water, acidified to pH 1 with 
60% HPF6, and solid NH4PF6 was added to induce precipitation.  The dark red/ purple  
precipitate was isolated by filtration over a fine glass frit and washed with cold water and ether. 
The product was recrystallized from acetone/ether and isolated as a red solid (260 mg, 83 % 
yield). 1H NMR (300 MHz, d-acetone, 25 oC) δ = 2.63 (s, 3H, bpy-CH3), 7.44-9.52 (m, 18H, bpy 
aromatic region). 
[Ru(BTFMB)2(bpy-Y)](PF6)2. [Ru(BTFMB)2(bpy-COOH)](PF6)2 (100 mg, 0.084 mmol, 
1eq), Y-OtBu (22 mg, 1.1 eq), HCTU (52 mg, 1.5 eq), and HOBt (17 mg, 1.5 eq) were combined 
in a 100 mL round bottom flask with 10 mL of dimethylformamide. NMM (37 μL, 4 eq) was 
added and the reaction was stirred for 5 hours. The reaction was diluted with 50 mL of 
methylene chloride and extracted with 3 x 30 mL of water, 10 % citric acid, 1 M NaHCO3, and 
water in that order.  The organics were dried over MgSO4, the drying agent removed by 
filtration, and the solvent removed in vacuo. The red residue was chromatographed on a 1 mm 
alumina Chromatotron plate using 3% MeOH / CH2Cl2 as the eluant.  The desired product was 
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isolated as a red band and the solvents removed in vacuo.  The resulting t-butyl ester protected 
product was dissolved in 10 mL of 1:1 CH2Cl2 / TFA and stirred for one hour at room 
temperature.  The solvents were evaporated under a stream of N2 and the product precipitated 
upon addition of ether.  The resulting red solid was isolated by filtration (62 mg, 55% yield). 1H 
NMR (300 MHz, d-acetone, 25 oC) δ = 2.62 (s, 3H, bpy-CH3), 3.05-3.29 (m, 2H, CβH2), 4.84 (m, 
1H, CαH), 6.73 (d, 7.7 Hz, 2H, phenol CH), 7.18 (d, 8.8 Hz, 2H, phenol CH),  7.40-9.50 (m, 
19H, bpy aromatic + amide NH region). MALDI-TOF Calcd. (Found): [M – PF6]+ 1207.8 
(1208.1); [M – 2 PF6]+ 1063.1 (1063.1). 
[Ru(BTFMB)2(bpy-F)](PF6)2. This compound was prepared by the same method as 
[Ru(BTFMB)2(bpy-Y)](PF6)2, except that F-OtBu•HCl was used instead of Y-OtBu (60 mg, 
53%). 1H NMR (300 MHz, d-acetone, 25 oC) δ = 2.61 (s, 3H, bpy-CH3), 3.13-3.43 (m, 2H, 
CβH2), 4.94 (m, 1H, CαH),  7.15-9.50 (m, 24H, bpy aromatic + phenyl aromatic + amide NH 
region). MALDI-TOF Calcd. (Found): [M – PF6]+ 1192.1 (1192.0); [M – 2 PF6]+ 1047.1 
(1047.1). 
[Ru(bpy)2(bpy-Y)](PF6)2. [Ru(bpy)2(bpy-COOH)](PF6)2 (300 mg, 0.322 mmol, 1eq), Y-
OtBu (115 mg, 1.5 eq), HOBt (65 mg, 1.5 eq), and WSC•HCl (123 mg, 2 eq) were combined in a 
round bottom flask with 20 mL of DMF. NMM (220 μL, 6 eq) was added and the solution was 
stirred overnight at room temperature.  The solvent was removed in vacuo and the residue was 
taken up in 100 mL of CH2Cl2 and extracted with 2 x 50 mL of water, 10 % citric acid, 1 M 
NaHCO3, and water in that order. The organics were dried over MgSO4, the drying agent 
removed by filtration, and the solvent removed in vacuo. The red residue was chromatographed 
on a 1 mm alumina Chromatotron plate using 3% MeOH / CH2Cl2 as the eluant. The desired 
product was isolated as a red/orange band and the solvent removed in vacuo. The resulting t-
butyl ester protected product was dissolved in 10 mL of 1:1 CH2Cl2 / TFA and stirred for one 
hour at room temperature.  The solvents were evaporated under a stream of N2 and the product 
precipitated upon addition of ether.  The resulting red/orange solid was isolated by filtration. 1H 
NMR (300 MHz, d-acetone, 25 oC) δ = 2.62 (s, 3H, CH3), 3.05 (m, 1H, CβH), 3.26 (m, 1H, CβH), 
4.88 (m, 1H, CαH), 6.73 (m, 2H, phenol CH), 7.16 (m, 2H, phenol CH), 7.42 – 9.00 (m, 23 H, 
bpy aromatic & amide NH). 
[Ru(bpy)2(bpy-F)](PF6)2. This compound was prepared by the same method as 
[Ru(bpy)2(bpy-Y)](PF6)2, except that F-OtBu•HCl was used instead of Y-OtBu. 1H NMR (300 
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MHz, d-acetone, 25 oC) δ = 2.61 (s, 3H, CH3), 3.12 (m, 1H, CβH), 3.37 (m, 1H, CβH), 4.96 (m, 
1H, CαH), 7.17-7.37 (m, 5H, phenyl CH), 7.44-8.96 (m, 23 H, bpy aromatic & amide NH). 
1-Pyrenecarboxyl-L-tyrosine [Py-Y]. Py-COOH (200 mg, 0.812 mmol, 1 eq), Y-OtBu (193 
mg, 1eq), WSC•HCl (171 mg, 1.1 eq), and HOBt (121 mg, 1.1 eq) were combined in a round 
bottom flask with 25 mL of CH2Cl2.  NMM (370 μL, 4.0 eq) was added and the solution was 
stirred overnight. The 75 mL of CH2Cl2 was added and the solution was extracted with 2 x 50 
mL of 10% citric acid, 1 M NaHCO3 and water. The organics were dried over MgSO4, the drying 
agent removed by filtration and the solvents removed to yield the t-butyl ester protected product 
as a  yellow foam. The foam was dissolved in 10 mL of 1:1 TFA/ CH2Cl2 with 1% MeOH and 
stirred for two hours. The solvents were removed under a stream of nitrogen and the resulting 
yellow powder was dried under vaccum (199 mg, 60 %). 1H NMR (300 MHz, d-acetone, 25 oC) 
δ = 3.14 (dd, 9.8 Hz, 14.0 Hz, 1H, CβH), 3.40 (dd, 4.6 Hz, 14.0 Hz, 1H, CβH), 5.11 (m, 1H, 
CαH), 6.84 (d, 8.5 Hz, 2H, phenol CH), 7.27 (d, 8.5 Hz, 2H, phenol CH), 7.89 (d, 7.8 Hz, 1H, 
amide NH), 8.03-8.44 (m, 9H, pyrene aromatic CH). 
1-Pyrenecarboxyl-L-alanine [Py-A]. This compound was made by the same method as Py-
Y, except A-OtBu•HCl was used instead of Y-OtBu. (176 mg, 68 %). 1H NMR (300 MHz, d-
acetone, 25 oC) δ = 1.63 (d, 7.2 Hz, 3H, CH3), 4.87 (qd, 7.5 Hz, 8.1 Hz, 1H, CαH), 8.01-8.35 (m, 
9H, pyrene aromatic CH), 8.73 (d, 9.4 Hz, 1H, amide NH). 
4-Benzoyl-L-Phenylalanyl-Tyrosyl Methyl Ester Trifluoroacetic Acid (BPA-Y-
OMe•CF3COOH) Y-OMe (0.432 mmol, 1.0 eq), Boc-BPA-OH (160 mg, 0.432 mmol, 1.0 eq), 
N-ethyl-N´-(3-dimethylaminopropyl)carbodiimide hydrochloride (91 mg, 0.475 mmol, 1.1 eq), 
and 1-hydroxybenzotriazole (HOBt) (64 mg, 0.475 mg, 1.1 eq) were combined in a 50 mL round 
bottom flask with 20 mL of methylene chloride. N-methylmorpholine (NMM) (175 μL, 1.73 
mmol, 4 eq) was added and the solution was stirred overnight at room temperature. The solution 
was diluted to 75 mL with methylene chloride and washed with 2 × 30 mL of 10% citric acid 
solution. The organic layer was dried over MgSO4 and the solvent removed in vacuo. The 
resulting clear oil was dissolved in a few mLs of methylene chloride and loaded onto a 1 mm 
thick silica gel Chromatotron plate. The product was eluted with 3% methanol/methylene 
chloride and the solvent was removed in vacuo. The resulting clear oil was dissolved in 1:1 
TFA:CH2Cl2 and stirred for 20 min at room temperature. The solvents were then evaporated 
under a stream of N2(g) and the resulting clear oil was dried under high vacuum. Trituration with 
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CH2Cl2 followed by the dropwise addition of ether resulted in the formation of white crystals, 
which were cooled to –20 °C and isolated by filtration 1H NMR (300 MHz, (CD3)2CO, 25 oC) δ 
= 2.88-3.18 (m, 2H, CβH), 3.37 (m, 2H, CβH), 3.68 (s, 3H, -OCH3), 4.62 (m, 1H, CαH), 4.88 (m, 
1H, Cα-H), 6.78 (m, 2H, phenol CH), 7.15 (m, 2H, phenol CH), 7.30 (d, 2H, C6H4OC6H5, 7.7 
Hz), 7.55 (m, 2H, C6H4OC6H5), 7.67 (m, 3H, C6H4OC6H5), 7.76 (m, 2H, C6H4OC6H5). 
N-[(9,10-Dihydro-9,10-dioxo-2-anthracenyl)carbonyl]-L-tyrosine (Anq-Y-OH). Anq-
COOH (300 mg, 1.19 mmol, 1.0 eq), Y-OtBu (282 mg, 1.0 eq), WSC·HCl (250 mg, 1.1 eq), and 
HOBt (177 mg, 1.1 eq) were combined in a 100 mL flask with 30 mL of DMF. NMM (530 μL, 
4.0 eq) was added and the solution was stirred overnight. The solvent was removed in vacuo, and 
the resulting oil was dissolved in 80 mL of methylene chloride. The organics were washed with 2 
× 50 mL of water, dried over MgSO4, and filtered to remove the drying agent. The solvent was 
removed in vacuo to yield a yellow oil, which was dissolved in a few mL’s of methylene 
chloride and loaded onto a Chromatotron plate (Si gel, 2mm). The product was eluted with 2% 
MeOH/ CH2Cl2. The solvent was removed in vacuo to yield a yellow oil, which was redissolved 
in 10 mL of 1:1 TFA/ CH2Cl2 and stirred for one hour. The solution was concentrated to < 1mL 
under a stream of N2(g) and taken up in ether. The resulting yellow precipitate was isolated by 
filtration and dried in vacuo to yield 500 mg of the title compound as a yellow powder (95 %). 
1H NMR (300 MHz, CD3OD, 25 oC) δ = 3.05 (m, 1H, Cβ-H), 3.26 (m, 1H, CβH), 4.83 (m, 1H, 
CαH), 6.72 (m, 2H, phenol- CH), 7.13 (m, 2H, phenol CH), 7.85 (m, 2H, Anq. arom. CH), 7.97 
(m, 1H, NH), 8.12 (m, 1H, Anq. arom. CH), 8.27 (m, 3H, Anq. arom. CH), 8.58 (d, 1H, NH, 1.6 
Hz). ESI-MS Calc’d (Found): [M+H]+ 416.11 (416.11), [2M+H]+ 831.22 (831.21) 
N-[(9,10-Dihydro-9,10-dioxo-2-anthracenyl)carbonyl]-L-phenylalanine (Anq-F-OH). 
The title compound was prepared by the same method as that used for Anq-Y-OH, except that F-
OtBu·HCl was used in place of Y-OtBu (63%). 1H NMR (300 MHz, (CD3)2CO, 25 oC) δ = 
3.14 (m, 1H, Cβ-H), 3.40 (m, 1H, Cβ-H), 4.93 (m, 1H, CαH), 7.17-7.35 (m, 5H, F phenyl-CH), 
7.87 (m, 2H, Anq. arom. CH), 8.11 (m, 1H, Anq. arom. CH), 8.29 (m, 3H, Anq. arom. CH), 8.58 
(d, 1H, Anq. arom. CH, 1.6 Hz), 9.00 (d, 1H, NH, 8.3 Hz). ESI-MS Calc’d (Found): [M+H]+ 
400.12 (400.12), [2M+H]+ 799.23 (799.22) 
Fl-A•CF3COOH. Boc-Fl-OH (394 mg, 0.835 mmol, 1 eq), A-OtBu•HCl (152 mg, 1eq), 
WSC•HCl (177 mg, 1.1 eq), and HOBt (125 mg, 1.1 eq) were combined in a round bottom flask 
with 50 mL of chloroform.  NMM (256 μL, 3.3 eq) and DMAP (10.2 mg, 0.1 eq) were added 
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and the solution was stirred overnight.  The reaction was diluted with 100 mL of chloroform and 
extracted with 3 × 75 mL of 10 % citric acid, water, 5 % sodium bicarbonate, and water again in 
that order.  The organic layer was dried over MgSO4, filtered to remove the drying agent, and the 
solvent removed in vacuo. The resulting reddish orange residue was purified by column 
chromatography (Si gel) with 5% MeOH / chloroform as the eluant. The product was isolated as 
a reddish orange band and the solvent removed in vacuo.  The resulting residue (Boc-Fl-A-OtBu) 
was dissolved in 10 mL of 1:1 TFA / CH2Cl2 and stirred for 2 hours.  The solvents were 
evaporated under a stream of N2 and the product was precipitated by the addition of ether as the 
trifluoroacetate salt. The resulting orange precipitate was isolated by filtration, washed with 
ether, and dried in vacuo. 1H NMR (300 MHz, CD3OD, 25 oC) δ = 1.43 (d, 3H, A-CH3), 1.68 (m, 
2H, Fl-CγH2), 1.84-2.15 (m, 4H, Fl-CβH2, Fl-CδH2) 2.45 (s, 3H, Fl-CH3), 2.58 (s, 3H, Fl-CH3), 
3.93 (m, 1H, Fl-CαH), 4.41 (m, 1H, A-CαH), 4.74 (m, 2H, Fl-CεH2), 7.74 (s, 1H, Fl-arom. CH), 
7.89 (s, 1H, Fl-arom. CH), 8.72 (br. d, amide CH). ESI-FT MS Calcd. (Found): [M + H]+ 
443.2043 (443.2021)  
Fl-Y•CF3COOH. This compound was prepared as described for Fl-A-OH•CF3COOH, 
except that Y-OtBu was used instead of A-OtBu•HCl. 1H NMR (500 MHz, CD3OD, 25 oC) δ = 
1.61 (m, 2H, Fl-CγH2), 1.90-2.10 (m, 4H, Fl-CβH2, Fl-CδH2), 2.48, (s, 3H, Fl-CH3), 2.59 (s, 3H, 
Fl-CH3), 2.92 (m, 1H, Y-Cβ-H), 3.15 (m, 1H, Y-Cβ-H), 3.88 (t, 1H, Fl-CαH, 6.5 Hz), 4.61 (td, 
1H, Y- CαH, 4.9 Hz, 4.9 Hz), 4.76 (m, 2H, CεH2), 6.68 (d, 2H, phenol CH, 8.0 Hz), 7.81 (d, 2H, 
phenol CH, 8.5 Hz), 8.58 (br. d, amide CH). ESI-FT MS Calcd. (Found): [M + H]+ 543.2227 
(543.2321) 
Physical Measurements. 
NMR Spectroscopy and Mass Spectrometry. 1H NMR spectra were recorded on a Varian 
Mercury 300 MHz or Varian Inova 500 MHz spectrometer at the MIT Department of Chemistry 
Instrumentation Facility (DCIF) and externally referenced to tetramethylsilane. MALDI-TOF 
mass spectrometry was performed on a Bruker Omniflex instrument in the DCIF using dithranol 
as the matrix. The instrument was calibrated with a quadratic polynomial using a mixture of 
bradykinin fragment 1-7 (757.3997), angiotensin II (1046.5423), and P14R synthetic peptide 
(1533.8582) (Sigma) with α-cyano-4-hydroxycinnamic acid as the matrix. ESI-FT mass 
spectrometry was performed with an Bruker Daltonics APEXII instrument housed in the DCIF. 
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Electrochemistry. Electrochemical measurements were performed using a Bioanalytical 
Systems (BAS) Model CV-50W potentiostat/galvanostat. Differential pulse voltammetry (DPV) 
and cyclic voltammetry (CV) was performed in dry MeCN with 0.1 M tetrabutylammonium 
hexafluorophosphate (Bu4N)PF6 as the supporting electrolyte. A platinum disk working, 
Ag/AgNO3 nonaqueous (0.1 M (Bu4N)PF6 / MeCN) reference, and a platinum wire auxiliary 
electrodes were used. Solutions were bubbled with Ar to remove dissolved O2. All potentials are 
reported vs. Eo(Fc+/Fc) = 0.65 V vs. NHE in CH3CN.12  
Absorption and Emission Spectroscopy. UV-vis absorption spectra were recorded on a Cary 
17D modified by On-Line Instrument Systems (OLIS) to include computer control or a Spectral 
Instruments 440 spectrophotometer. Steady state emission spectra were recorded on an 
automated Photon Technology International (PTI) QM 4 fluorimeter equipped with a 150-W Xe 
arc lamp and a Hamamatsu R928 photomultiplier tube. The E00 for the 1Py* excited state was 
measured from the intersection of the normalized lowest energy singlet absorption peak and the 
normalized highest energy emission peak. Both spectra were plotted in wavenumbers (cm–1), and 
the intensity values converted to units of quanta (I × λ2) by the correction of Parker and Rees.66 
Fluorescence quantum yields for Py-A and Py-Y were measured using the equation: 
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where Φref is the quantum yield of the reference actinomter quinine sulfate in 1N H2SO4 (Φref = 
0.55).67 A is the measured absorbance, η is the refractive index of the solvent, and I is the 
integrated emission intensity of the corrected emission band plotted in wavenumbers. The 
measured quantum yields were identical, within 5% experimental error, in the presence and 
absence of oxygen indicating that O2 does not react with the singlet excited state of pyrene in 
these dipeptides to a significant extent. The Franck-Condon analysis method15-17 for fitting the 
3MLCT emission band of Ru(BTFMB)2(bpy-F)(PF6)2 to obtain ΔG°MLCT is described in detail in 
Chapter 4.  
Transient Absorption Spectroscopy. Transient absorption (TA) measurements were made 
with pump light provided by the third harmonic (355 nm) of an Infinity Nd:YAG laser 
(Coherent) running at 20 Hz as previously described.68 In the case of the BPA-Y-OMe, 300 nm 
pump light was used as previously described owing to the lack of absorption at 355 nm for this 
chromophore. For this task, the third harmonic (355 nm, 200 mJ per pulse) was used to pump a 
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Type II XPO (Coherent). The 600 nm signal beam was isolated and frequency doubled in a 
XPO-UV frequency doubling crystal (Coherent) to produce a slightly divergent 300 nm beam 
with a ~5 ns pulse width and a pulse energy of ~500 μJ. This beam was then passed through a 
slow focusing lense and through the sample at a ~160°, producing a beam spot of 2 mm diameter 
on the sample. A 75 W Xe arc lamp (unpulsed, PTI) provided the probe light, which was focused 
onto the sample, overlapped with the pump beam, re-collimated after the sample, and focused 
onto the entrance slit of a Triax 320 spectrometer. 
Transient absorption experiments for BPA and Anq compounds were performed in a 2 mm 
cuvette under ambient conditions at 350 μM concentration for the Anq and 500 μM for BPA-Y-
OMe. Anq dipeptides were buffered to pH 7.5 with 20 mM Tris buffer, while BPA-Y-OMe was 
buffered to pH 4 with 20 mM succinic acid. For transient absorption experiments involving Anq-
Y-OH, 10 mL of solution were continuously flowed through a 2 mm cuvette during data 
collection to ensure that fresh sample was present for each laser shot. Time resolved experiments 
on Fl compounds were performed in a 1 cm cuvette with compounds at an optical concentration 
of 0.4 OD. These solutions were prepared with 10 mM KPi buffer at pH 7 and degassed on a 
high vac line to 10^–6 torr.  
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 Chapter IV 
 
 
Design of MLCT Excited States of Rhenium Polypyridyl 
Complexes for Direct Tyrosine Oxidation 
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4.1 Motivation 
We wish to develop electron transfer photo-oxidants with large absorption cross sections 
for λ > 300 nm and that are capable of oxidizing tyrosine directly from their excited state with 
charge separated states that persist into the nanosecond regime. Success in this area will allow 
the radical chemistry of RNR to be initiated with light in the absence of sacrificial electron 
acceptors, which can interfere with the RNR biochemistry. This chapter describes the 
synthesis and photophysical characterization of ReI polypyridal complexes designed for direct 
Y photo-oxidation from their MLCT excited state. 
4.2 Background 
In Chapter III, we discussed the utility of the 3MLCT excited state of Ru(bpy)32+ in 
photochemical oxidation of tyrosine. Tyrosine oxidation in these systems requires the flash-
quench generation of the more oxidizing RuIII intermediate.1 Unfortunately, the metallo-based 
quenchers (Ru(NH3)63+ and Co(NH3)63+) commonly used in this chemistry can inactive RNR 
(see Chapter IX). Other quenchers, such as methyl viologen, are strongly absorbing in their 
one-electron reduced state, thereby obscuring the spectral features of Y•.2 The flash-quench 
method of generating Y• can be circumvented by the design of long-lived, highly oxidizing 
3MLCT excited states, which can directly oxidize tyrosine.  
In this regard, ReI(NN)(CO)3(L) (NN= bpy, phen; L= halogen, pyridine, imidazole, or 
phosphine) compounds should prove useful. These complexes typically have MLCT bands 
that can be excited near 355 nm and their 3MLCT excited states are more oxidizing than that 
of Ru(bpy)32+ by ~0.4-0.7 V.3,4 These complexes also afford a certain degree of synthetic 
flexibility in that either the NN ligand5 or L may be functionalized with amide bonds, 
allowing for coupling of tyrosine and intramolecular Y• generation upon excitation with light. 
The excited state energies and lifetimes can be modulated by changes in both the NN and L 
ligand.3,4,6 We now present a foray into the synthesis and spectroscopy of ReI complexes 
designed for oxidation of tyrosine directly from their 3MLCT excited state. 
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4.3 Results  
Synthesis. Scheme 1 highlights the two approaches undertaken in the syntheses of the 
amino acid containing ReI complexes. The Re(bpy–AA–OtBu)(CO)3(X) complexes (AA = 
amino acid, A and Y; X = Cl–, SCN–) were prepared by pre-coupling the tert-butyl ester 
protected amino acid to the carboxylic acid of the bpy ligand using standard peptide coupling 
conditions. This modified bpy ligand was then added to the appropriate ReI synthon, followed 
by deprotection of the amino acid with trifluoroacetic acid. We note that these deprotection 
conditions led to scrambling of the 1H NMR peaks in the bpy-aryl region and the observation 
of biexponential emission decay lifetimes. These results are consistent with an exchange of 
the X– ligand by the deprotected carboxylate of the coupled amino acid. Similar complexes, 
Re(phen)(CO)3(L)+ (L = pyridine, imidazole, His), have previously been shown to exchange L 
for carboxylate in reactions with acetic acid and/or synthetically appended carboxylate 
groups.7 For the preparation of Re(bpy–AA–OtBu)(CO)3(CN) (AA = F and Y), exchange of 
X = Cl– by CN– did not proceed cleanly in the pre-coupling synthesis scheme and thus this 
method was abandoned. Instead, we found that a post-coupling strategy proved more 
synthetically feasible, in which bpy–COOH was first complexed to a ReI synthon employing 
methods used to obtain other Re(NN)(CO)3Cl (NN = polypyridyl) complexes.8 The Cl– anion 
was then exchanged for CN– and the amino acid coupled to the Re(bpy–COOH)(CO)3(CN) 
complex. Unlike the X = Cl– and SCN– derivatives, the X = CN– derivative proved to be inert 
to carboxylate exchange under the conditions of amino acid deprotection, thus enabling the 
isolation of pure Re(bpy–AA)(CO)3(CN) compounds for spectroscopic study. 
The amide linkage required for amino acid modification can also be furnished from 
carboxylic acid containing phosphine ligands of the analogous monodentate (P) 
Re(NN)(P)(CO)3+ 9- 12 and bidentate (PP) Re(NN)(PP)(CO)2+ 13 complexes. The dppe analog 
can be derivatized by introducing carboxylic acid functionality on the ethylene backbone in 
the protected form as the 2,3-bis(diphenylphosphino)maleic anhydride (bma). The anhydride 
can be allowed to react with the ReBr(CO)3(THF)2 synthon to form Re(bma)(CO)3Br.14 
Reaction of the anhydride with methanol yields the asymmetric methyl ester, carboxylic acid 
functionalized PP ligand.15 However, the free carboxylic acid and methyl ester groups are 
heat sensitive. Attempts to chelate phen to this complex at the high temperatures required for 
CO dissociation yielded the parent complex [Re(phen)(dppe)(CO)2](PF6), originally 
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synthesized by Schutte et al.,13 which was 
obtained in single crystal form, and 
structurally characterized by X-ray 
diffraction (Figure 4.1).  
An amide bond linkage can be 
established through the nucleophilic attack of 
benzyl amine on bma.37 This amide 
functionalized ligand was adapted to ReI 
coordination chemistry by reacting it with 
Re(CO)5Cl and subsequently chelating with 
phen to yield the model complex, 
[Re(phen)(PP–Bn)(CO)2](PF6). The extra 
carboxylic acid group, which remained on 
the Bn–PP–COOH ligand upon ring opening 
the anhydride, was observed to decarboxylate with the application of the heat required for 
subsequent PP and phen chelation. The crystal structure of one geometric isomer of 
[Re(phen)(PP–Bn)(CO)2](PF6), shown in Figure 4.2, confirms the formation of the crucial 
amide bond to one carboxylic acid and the decarboxylation of the other. The two CO ligands 
adopt a cis stereochemistry and the phosphorus atom on the derivatized side of the chelating 
ligand is trans to CO. The other isomer, which did not crystallize, has this phosphorus trans 
to the nitrogen of phen. The bite angles of the PP–Bn and phen ligands (∠P(1)–Re(1)–P(2) = 
 
Figure 4.1. Thermal ellipsoid plot of single 
isomer of [Re(phen)(PP)(CO)2]PF6 shown at 
50% probability. The PF6– anion has been 
removed for clarity. 
 
Scheme 4.1. Syntheses of amino acid containing ReI complexes. 
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80.72o and ∠N(1)–Re(1)–N(2) = 75.37o) 
create a distorted octahedral coordination 
geometry. The Re–C bond distances are 
slightly longer (d(Re–C) = 1.902 and 1.928 
Å) and the C–O bond distances slightly 
shorter (d(C–O) = 1.169 and 1.164 Å) than a 
crystallographically characterized relative, 
Re(CO)2(P(OEt)3)(PPh3) (4,4´-Me2-2,2´-
bpy)+, which features two monodentate 
phosphine ligands trans to one another 
(d(Re–C) = 1.84(3) and 1.88(3) Å; d(C–O) = 
1.18(4) and 1.17(3) Å).11  
The carboxylic acid derivatives of the 
monodentate and bidentate phosphines can be modified with amino acids. We present the 
chemistry of only the former owing to their greater water solubility and higher MLCT energy 
(vide infra). The [Re(phen)(P–AA)(CO)3](PF6) (AA = F and Y) complexes were synthesized 
using the AA-ligand post-coupling strategy of Scheme 1. These compounds were inert to 
carboxylate exchange upon amino acid deprotection, as exhibited by the single, downfield 
shifted peak in the 31P NMR spectrum (versus free phosphine), satisfactory MALDI-TOF and 
elemental analysis, and the single exponential behavior of the emission decay (vide infra).  
 
Figure 4.2. Thermal ellipsoid plot of single 
isomer of [Re(phen)(PP-Bn)(CO)2]PF6• 
CDCl3 shown at 50% probability. The PF6– 
anion, the solvent molecule and phosphine 
phenyl groups have been removed for clarity. 
Photophysics. The spectroscopic properties for the ReI polypyridyl carbonyl complexes 
are summarized in Table 4.1. The MLCT transition for the ReI polypyridyl carbonyl 
complexes appears as a shoulder on the strong π → π* absorption profile of the polypyridyl 
ligand. As has been observed previously,12 the MLCT absorption band of the biscarbonyl 
complexes is red-shifted from that of their tricarbonyl counterparts. Excitation into the MLCT 
absorbance manifold produces the broad, structureless emission bands shown in Figure 4.3, 
where the intensity has been scaled in quanta (I × λ2) and normalized.  
The emission maximum (Eem) of Re(bpy-COOH)(CO)3(X) decreases across the series X = 
CN– > Cl– > SCN–. Derivatization of the bpy ligand with an amino acid causes a red-shift of 
the MLCT emission as evidenced from the comparison of the Re(bpy–COOH)(CO)3(CN) and 
Re(bpy–F)(CO)3(CN) emission maxima in Table 4.1. Numerous studies of the room 
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temperature emission properties of 
ReI(NN)(CO)3L+ complexes establish the emission 
to be of 3MLCT parentage.16 A more detailed 
analysis of ReI(NN)(CO)3Cl photophysics reveals 
that the MLCT emission arises from three states of 
triplet orbital parentage in thermal equilibrium at 
room temperature.17 The situation may be further 
complicated by the presence of an intraligand 3ππ* 
excited state that is energetically proximate to the 
3MLCT excited state, as observed for ReI(s-
hen)(CO)3Cl complexes (s-phen = 4,7-Me2-1,10-
phen, 5,6-Me2-1,10-phen, 3,4,7,8-Me2-1,10-
phen).
p
18 The case of energetically proximate 
intraligand and charge transfer excited states, 
however does not appear to be pertinent to 
ReI(phen)(CO)3(phosphine)+ complexes because the room temperature emission does not 
exhibit vibronic structure, which is a signature of 3ππ* emission from transition metal 
polypyridyl complexes.19 Accordingly, we ascribe the emission band of ReI(phen)(CO)3(P–
F)+ shown in Figure 4.3 to a predominantly 3MLCT parentage, as assigned for other 
Re(phen)(CO)3(L)+ (L ≠ phosphine) complexes with long lifetimes and similar emission 
envelopes.20 As noted previously, removal of a CO ligand to form ReI(NN)(dicarbonyl)+ 
complexes lowers the energy of the 3MLCT excited state relative to their tricarbonyl 
counterparts. In accordance with these observations, the emission band maximum of 
[Re(phen)(dppe)(CO)2](PF6) is 2800 cm–1 to the red of [Re(phen)(P–F)(CO)3](PF6).  
 
Figure 4.3 Normalized, corrected 
emission spectra for Re(bpy-
COOH)(CO)3(X) [X = CN– (▬), Cl– 
(▬), SCN– (▬)] and [Re(phen)(P–
F)(CO)3](PF6) (▬) in 10 mM phosphate 
buffer at pH 7 and [Re(phen)(dppe) 
(CO)2](PF6) (▬) in CH3CN. 
The precise determination of the 3MLCT excited state energy of the ReI polypyridyl 
carbonyl complexes is problematic for several reasons. Location of the E00 for the emitting 
state cannot be deduced from the overlap of the absorption and emission bands, as predicted 
by the Franck-Condon principle, because absorption occurs into the 1MLCT state and 
emission occurs from the corresponding 3MLCT state. Moreover, the room temperature 
emission bands of d6 polypyridyl complexes are usually broad and featureless and thus the υ´ 
= 0 → υ = 0 transition cannot be directly observed within the emission envelope. Evaluation 
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of the emission energy from low temperature glasses of ReI complexes is further complicated 
by the rigidochromic effect.36,21 
In the absence of a direct measure of the excited state energy, a Frank-Condon analysis of 
the emission band shapes was employed. The values of E0, S, frequency ( ωh ), and band 
width ( 21vΔ ) listed in Table 4.2 were obtained by fitting the emission spectra shown in Figure 
4.3 to eq (3) (see Experimental Section). The E0 and 21vΔ  values may be used calculate the 
free energy of the MLCT excited state, , according to the following:oMLCTGΔ 41,42  
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)Δ(
       Δ
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The values of  are listed in Table 4.2. Within the homologous polypyridyl series, 
Re(bpy)(CO)3X, the decrease in  across the series X = CN– > SCN– > Cl– is paralleled 
by a decrease in the emission quantum yields (Φem) and lifetimes (τem) listed in Table 4.1. 
This behavior is in accordance with the predictions of the energy gap law.
o
MLCTGΔ
o
MLCTGΔ
o
MLCTGΔ
16 There are several 
other notable features of the Φem and τem listed in Table 4.1: (1) [Re(phen)(dppe)(CO)2](PF6) 
in CH3CN exhibits a slightly faster τem and lower Φem than that previously reported in the less 
polar CH2Cl2 solvent.13 (2) Solutions of the benzyl amide conjugate, [Re(phen)(PP–
Bn)(CO)2](PF6), exhibit bi-exponential emission decay behavior (τ1 = 1.1 μs and τ2 = 4.3 μs) 
as a result of a mixture of geometric isomers. A crystal of the isomer characterized by X-ray 
diffraction (shown in Figure 4.1) dissolved in CH3CN exhibits a monoexponential decay (τ = 
0.96 μs) equivalent to τ1 of the isomer mixture. We therefore ascribe the short lifetime decay 
to the excited state of the isomer shown in Figure 4.1 and the longer lifetime decay to the 
other isomer. (3) The [Re(phen)(CO)3(P–F)](PF6) complex exhibits the longest τem and 
highest Φem and  of all the complexes in this study. The more energetic excited state 
and/or disposition of a phosphine trans to a CO may be responsible for a photolysis reaction 
that we observe for this complex upon extensive laser irradiation. A similar photochemical 
behavior observed for ReI(NN)(CO)3(PR3)+ complexes upon irradiation with light (λ > 320 
nm) has been attributed to loss of a CO ligand.12   
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Table 4.1. Spectroscopic and Photophysical Properties of the MLCT Excited State of 
ReI Polypyridyl Carbonyl Complexes in Aqueous Solution at Room Temperature 
Complex Eabs(cm–1) Eem(cm–1)a Φem a  τem(ns)a
Re(bpy–COOH)(CO)3Cl ~28500 15700 1.1 × 10–3 5.5 
Re(bpy–COOH)(CO)3SCN 27400 15100 1.6 × 10–3 12.0 
Re(bpy–COOH)(CO)3CN 28600 16400 1.4 × 10–2 86.5 
Re(bpy–F)(CO)3CN 27900 15800 – 59.4 
[Re(phen)(P–F)(CO)3](PF6) 27100 19100 9.4 × 10–2 3900 
[Re(phen)(dppe)(CO)2](PF6)b ~27000 16300 7.8 × 10–2 3200 
[Re(phen)(PP–Bn)(CO)2](PF6)b,c –  – – 940 
a λexc = 355 nm.  b CH3CN solvent. c Isomer shown in Figure 1. Isolated solids from synthesis 
exhibit biexponential behavior arising from the presence of the two isomers (see text). 
 
Table 4.2. Emission Spectral Parameters Obtained from Fitting Corrected Emission Band 
to Eq. (3) and Energy of the MLCT Excited State Calculated from Eq. (1) 
Compound E0 
cm–1 
S ωh  
cm–1 
21vΔ  
cm–1 
o
MLCTGΔ  
eV 
Re(bpy–COOH)(CO)3Cl 16400 1.0 1900 2800 2.47 
Re(bpy–COOH)(CO)3SCN 16300 1.5 1700 3000 2.52 
Re(bpy–COOHOH)(CO)3CN 16800 0.8 2000 3100 2.60 
Re(bpy–F)(CO)3CN 16500 0.9 1800 3200 2.59 
[Re(phen)(P–F)(CO)3](PF6) 20300 1.8 1200 1800 2.70 
[Re(phen)(dppe)(CO)2](PF6)a 16700 0.7 1700 2600 2.42 
a Solvent is CH3CN 
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The high values of  for the amino acid conjugates, [Re(phen)(CO)3(P–F)](PF6) 
and Re(bpy–F)(CO)3CN, make these platforms excellent candidates for promoting the 
oxidation of tyrosine directly from the excited state. The excited state reduction potentials for 
the ReI polypyridyl tricarbonyl complexes are listed in Table 4.3 along with the modified 
Latimer diagram from which they were determined. The portion of the diagram relevant to 
tyrosine oxidation is highlighted in black. The ground state Eo(ReI/0) and Eo(ReII/I) reduction 
potentials were determined from differential pulse voltammetry (DPV) measurements. 
Reversible electrochemical behavior is observed for the Eo(ReI/0) redox process, whereas the 
Eo(ReII/I) redox couple is quasi-irreversible and is therefore reported as a peak potential, Ep, in 
Table 4.3.  
o
MLCTGΔ
Photochemical Y• generation in ReI Complexes. With the excited state reduction potentials in 
hand, we next investigated the facility of tyrosine to quench the emission of these powerful 
Table 4.3. Differential Pulse Voltammetrya and Excited State Reductionb and 
Oxidation Potentialsc of Amino Acid-Derivatized ReI Polypyridyl Tricarbonyl 
Complexes 
 
Complexes Ep(ReI I / I)a Eo(ReI / 0) a Eo(ReI*/ 0) b Eo(ReI*/ II)c 
Re(bpy–A–OtBu)(CO)3Cl 0.94 –1.58 – – 
Re(bpy–F)(CO)3CN 1.09 –1.65 1.59 0.85 
[Re(phen)(P–F)(CO)3](PF6) 1.52 –1.57 1.78 0.53 
a Reported in V vs. Fc+/Fc with 0.1 M (Bu4N)PF6 supporting electrolyte in CH3CN. b 
Eo(ReI* / 0) =  + E○( ReI / 0) vs. NHE.  c Eo(ReI* / II) =  – E○(ReI I / I) vs. 
NHE. 
o
MLCTGΔ oMLCTGΔ
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excited state oxidants. A comparison of 
the luminescence properties of Re(bpy–
AA)(CO)3CN (AA = Y and F) 
complexes in 10 mM aqueous phosphate 
buffer at pH 7 established no 
phosphorescence quenching of the 
tyrosine complex. However, 
deprotonation of the tyrosine phenol 
(pKa = 10.1 for L-tyrosine)22 at pH 12 
induces significant emission quenching. 
A rate constant for this process may be 
determined from the excited state 
lifetimes in the presence and absence of 
quenching, 
 
FY
q
1    1      ττ −=k  (2) 
where τY and τF are the lifetimes of 
emission decay for the Y and F 
derivatives, respectively. The measured 
lifetime of τY = 1.2 ns for Re(bpy–
Y)(CO)3CN yields a kq = 8.2 × 108 s–1. 
 
Figure 4.4 Top: TA spectra of a pH 7 solution of 
Re(bpy–Y)(CO)3(CN) at 15 (▬), 65 (▬), 115 (– –
), and 215 ns (• – •) (Insets: Single wavelength 
kinetic traces and monoexponential fits for the 
disappearance of the 380  and 475 nm (3MLCT) 
signal). Bottom: Same experiment at pH 12 
(Insets: Single wavelength kinetic traces and 
monoexponential fits for the disappearance of the 
410 (Y•)  and 500 nm (bpy•–) signal. 
In contrast to the pH behavior of Re(bpy–Y)(CO)3CN quenching, the emission from 
[Re(phen)(P–Y)(CO)3](PF6) was quenched at all pHs. At pH 7 in 10 mM phosphate buffer, τY 
= 2.2 μs and Φem,Y = 0.059 for the tyrosine derivative whereas τF = 3.9 μs and Φem,F = 0.094 
for the phenylalanine derivative (τF and Φem,F are independent of pH), yielding a quenching 
rate constant of kq = 2.0 × 105 s–1. As noted above, the [Re(phen)(P–AA)(CO)3](PF6) 
complexes are subject to CO dissociation under prolonged irradiation. We contend that the 
kinetics for CO dissociation upon complex excitation are the same for the F and Y derivatives 
and do not vary with pH. Under this assumption, eq. (2) isolates the quenching process due to 
Y, and we assign this process to the PCET oxidation of Y by the 3MLCT excited state. 
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Chapter V will present a detailed analysis of the 
PCET mechanisms involved with this reaction. 
Nanosecond transient absorption 
spectroscopy (TA) was then performed to 
characterize the electron transfer products of 
these photochemical reactions. The TA profiles 
following 355 nm excitation for Re(bpy–
Y)(CO)3(CN) in pH 7 and 12 solutions are 
presented in Figure 4.4. The ΔOD spectrum at 
pH 7 (Figure 4.4, top panel) is the same as that 
obtained for Re(bpy–F)(CO)3(CN) (not shown) 
and consists of maxima at 380 and ~475 nm and 
a minimum at 400 nm. These features are in 
accord with that observed for the 3MLCT state of ReI(NN)(CO)3L complexes.16,23 In support 
of a similar assignment here, the single wavelength transient signals obtained at 380 and 475 
nm shown in the top insets of Figure 4.4 decay to baseline with time constants (60.6 and 59.8 
ns, respectively) identical to the emission lifetime of the 3MLCT excited state (60.4 ns). In 
contrast, the time-resolved absorption spectra at pH 12 (Figure 4.4, bottom panel) are not that 
of the 3MLCT excited state. The transient profile is dominated by absorptions at 410 and 520 
nm. The 410 nm feature coincides with the absorption maximum of Y•24 and the 520 nm 
feature resembles the absorption maxima of bpy•–.25,26 For comparison, the 
spectroelectrochemical UV/Vis absorption spectrum of the reduced Re(bpy•––Y-
OtBu)(CO)3CN in DMF is shown Figure 4.5. The spectrum contains a maximum at 530 nm 
with vibronic fine structure similar to that observed in the TA spectra at the bottom of Figure 
4.4. These results provide direct evidence for the charge separated state, Re(bpy•––
Y•)(CO)3(CN). The time-evolved gray traces establish that the overall profile does not change 
with time. The single wavelength transient signals obtained at 410 and 500 nm and shown in 
the bottom insets decay concomitantly with a rate constant of kCR = 2.2 × 107 s–1, which we 
attribute to charge recombination. Unfortunately, the [Re(phen)(P–Y)(CO)3](PF6) was not 
sufficiently soluble in aqueous solution to allow for TA experiments. 
 
Figure 4.5 Spectroelectrochemical UV/Vis 
absorption spectrum of Re(bpy–Y–
OtBu)(CO)3(CN) at -0.75 V vs. Fc+/Fc in 
DMF.
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4.4 Discussion 
Electron Shuttling in Y Oxidation. Intramolecular shuttling of electrons between tyrosine 
and the MLCT excited state may occur along two fundamentally different pathways, 
designated in Scheme 4.2 as pop-pop and pop-fizz. The latter describes the electron transfer 
events induced by excitation of typical Re(NN)(CO)3X complexes, in which the donor is 
attached to the polypyridyl ligand, as is the case for Re(bpy–Y)(CO)3CN. Photon absorption 
(“pop”) forms the 3ReII(bpy•––Y)(CO)3CN MLCT state. Subsequent tyrosine oxidation occurs 
by a contraposed electron flow, whether through the bpy or through space. The pathway is 
anticipated to incur several barriers to Y• generation. Oxidation of tyrosine brings the electron 
through the reduced bpy ligand. Though the effect of superexchange through a reduced 
polypyridyl ligand has not been investigated critically, general theory suggests that the 
increased energy gap between reduced donor and oxidized acceptor levels would retard the 
tunneling rate for Y• generation.27 More problematic is the favored back reaction resulting 
from the disposition of a neighboring hole and electron on Y• and bpy•– respectively. The 
correlation between the back electron transfer rate and proximity of hole/electron pairs has 
been examined in a comparative study of ReI(bpy)(CO)3(py)+ complexes containing a 
phenothiazine (PTZ) electron donor coupled to the pyridine ligand in Re(4,4´-Me2-
bpy)(CO)3(py–PTZ)+, and bipyridine ligand in Re(PTZ–CH2–bpy)(CO)3(4-Etpy)+.28 An 
accelerated back electron transfer rate was established for the former, which exhibits a 
Re(PTZ•+–CH2-bpy•–)(CO)3(4-Etpy)+ charge distribution upon intramolecular quenching of 
the MLCT excited state. A similar charge distribution is retained in the charge separated state 
of the tyrosine-modified ReI polypyridyl complex, ReI(bpy•––Y•)(CO)3CN, thus accounting 
for its short lifetime of 45 ns (“fizz”).  
The hole/electron pair is optimally separated by appending the tyrosine ligand to the sixth 
ligand, away from the polypyridyl ligand. We chose phosphine ligands as the scaffold for the 
amino acid owing to the high energies and long lifetimes of Re(NN)(PP)(CO)2+ and 
Re(NN)(P)(CO)3+ model compounds. Of these two platforms, the latter was more ideally 
suited to Y• generation owing to a greater water solubility and intrinsically higher MLCT 
excited state energy. The architecture of the ReI(phen)(CO)3(P–Y)+ complex permits the 
charge distribution in Scheme 4.2 to be established. Excitation pops the electron to the phen 
ligand in the MLCT state to produce ReII(phen•–)(CO)3(P–Y)+, which then allows for the 
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Scheme 4.2 Electron shuttling mechanisms in oxidation of Y by 3MLCT excited states of ReI 
complexes 
electron to flow from the phosphine ligand, quenching the ReII hole and furnishing the 
ReI(phen•–)(CO)3(P–Y•)+ radical intermediate. The electron and hole are disposed at maximal 
distance within the primary coordination sphere of the complex, presumably retarding the rate 
of charge recombination.  
4.5 Conclusions 
Rhenium(I) polypyridyl complexes provide suitable platforms for the intramolecular 
photogeneration of tyrosyl radicals owing to the significant oxidizing power of their MLCT 
excited states. The excited state of Re(bpy)(CO)3CN complex can oxidize Y, but only at pHs 
where the tyrosine phenol is deprotonated. For this complex to find application to our work 
with photochemical RNRs and to generate Y• at near neutral pH, we need to develop a 
method to lower the pKa of the tyrosine phenol. Unnatural amino acids can prove useful in 
this regard and are discussed in Chapter VI. 
 On the other hand, phosphine-containing ReI polypyridyl complexes are particularly 
useful excited state oxidants of Y for three reasons. First, the MLCT excited state is highly 
energetic and presents a significant overpotential for tyrosine oxidation. The additional energy 
of the MLCT excited state is crucial for amino acid oxidation because, unlike a simple ET 
quenching process, it is needed to overcome the barrier for proton transfer as well.29,30 
Second, the phosphine complexes exhibit a dramatically extended lifetime of the MLCT 
excited state, allowing for a higher Stern-Volmer constant (SV = kqτo) for quenching.31 
Finally, by appending the tyrosine to an ancillary ligand, remote from the electron accepting 
polypyridyl ligand in MLCT excitation, the intramolecular shuttling occurs via a 
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unidirectional electron cascade for the efficient generation and preservation of the 
photogenerated Y•.  
The ReI phosphine scaffolds presented here provide a convenient method for investigating 
radical-based mechanisms in biology because, unlike previous approaches, the amino acid 
radical can be generated directly and on microsecond timescales without the need for external 
oxidants or reductants. Moreover, unlike previous ReI complexes used to photogenerate 
amino acid radicals, such as ReI(phen)(CO)3(His)+,32- 34 the ReI  phosphine complexes are 
resistant to carboxylate exchange. Thus these MLCT states may be used to initiate and study 
radical reactions from peptides or within proteins containing multiple aspartate or glutamate 
residues. Finally, we note that this method is not necessarily specific to tyrosine but can be 
extended to other amino acids by simple derivatization of the monophosphine.  
4.6 Experimental Section 
Materials and Methods. L-Tyrosine tert-butyl ester (Y–OtBu), L-alanine tert-butyl ester 
hydrochloride (A–OtBu•HCl), 1-hydroxybenzotriazole (HOBt) (NovaBiochem), L-phenyl-
alanine tert-butyl ester hydrochloride (F–OtBu•HCl) (Advanced ChemTech), magnesium 
sulfate (MgSO4) (EMD), thallium hexafluorophosphate (TlPF6) (Strem), potassium 
thiocyanate (KSCN), sodium cyanide (NaCN), 1-(3-dimethylamino-propyl)-3-
ethylcarbodiimide hydrochloride (WSC•HCl), dimethylaminopyridine (DMAP), N-
methylmorpholine (NMM), pentacarbonylchlororhenium (Re(CO)5Cl), 1,10-phenanthroline 
(phen), 4-diphenylphosphinobenzoic acid (Ph2PPh–COOH) (Aldrich) and trifluoroacetic acid 
(TFA, 99.9%) (J. T. Baker) were used as received. 4´-Methyl-2,2´-bipyridine-4-carboxylic 
acid (bpy–COOH),35 cis-1,2-(bisdiphenylphospino)ethylene)(1,10-
phenanthroline)(dicarbonyl)rhenium(I) hexafluorophosph- 
ate ([Re(phen)(dppe)(CO)2](PF6)),13 and tricarbonylchloro(1,10-phenanthroline)rhenium(I) 
(Re-(phen)(CO)3Cl)36 were prepared as previously described. cis-1-Carboxy-2-(N-
benzylcarbamoyl)-1,2-bis(diphenylphosphino)ethene (HOOC–PP–Bn)37 was prepared from 
2,3-bis(diphenylphosphino)maleic anhydride (bma)38 and benzylamine (Aldrich). 
Tricarbonylchloro(4´-methyl-2,2´-bipyridine-4-carboxylic acid)rhenium(I) (Re(bpy–
COOH)(CO)3Cl). Re(CO)5Cl (347 mg, 0.962 mmol, 1.0 eq) and bpy–COOH (206 mg, 0.962 
mmol, 1.0 eq) were added to toluene (25 mL) contained in a round bottom flask and the 
mixture was heated at reflux overnight. The bright orange solution was cooled to room 
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temperature, and the yellow/orange solid was isolated by filtration, washed with ether, and 
dried under vacuum (470 mg, 94%). 1H NMR (300 MHz, d-acetone, 25 oC) δ = 2.67 (s, 3H, 
bpy-CH3), 7.66 (m, 1H, bpy-H), 8.21 (m, 1H, bpy-H), 8.81 (s, 1H, bpy-H), 8.95 (d, 1H, bpy-
H), 9.00 (s, 1H, bpy-H), 9.29 (d, 1H, bpy-H). 1H NMR (300 MHz, CD3OD, 25 oC) δ = 2.62 
(s, 3H, bpy-CH3), 7.55 (m, 1H, bpy-H), 8.13 (m, 1H, bpy-H), 8.57 (s, 1H, bpy-H), 8.87 (d, 
1H, bpy-H), 8.98 (s, 1H, bpy-H), 9.19 (d, 1H, bpy-H). 
Tricarbonylthiocyanato(4´-methyl-2,2´-bipyridine-4-carboxylic acid)rhenium(I) (Re-
(bpy–COOH)(CO)3SCN). Re(bpy–COOH)(CO)3Cl (200 mg, 0.385 mmol, 1.0 eq) and 
KSCN (3.73 g, 38.5 mmol, 100 eq) were combined in a flask with 20 mL of 1:1 95% 
ethanol/water and refluxed overnight under N2. The ethanol was removed in vacuo, and the 
mixture was extracted with ethyl acetate. The various extracts were combined, dried over 
MgSO4, and the solvent was removed in vacuo to furnish a red powder (136 mg, 65%). 1H 
NMR (300 MHz, d-acetone, 25 oC) δ = 2.70 (s, 3H, bpy-CH3), 7.73 (d, 1H, bpy-H), 8.28 (m, 
1H, bpy-H), 8.87 (s, 1H, bpy-H), 8.99 (d, 1H, bpy-H), 9.07 (s, 1H, bpy-H), 9.33 (d, 1H, bpy-
H). Anal. Calcd for C16H10N3O5ReS: C, 35.42 H, 1.86; N, 7.75; S, 5.91. Found: C, 35.35; H, 
1.81; N, 7.71; S, 5.97. 
Tricarbonylcyano(4´-methyl-2,2´-bipyridine-4-carboxylic acid)rhenium(I) (Re(bpy–
COOH)(CO)3CN). Re(bpy–COOH)(CO)3Cl (200 mg, 0.385 mmol, 1.0 eq) and NaCN (1.89 
g, 38.5 mmol, 100 eq) were combined in a round bottom flask with 40 mL of 1:1 95% 
ethanol/water, and the mixture was heated at reflux for 6 h. The ethanol was removed in 
vacuo yielding a bright yellow precipitate, which was isolated by filtration, washed with 
copious amounts of water and ether, and dried under vacuum (168 mg, 86%). 1H NMR (300 
MHz, d-CD3OD, 25 ºC) δ = 2.63 (s, 3H, bpy-CH3), 7.54 (d, 1H, bpy-H), 8.03 (m, 1H, bpy-
H), 8.49 (s, 1H, bpy-H), 8.89 (m, 2H, bpy-H), 9.08 (d, 1H, bpy-H). Anal. Calcd for 
C16H10N3O5Re: C, 37.65; H, 1.97; N, 8.23. Found: C, 37.53; H, 2.06; N, 8.20. 
4´-Methyl-2,2´-bipyridine-4-alanine tert-butyl ester (bpy–A–OtBu). Bpy–COOH 
(0.502 g, 2.34 mmol, 1.0 eq), A–OtBu•HCl (0.425 g, 2.34 mmol, 1.0 eq), WSC•HCl (0.493 
g, 2.57 mmol, 1.1 eq), and HOBt (0.374 g, 2.57 mmol, 1.1 eq) were combined in a round 
bottom flask. CH2Cl2 100 mL and NMM (1 mL, 9.4 mmol, 4 eq) were added and the reaction 
was stirred overnight. The reacted solution was washed in a separatory funnel with 2 × 50 mL 
of water, 10% citric acid, and 1.0 M NaHCO3 and the organic layer was collected and dried 
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over MgSO4. The solvent was removed in vacuo to yield an oil, which solidified under high 
vacuum as a white mass (0.5947 g, 57%). 1H NMR (300 MHz, CDCl3, 25 oC) δ =1.47 (m, 
12H, tBu and A-CH3), 2.45 (s, 3H, bpy-CH3), 4.72 (m, 1H, A-CH), 7.07 (d, 1H, N-H), 7.15 
(d, 1H, bpy-H), 7.70 (d, 1H, bpy-H), 8.25 (s, 1H, bpy-H), 8.55 (d, 1H, bpy-H), 8.70 (s, 1H, 
bpy-H), 8.78 (d, 1H, bpy-H). 
4´-Methyl-2,2´-bipyridine-4-tyrosine tert-butyl ester (bpy–Y–OtBu). Bpy–COOH 
(0.750 g, 3.50 mmol, 1.0 eq), Y–OtBu (0.830 g, 3.50 mmol, 1.0 eq), WSC•HCl (0.738 g, 3.85 
mmol, 1.1 eq), HOBt (0.520 g, 3.85 mmol, 1.1 eq) and DMAP (43 mg, 0.35 mmol, 0.1 eq) 
were combined in a round bottom flask. Methylene chloride (CH2Cl2, 200 mL) and NMM 
(1.7 mL, 15.4 mmol, 4.4 eq) were added and the reaction was stirred overnight. The reacted 
solution was washed in a separatory funnel with 4 × 100 mL of water and the organic layer 
was collected and dried over MgSO4. The solvent was removed in vacuo to yield a yellow oil, 
which under high vacuum produced an off-white solid. The solid was dissolved in a few mL 
of ethyl acetate, loaded onto a Chromatotron plate (alumina, 2mm), and eluted with ethyl 
acetate. The first band to elute was collected and the solvent removed in vacuo to yield an oil, 
which solidified under high vacuum as an off-white solid (0.5921 g, 39%). 1H NMR (300 
MHz, CDCl3, 25 oC) δ =1.47 (s, 9H, tBu), 2.45 (s, 3H, bpy-CH3), 3.16 (m, 2H, Y-CH2), 4.96 
(m, 1H, Y-CH), 6.68 (d, 2H, phenol-H), 7.02 (m, 2H, phenol-H and bpy-H), 7.17 (d, 1H, N-
H), 7.70 (m, 1H, bpy-H), 8.23 (s, 1H, bpy-H), 8.53 (d, 1H, bpy-H), 8.63 (s, 1H, bpy-H), 8.78 
(d, 1H, bpy-H). 
Tricarbonylchloro(4´-methyl-2,2´-bipyridine-4-alanine tert-butyl ester) rhenium(I) 
(Re(bpy–A–OtBu)(CO)3Cl. Re(CO)5Cl (500 mg, 1.38 mmol, 1.0 eq) and bpy–A–OtBu (471 
mg, 138 mmol, 1.0 eq) were combined in a round bottom flask with 50 mL of toluene and the 
mixture heated at reflux overnight. The yellow suspension was cooled in an ice bath and the 
yellow solid was isolated by filtration, washed with ether and dried under vacuum (722 mg, 
81%). 1H NMR (300 MHz, d-acetone, 25 oC) δ = 1.47 (m, 12H, tBu), 2.59 (s, 3H, bpy-CH3), 
4.41 (m, 1H, Y-CH), 7.61 (d, 1H, bpy-H), 8.02 (m, 1H, bpy–H), 8.70 (s, 1H, bpy-H), 8.85 (d, 
1H, bpy-H), 8.95 (s, 1H, bpy-H), 9.13 (d, 1H, bpy-H), 9.31 (m, 1H, N-H) Anal. Calcd for 
C22H23ClN3O6Re: C, 40.83 H, 3.58; N, 6.49. Found: C, 40.96; H, 3.72; N, 6.52. 
Tricarbonylchloro(4´-methyl-2,2´-bipyridine-4-tyrosine tert-butyl ester)rhenium(I) 
(Re(bpy–Y–OtBu)(CO)3Cl. Re(CO)5Cl (467 mg, 1.29 mmol, 1.0 eq) and bpy–Y–OtBu (560 
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mg, 1.29 mmol, 1.0 eq) were combined in a round bottom flask with 50 mL of toluene and the 
mixture heated at reflux overnight. The yellow suspension was cooled in an ice bath and the 
yellow solid was isolated by filtration, washed with ether and dried under vacuum (668 mg, 
70%). 1H NMR (300 MHz, d-acetone, 25 oC) δ = 1.36 (s, 9H, tBu), 2.58 (s, 3H, bpy-CH3), 
3.01 (m, 2H, Y-CH2), 4.57 (m, 1H, Y-CH), 6.66 (d, 2H, phenol-H), 7.08 (d, 2H, phenol-H), 
7.61 (d, 1H, bpy-H), 7.97 (m, 1H, bpy-H), 8.65 (s, 1H, bpy-H), 8.86 (m, 2H, bpy-H), 9.17 (m, 
1H, bpy-H), 9.33 (m, 1H, N-H) Anal. Calcd for C28H27ClN3O7Re: C, 45.50 H, 3.68; N, 5.68. 
Found: C, 45.36; H, 3.75; N, 5.74. 
Tricarbonylthiocyanato(4´-methyl-2,2´-bipyridine-4-tyrosine tert-butyl ester)rhe-
nium (I) (Re(bpy–Y–OtBu)(CO)3SCN. Re(bpy–Y–OtBu)(CO)3Cl (111 mg, 0.150 mmol, 1.0 
eq) and KSCN (1.46 g, 15 mmol, 100 eq) were combined in a round bottom flask with 40 mL 
of 1:1 95% ethanol/water and heated at reflux overnight. The ethanol was removed in vacuo 
and the red precipitate was isolated by filtration, washed with copious amounts of water, and 
dried under high vacuum (91 mg, 80%). 1H NMR (300 MHz, d-acetone, 25 oC) δ = 1.45 (s, 
9H, tBu), 2.70 (s, 3H, bpy-CH3), 4.87 (m, 1H, Y-CH), 6.79 (m, 2H, phenol-CH2), 7.19 (m, 
2H, phenol-CH2), 7.73 (m, 1H, bpy-H), 8.12 (m, 1H, bpy-H), 8.46 (d, 1H, N-H), 8.69 (m, 1H, 
bpy-H), 8.90 (m, 1H, bpy-H), 8.98 (m, 1H, bpy-H), 9.25 (m, 1H, bpy-H). 
Tricarbonylcyano(4´-methyl-2,2´-bipyridine-4-phenylalanine)rhenium(I) (Re(bpy–
F)-(CO)3CN). Re(CO)3(bpy–COOH)(CN) (130 mg, 0.321 mmol, 1.0 eq), F–OtBu•HCl (72 
mg, 0.321 mmol, 1.0 eq), WSC•HCl (53 mg, 0.353 mmol, 1.1 eq) and HOBt (37 mg, 0.353 
mmol, 1.1 eq) were combined in a round bottom flask with 25 mL of DMF. NMM (0.12 mL, 
4.0 eq) was added and the mixture was stirred overnight. The solvent was removed in vacuo, 
and the resulting yellow oil was dissolved in 100 mL CH2Cl2 and washed with 2 × 25 mL 
water, 10% citric acid, 1.0 M NaHCO3 and water in that order. The organic phase, isolated 
with a separatory funnel, was dried over MgSO4 and the solvent was removed in vacuo. The 
resulting yellow solid was dissolved in 10 mL of 1:1 TFA/CH2Cl2 and stirred for 1 h. The 
solution was concentrated to <1 mL under a stream of N2 and triturated with ether. The bright 
yellow solid that precipitated was isolated by filtration, washed with copious amounts of ether 
and dried under vacuum (82 mg, 39%). 1H NMR (300 MHz, d-CD3OD, 25 oC) δ = 2.64 (s, 
3H, bpy-CH3) 3.13 (m, 2H, F-CH2), 4.96 (m, 1H, F-CH), 7.30 (m, 5H, F-ph), 7.57 (m, 1H, 
bpy-H), 7.86 (m, 1H, bpy-H,), 8.49 (m, 1H, bpy-H), 8.79 (m, 1H, bpy-H), 8.89 (m, 1H, bpy-
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H), 9.14 (m, 1H, bpy-H) Anal. Calcd for C25H19N4O6Re: C, 45.66 H, 2.91; N, 8.52. Found: C, 
45.48; H, 2.85; N, 8.42. 
Tricarbonylcyano(4´-methyl-2,2´-bipyridine-4-tyrosine)rhenium(I) (Re(bpy–
Y)(CO)3-(CN). The synthesis of the tyrosine derivative was the same as that for the 
phenylalanine derivative, except that Re(CO)3(bpy–COOH)(CN) (193 mg, 0.377 mmol, 1.0 
eq), WSC•HCl (80 mg, 0.415 mmol, 1.1 eq), and HOBt (43 mg, 0.415 mmol, 1.1 eq) were 
combined with Y–OtBu (90 mg, 0.377 mmol, 1.0 eq), instead of F–OtBu•HCl (49%). 1H 
NMR (300 MHz, d-CD3OD, 25 oC) δ = 2.64 (s, 3H, bpy-CH3), 3.03 (m, 2H, Y-CH2), 4.87 (m, 
1H, F-CH), 6.71 (d, 2H, phenol-H), 7.11 (d, 2H, phenol-H), 7.57 (m, 1H, bpy-H), 7.87 (m, 
1H, bpy-H,), 8.48 (m, 1H, bpy-H), 8.76 (m, 1H, bpy-H), 8.89 (m, 1H, bpy-H), 9.15 (m, 1H, 
bpy-H) Anal. Calcd for C25H19N4O7Re: C, 44.57 H, 2.84; N, 8.23. Found: C, 44.42; H, 2.76; 
N, 8.17. 
Tricarbonyl(acetonitrile)(1,10-phenanthroline)rhenium(I) hexafluorophosphate, 
([Re-(phen)(CO)3(CH3CN)](PF6)). Re(phen)(CO)3Cl (400 mg, 0.823 mmol, 1.0 eq) and 
TlPF6 (374 mg, 1.07 mmol, 1.3 eq) were combined in a round bottom flask with 40 mL of 
CH3CN and heated at reflux in the dark overnight. The solvent was removed in vacuo leaving 
a yellow oil, which was dissolved in CH2Cl2. Any remaining solids were filtered off, and 
ether was slowly dripped into the solution to produce long yellow/green luminescent crystals, 
which were isolated by filtration, washed with ether and dried under vacuum (450 mg, 86%). 
1H NMR (300 MHz, d-acetone, 25 oC) δ = 2.17 (s, 3H, CH3CN-Re), 8.27 (m, 2H, phen-H), 
8.42 (m, 2H, phen-H), 9.11 (d, 2H, phen-H), 9.63 (d, 2H, phen-H). Anal. Calcd. 
C17H11F6N3O3PRe: C, 32.08; H, 1.74; N, 6.60. Found: C, 32.15; H, 1.66; N, 6.47. 
Tricarbonyl(diphenylphosphinobenzoic acid)(1,10-phenanthroline)rhenium(I) hexa-
fluorophosphate, ([Re(phen)(Ph2PPh-COOH)(CO)3](PF6)). 
[Re(phen)(CO)3(CH3CN)](PF)6 (877 mg, 1.37 mmol, 1.0 eq) and Ph2PPh-COOH (633 mg, 
2.07 mmol, 1.5 eq) were combined in a round bottom flask with 40 mL of N2 purged acetone. 
The solution was heated at reflux overnight under an N2 atmosphere in the dark. The solvent 
was removed in vacuo without heating and the yellow solid was taken up in CH2Cl2. The 
resulting light yellow precipitate was isolated by filtration and washed with CH2Cl2 (1.118 g, 
90%). 1H NMR (300 MHz, d-acetone, 25 oC) δ = 7.05-7.80 (m, 14H, Ph2PPh-R), 8.02 (m, 2H, 
phen-H), 8.27 (s, 2H, phen-H), 8.90 (d, 2H, phen-H), 9.44 (d, 2H, phen-H) MALDI-TOF 
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Calcd. (Found): [M – PF6]+ 757.09 (757.03); [M – CO,PF6]+ 729.10 (729.05). Anal. Calcd. 
C34H23F6N2O5P2Re: C, 45.29; H, 2.57; N, 3.11. Found: C, 45.21; H, 2.63; N, 3.06. 
[Re(phen)(P–Y)(CO)3](PF6). Re(phen)(CO)3(Ph2PPh–COOH)](PF6) (200 mg, 0.222 
mmol, 1.0 eq), Y–OtBu (53 mg, 0.222 mmol, 1.0 eq), WSC•HCl (47 mg, 0.244 mmol, 1.1 
eq), HOBt (33 mg, 0.244 mmol, 1.1 eq), and NMM (100 μL, 0.888 mmol, 4.0 eq) were 
combined in a round bottom flask with 20 mL of CH2Cl2 and stirred overnight. The solution 
was diluted with 50 mL of CH2Cl2, washed with 2 × 25 mL of water, and dried over MgSO4. 
The solution was concentrated to a few mL in vacuo and loaded onto a silica gel 
Chromatotron plate (2 mm). The highly emissive band that eluted with 5% MeOH/CH2Cl2 
was collected and the solvent removed in vacuo to yield a yellow solid, which was dissolved 
in 10 mL of 1:1 TFA/CH2Cl2 and stirred for 1 h. The solution was concentrated under a 
stream of N2. Addition of ether caused a yellow solid to precipitate; the solid was isolated by 
filtration and dried under vacuum (140 mg, 59%). 1H NMR (300 MHz, d-acetone, 25 oC) δ = 
3.18 (m, 2H, Y-CH2), 4.89 (s, 1H, Y-CH), 6.85 (d, 2H, phenol-H), 7.20 (d, 2H, phenol-H), 
7.27-7.85 (m, 14H, Ph2-P-Ph-R), 7.98 (m, 2H, phen-H), 8.14 (s, 2H, phen-H), 8.80 (m, 2H, 
phen-H), 9.42 (m, 2H, phen-H) 31P NMR (300 MHz, d-acetone, 25 oC) δ = 19.5 (s, Re-P) 
MALDI-TOF Calcd. (Found): [M – PF6]+ 920.15 (920.05); [M – CO,PF6]+ 892.16 (892.07). 
Anal. Calcd. C43H32F6N3O7P2Re: C, 48.50; H, 3.03; N, 3.95. Found: C, 48.42; H, 2.95; N, 
4.06. 
[Re(phen)(P–F)(CO)3](PF6). The synthesis of the phenylalanine derivative was the same 
as that for the tyrosine derivative, except that F–OtBu•HCl was used instead of Y–OtBu (74 
%). 1H NMR (300 MHz, d-acetone, 25 oC) δ = 3.29 (m, 2H, F-CH2), 4.93 (m, 1H, F-CH), 
6.72-7.54 (m, 19H, F-ph and Ph2PPh-R), 7.97 (m, 2H, phen-H), 8.14 (s, 2H, phen-H), 8.81 
(m, 2H, phen-H), 9.43 (m, 2H, phen-H). 31P NMR (300 MHz, d-acetone, 25 oC) δ = 19.3 (s, 
Re-P) MALDI-TOF Calcd. (Found): [M – PF6]+ 904.16 (903.94); [M – CO,PF6]+ 876.16 
(875.98). Anal. Calcd. C43H32F6N3O6P2Re: C, 49.24; H, 3.08; N, 4.01. Found: C, 49.18; H, 
3.04; N, 3.96. 
Re(PP–Bn)(CO)3Cl. Re(CO)5Cl (126 mg, 0.14 mmol, 1.0 eq) and HOOC–PP–Bn (200 
mg, 0.174 mmol, 1.0 eq) were combined in a flask with 25 mL of N2-purged toluene and the 
mixture was heated at reflux under an N2 overnight. The solution was concentrated to a few 
mL in vacuo and triturated with hexanes. The white precipitate was isolated by filtration, 
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washed with hexanes and dried under vacuum (0.258 g). The crude product, which contained 
some Re(HOOC–PP–Bn)(CO)3Cl, was used in the next step without further purification. 
MALDI-TOF Calcd. (Found): [M – Cl]+ 800.11 (800.22). 
[Re(phen)(PP–Bn)(CO)2](PF6). Re(PP–Bn)(CO)3Cl (150 mg, 0.171 mmol, 1.0 eq), phen 
(34 mg, 0.188 mmol, 1.1 eq) and TlPF6 (64 mg, 0.188 mmol, 1.1 eq) were combined in a 
round bottom flask with 25 mL of anhydrous o-dichlorobenzene. The mixture was bubbled 
with N2 for 30 min and heated at reflux for 5 h under N2. The dark yellow solution was 
filtered over Celite, which was rinsed with CH2Cl2. The solvent was then removed from the 
filtrate in vacuo; the residue was dissolved in a minimal volume of CH2Cl2 and loaded onto a 
Chromatotron plate (alumina, 1 mm). The product eluted with 10% CH3CN/CH2Cl2 as a 
golden yellow band. The solvent was removed in vacuo yielding a yellow solid, which was 
characterized as a mixture of two isomers. 31P NMR (300 MHz, CDCl3, 25 oC) δ = 35.3 (d), 
44.0 (d), 49.9 (d), 60.9 (d). MALDI-TOF Calcd (Found): [M – PF6]+ 952.19 (952.25); [M – 
CO,PF6]+ 924.19 (924.25). 
X-ray Crystal Structure of [Re(phen)(dppe)(CO)2](PF6) and [Re(phen)(PP–Bn)-
(CO)2](PF6)•CDCl3. Single crystals of the complexes were grown by slow evaporation from 
a concentrated solution in CDCl3. A crystal was removed from the supernatant, coated with 
Paratone N oil, and mounted on a glass fiber. X-ray diffraction data were collected at –123 ºC 
on a Siemens diffractometer equipped with a CCD detector, using the Mo Kα radiation. The 
data were integrated to hkl-intensity and the unit cell calculated using the SAINT v.4.050 
program from Siemens. Solution and refinement were performed by direct methods 
(SHELXTL v.6.10, Sheldrick, G. M., and Siemens Industrial Automation, Inc., 2000). The 
structures were solved by the Patterson method, non-hydrogen atoms were refined 
anisotropically, and hydrogen atoms were placed at calculated positions. Table 4.4 contains 
details regarding the refined data, cell parameters and results of the solution of the X-ray 
diffraction data for [Re(phen)(dppe)(CO)2](PF6) and [Re(phen)(PP–Bn)(CO)2](PF6)•CDCl3. 
Physical Measurements. 1H and 31P NMR spectra were recorded on a Varian Mercury 
300 MHz NMR at the MIT Department of Chemistry Instrumentation Facility (DCIF) and 
externally referenced to tetramethylsilane (1H) and phosphoric acid (31P). MALDI-TOF mass 
spectrometry was performed on a Bruker Omniflex instrument in the DCIF using dithranol as 
the matrix. The instrument was calibrated with a quadratic polynomial using a mixture of 
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bradykinin fragment 1-7 (757.3997), angiotensin II (1046.5423), and P14R synthetic peptide 
(1533.8582) (Sigma) with α-cyano-4-hydroxycinnamic acid as the matrix. Elemental analysis 
was performed by H. Kolbe Mikroanalytisches Laboratorium in Mülheim an der Ruhr, 
Germany. 
UV-vis absorption spectra were recorded on a Cary 17D modified by On-Line Instrument 
Systems (OLIS) to include computer control or a Spectral Instruments 440 spectrophotometer. 
Steady state emission spectra were recorded on an automated Photon Technology 
International (PTI) QM 4 fluorimeter equipped with a 150-W Xe arc lamp and a Hamamatsu 
R928 photomultiplier tube. Time resolved emission and transient absorption (TA) 
measurements on the >20 ns timescale were made with pump light provided by the third 
harmonic (355 nm) of an Infinity Nd:YAG laser (Coherent) running at 20 Hz as previously 
described.39 Time resolved emission measurements on the <20 ns timescale were made with 
the frequency doubled (400 nm) pump light provided by a Ti:sapphire laser system (100 fs 
pulsewidth) and collected on a Hamamatsu C4334 Streak Scope streak camera as previously 
described.40  
The corrected emission spectra were analyzed by a standard Franck-Condon analysis:41- 43 
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Φref is the emission quantum yield of the Ru(bpy)32+ reference taken to be 0.062 in CH3CN 44 
and 0.053 in water.45 A is the measured absorbance, η is the refractive index of the solvent, 
and I is the integrated emission intensity, which was obtained by plotting and integrating the 
entire emission band fitted using eq. (3). Samples for phosphorescence quantum yield and 
time resolved spectroscopic measurements were freeze-pump-thaw degassed for 5 cycles to 
10–6 torr. Unless otherwise noted, all spectroscopy was performed in 10 mM aqueous 
phosphate buffer with the pH adjusted using 1 M NaOH or HCl. In cases of limited solubility, 
the samples were sonicated in a Branson 3200 sonicator and filtered through a 0.2 micron 
Gelman Acrodisc polypropylene syringe filter prior to measurement. pD measurements were 
made with a glass pH electrode that had been calibrated in standard H2O buffers by applying 
the standard correction of +0.4 to the meter reading of the D2O solution.46 
Electrochemical measurements were performed using a Bioanalytical Systems (BAS) 
Model CV-50W potentiostat/galvanostat. Differential pulse voltammetry (DPV) was 
performed using a platinum disk working electrode, a Ag/AgCl reference electrode, and a 
platinum wire auxiliary electrode. DPV experiments were performed in dry CH3CN with 0.1 
M tetrabutylammonium hexafluorophosphate (Bu4N)PF6 as the supporting electrolyte, and 
solutions were bubbled with Ar to remove dissolved O2. All potentials are reported vs. 
Eo(Fc+/Fc) = 0.65 V vs. NHE in CH3CN.47 Spectroelectrochemistry was performed in dry 
DMF with 0.1 M (Bu4N)PF6 as the supporting electrolyte and Pt gauze as the working 
electrode in a 2 mm pathlength quartz optical cell. A blank spectrum was recorded on the 
solution prior to electrolysis at -0.75 V vs. Fc+/Fc. Spectra were recorded every 10 seconds 
for 5 minutes. 
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Table 4.4. Crystal data and structure refinement. 
Compound [Re(phen)(PP–
Bn)(CO)2](PF6)•CDCl3 
[Re(phen)(dppe)(CO)2](PF6). 
Empirical formula C49H37DCl3F6N3O3P3Re C40H30F6N2O2P3Re 
Formula weight 1217.33 963.77 
T (K) 150(2) 150(2) 
λ (Å) 0.71073  0.71073  
Crystal system Triclinic Monoclinic 
Space group 1P  P2(1)/n 
a (Å) 13.1590(14) 15.1299(10) 
b (Å) 13.9281(15) 15.6153(11) 
c (Å) 15.1161(16) 16.7302(12) 
α (º) 73.916(2) 90 
β (º) 64.282(2) 109.328(2) 
γ (º) 83.849(2) 90 
V (Å3) 2398.1(4) 3729.9(4) 
Z 2 4 
ρcalcd (Mg/m3) 1.683 1.716 
Abs. coeff (mm–1) 2.870 3.456 
θ range for data collection (°) 1.52 to 23.27 1.83 to 23.15 
Index ranges –14 ≤ h ≤ 14, –15 ≤ k ≤ 11, 
–16 ≤ ℓ ≤ 11 
–16 ≤ h ≤ 15, 0 ≤ k ≤ 17, 0 ≤ 
ℓ ≤ 18 
Reflections collected 13421 5287 
Independent reflns (Rint) 6833 (0.0316) 5287 
Completeness to θmax 98.7% 99.8 % 
Data/restraints/parameters 6833 / 0 /613 5287 / 0 / 487 
GOFa on F2 1.038 0.970 
R1b 0.0348 0.0546 
wR2c 0.0904 0.0981 
Largest diff. peak, hole 1.053, –1.688 eÅ–3 1.074 and –0.672 e.Å–3 
 aGOF = (Σ w(Fo2 – Fc2)2/(n – p))1/2 where n is the number of data and p is the number of 
parameters refined. bR1 = Σ||Fo – |Fc||/Σ|Fo|. cwR2 = (Σ(w(Fo2 – Fc2)2)/Σ(w(Fo2)2))1/2.  
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5.1 Motivation 
We wish to understand the PCET mechanism of Y oxidation in the [Re(phen)(CO)3(P–
Y)](PF6), Re(P–Y), complex presented in Chapter IV. This reaction has relevance to the radical 
chemistry of ribonucleotide reductase and Photosystem II, as discussed in Chapter I. In this 
chapter we present a detailed pH and buffer dependent analysis of the emission quenching in 
Re(P–Y) and, in comparison with other RuII systems in the literature, present a unified picture of 
the parallel PCET mechanisms that facilitate tyrosine oxidation. 
5.2 Background 
Proton-coupled electron transfer (PCET) in reactions of amino acid radicals are of great 
interest as they are frequently encountered in biological systems.1- 3 The proton and the electron 
need not transfer as a hydrogen atom to be coupled.4 An 
example of this type of mechanism, in which the proton 
and electron are transferred between one donor and 
separate acceptors, has been termed MS-EPT5 or 
bidirectional PCET.4,6 This reaction is exemplified by YZ 
in Photosystem II, in which tyrosine oxidation is coupled 
to proton transfer to a hydrogen bonded H190 residue 
(see Chapter I).7 YZ oxidation could proceed by either a 
stepwise (ETPT or PTET; Scheme 1) or concerted 
electron-proton transfer (CEP) mechanism, the latter 
defined as occurring with a single transition state. 
Previous studies on systems with Y appended to 
Ru(bpy)32+ (RuY),8 Ru(bpy-4,4´-COOEt)2(bpy)2+ 
(RuesterY),9 and Re(phen)(CO)3(PPh3)+ (Re(P-Y))10 (see 
Chart 5.1 for chemical structures) showed a pH-
dependent rate constant for the PCET oxidation of Y. The 
nature of this pH-dependence has recently been of some 
debate.5,11   
 
Chart 5.1 Compounds discussed in 
this chapter. 
For the RuY system, the data was analyzed within a Marcus framework for electron transfer 
(ET)12 with the driving force defined including the pH dependent Y•/Y reduction potential: 
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E°(Y•/Y) = E°(Y•/Y–) + 59 mV log(1 + (10–pH/10–pKa(Y))). This analysis yielded a slope of 0.4 - 
0.5 in the log(kPCET) vs. pH plot, which 
was interpreted as a CEP mechanism 
with PT to bulk solvent.8 However, a 
pH dependence in Y oxidation may also 
be explained by a PCET reaction with 
PT to OH– or the basic form of 
buffer,5,11 which may call into question 
previous interpretations.8,9 In this 
chapter, we clearly distinguish the contributions from these two mechanisms from the rate of Y 
oxidation in RuY, RuesterY, and Re(P-Y). We explicitly show that a pH dependence in the rate 
of tyrosine oxidation can arise in the absence of buffer and that, at high buffer concentrations, 
the basic form of the buffer acts as a proton acceptor. Analysis of the series of compounds 
reveals parallel PCET mechanisms, the relative contribution of which varies with the oxidant 
strength. 
Scheme 5.1 Mechanisms of PCET, where B is solvent 
or base form of the buffer: Stepwise ETPT (pathway 1) 
or PTET (pathway 2) and CEP mechanisms. 
5.3 Results 
Laser flash photolysis and/or time 
resolved emission spectroscopy was used to 
directly measure the rate of Y oxidation in 
the RuY, RuesterY, and Re(P-Y) systems. 
Figure 5.1 plots ln(kobs) vs. pH for the Re(P-
Y) system, where kobs is the emission 
quenching rate constant calculated by 
comparison to the Re(P-F) control (see 
Chapter IV). The points are separated into 
three color coded regions. The black and red 
points were collected in 10 mM KPi buffer 
and correspond to the protonated and 
deprotonated forms of the tyrosine 
carboxylic acid, respectively. The green 
points are in a higher pH region where KPi is not as effective a buffer, and, for this reason, 50 
 
Figure 5.1. Plot of the rate constant for 
emission quenching, kobs, vs. pH for [Re(P–
Y)(phen)(CO)3]PF6. Three pH regions are 
highlighted corresponding to the protonated (○) 
and deprotonated (○) forms of the tyrosine 
carboxylic acid (10 mM KPi buffer) and the 50 
mM KPi high pH region (○). 
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mM KPi was used. Above pH 10, the quenching of the excited state increases significantly. At 
pH 12, effectively no emission was visible at the concentrations used for the experiment. We 
attribute this quenching to direct ET from the deprotonated phenol at high pH. Unfortunately, the 
low solubility of Re(P-Y) in water prevented further investigation of the emission quenching by 
transient absorption methods. 
We next investigated the effect of the phosphate buffer on kobs for the Re(P-Y) system. 
Figure 5.2 (upper left panel) shows a plot of the rate of Y oxidation, kobs, in Re(P-Y) as a 
function of phosphate buffer concentration and pH. The rate is independent of buffer at low 
concentrations (<10–3 M) and increases linearly with buffer at high concentrations. The buffer 
concentration dependence becomes more pronounced as the pH is increased from 4.5 to 9.2. The 
right panel of Figure 5.2 shows the pH titration of H2PO4–/HPO42– with pKa = 7.2.13 These data 
are consistent with HPO42– acting as the proton acceptor at high buffer concentrations, as 
previously described for Y oxidation in other systems.5 The entire data set can be fit to eq 1: 
 
Figure 5.2. Top left: Phosphate buffer dependence of kobs with fits to eq. 1 
for Re(P–Y) at pH 4.5 (○), 6.1 (○), 7.5 (○), 8.3 (○), and 9.2 (○). Bottom left: 
Same experiment with RuesterY at pH 9.9 (z), 7.7 (z) and pH 6 (z). Right: 
Mole fraction of relevant buffer species as a function of pH.  
 kobs = kw + fb·[Buffer]·kb  (1) 
where kw is the PCET rate obtained in the absence of buffer (with solvent as proton acceptor), fb 
is the fraction of the basic form of the buffer in solution (HPO42–), and kb is the bimolecular 
PCET rate with proton transfer to HPO42–. The bottom left panel of Figure 5.2 plots kobs in 
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RuesterY vs. buffer concentration following 
flash-quench generation of the RuIII 
intermediate9 and indicates a similar trend to 
that observed for Re(P-Y). 
Figure 5.3 shows a plot of kobs for the 
RuY system as a function of phosphate buffer 
concentration at pH 7 and 9. The fit of these 
data to eq. 1, however, results in a pH-
dependent kw, as illustrated by the offset in the 
pH 9 (blue line) and pH 7 (green line) data. 
The inset of Figure 5.3 plots the pH 
dependence of kobs (= kw) at 0.5 mM 
concentration of different buffers with various 
pKas. The main figure indicates an 
independence of kobs on the buffer at this concentration (dashed line). The linear correlation in the 
inset shows a genuine pH dependence of kw that is independent of buffer identity and pKa. The 
rate does not level out at pH > pKa of 2-(N-morpholino)ethanesulfonic acid (MES) and [H2PO4–], 
as would be the case if the base form of the buffer were the proton acceptor. The pH-dependent 
data at 0.5 mM are in good agreement with our previously reported data at 10 mM.8 Note that 
even without buffer, the data in Figure 5.3 span the same range of rates between pH 3 and 9. 
 
Figure 5.3. Phosphate buffer dependence of kobs, 
for RuY and fits to eq. 1 at pH 7 (■,▬), pH 9 
(■,▬) and pH 3 (■). Inset: pH dependence of 
kobs in RuY at 0.5 mM buffer concentration 
(dashed line in main figure) with MES (●, pKa = 
6.2), borate (●, pKa = 9.1), phosphate (●, pKa = 
7.2) and borate/phosphate mixture (○). 
Deuterium isotope effect studies were undertaken to further probe the PCET mechanism in 
these systems. In D2O the pKa of D2PO4– shifts to 7.814 while we measure a shift of the tyrosine 
pKa to 10.6. Both the pKas shift by the same amount, therefore, the driving force for deuteron 
Table 5.1. Rate of the Tyrosine Oxidation in Three Separate 
Systems with Water or Water Containing HPO42–.  
 kw /  
105 s–1  
kH / kD 
(H2O) 
kb /  
 107 M–1s-1
kH / kD 
(HPO42–) 
kET2 / 
107 s–1 
RuY 0.1a,b 2.2-2.5c 0.3 1.8-2.0 5 b 
RuesterY 4.4a 2c, >10e 3.0 N/A >10d 
Re(P-Y) 1.0 < 3 1.7 3.0 >10 
a pH-dependent, at pH 7; b Ref. 8; c Ref. 2; d Ref 9; e pH 10 
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transfer should be the same as for proton transfer. The bimolecular rate for quenching of Re(P–
Y) emission with DPO42– in D2O was measured as 5.7 × 106 M–1s–1, yielding a deuterium isotope 
effect (kH/kD) of 3.0. For RuY and phosphate buffer kH/kD = 1.8 to 2.0 in the buffer-dependent 
region (ca. 50 mM). The kw, kb and deuterium isotope effects for each rate and for each system 
are summarized in Table 5.1. 
We can extend the Re(P–Y) / HPO42– system to other “buffers” to systematically change the 
driving force for proton transfer along with the hydrogen bond geometry between the tyrosine 
phenol and hydrogen bonded base. As a first step towards this study, we show that pyridine and 
imidazoles are also effective bases in enhancing the emission quenching in Re(P–Y) in aqueous 
solution. Figure 5.4 (left) plots the rate of emission quenching vs. the total concentration of 
added pyridine at different pHs. The “buffer effect” is turned on at higher pH as proton transfer 
occurs to pyridine in the PCET oxidation of tyrosine. The effect is similar to that observed for 
phosphate, however now the bimolecular rate constant for quenching increases as the pH is 
titrated from 3.8-7.6 (instead of pH 4.5-9 as observed for phosphate).  This is as expected since 
the pKa of pyrdinium is lower than that of H2PO42– (see Table 5.2). The data were analyzed with 
equation 1 to yield a value of 1.1 × 107 M–1s–1 for kb. Figure 5.4 (right) plots the rate of emission 
quenching vs. the concentration of added imidazole for a series of imidazoles with different pKas 
for their conjugate acids.  The data were collected at a pH where the imidazole was deprotonated. 
 
Figure 5.4. (Left) Plot of the rate constant for emission quenching, kq, vs. concentration of 
pyridine buffer for [Re(P–Y)(phen)(CO)3]PF6 at pH 3.75 (○), 4.65 (○), 5.35 (○), and 7.6 (○) 
(Right)  Plot of, kq, vs. concentration of imidazole buffers for [Re(P–Y)(phen)(CO)3]PF6 with 4-
Br-Im (○), Im (○), and 4-Me-Im (○). The dotted line represents the limit of detection using the 
nanosecond pulsed laser for excitation. 
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Table 5.2. Thermodynamic and kinetic data for the series of 
bases used in the PCET oxidation of tyrosine in Re(P–Y). 
Buffer pKa(BH)+ kb  / 
107 M–1s–1 
kH/kD KC / 
 M–1 
HPO42– 7.2a 1.7 + 0.1 3.0 0.5d 
Pyridine 5.23b 1.1 + 0.1 2.9 0.6-0.7e 
4-Me-Im 7.45c 24.3 - - 
Im 6.95c 10.3 1.8 - 
4-Br-Im 3.7c 0.3 - - 
aRef.13; bRef.15; cRef.16 dRef.17; eRef.18. kb is the second-
order rate constant for buffer-assisted PCET; kH/kD is the 
kinetic isotope effect; KC is the association constant for the 
tyrosine-buffer complex (Scheme 5.1). 
The bimolecular kb rate constants for each imidazole were determined from the slopes of the 
lines in Figure 5.4 (right). 
Table 5.2 presents a summary of the data for the pyridine, phosphate, and imidazole systems 
including the measured deuterium isotope effects and kb, and the literature values for the pKa of 
the conjugate acid of the base and the association constant of the base to tyrosine or phenol. 
Some striking observations can be made from this data: (1) the bimolecular kb rate does not 
correlate with the pKa of the conjugate acid of the base across the pyridine, phosphate, imidazole 
series; (2) within the series of imidazoles kb does correlate with pKa of the conjugate acid of the 
base; (3) an inverse relationship may exist between the measured deuterium isotope effect and kb.  
5.4 Discussion 
5.4.1 pH Dependence of kobs in the Absence of Buffer 
The pH-dependence for RuY in the absence of buffer cannot be explained by a PTET 
mechanism to H2O or OH– (Scheme 5.1), or by a reversible PCET reaction as we now describe: 
PCET via an ETPT mechanism 
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As the pKa for the tyrosine radical is c.a. –2, its deprotonation in aqueous media is very rapid, 
on the order of 100 fs.19 Therefore, the ETPT reaction will be ET-limited, and not expected to 
depend on either pH or buffer concentration. 
PCET via CEP or PTET, in the absence of buffer 
A pH dependence for tyrosine oxidation in absence of buffer may arise via PCET reactions 
with proton transfer to a single molecular acceptor, such as OH–. For concerted (CEP) or 
stepwise PTET mechanism, both are predicted to be first-order in [OH–]: 
 
For PTET with OH– as acceptor, the initial PT step will be rate-determining in the pH-
interval examined, as the following ET is comparatively rapid: kET2 ≥ 5 × 107 s–1 for the 
complexes examined here (see Table 5.1). Therefore both PTET and CEP with OH– as acceptor 
will be limited by diffusional encounter with OH– and show the same rate dependence on [OH–].  
Thus, if OH– is the proton acceptor, the log(kobs) vs. pH plot should have a slope of 1 for both 
mechanisms, rather than the slope of 0.4-0.5 observed for RuY. The limiting rate at pH = 7 is 
given by the diffusional encounter between tyrosine and OH–, and is expected to give an upper 
limit for the pseudo first order rate of 103 s–1, which is significantly lower than what we observe 
for any of the systems at pH 7.  
If a single H2O is the proton acceptor in an irreversible reaction, the driving force for proton 
transfer depends on the difference in pKa for tyrosine and H3O+, and therefore we would not 
expect a pH dependence in kobs for either PTET or CEP. In addition, for PTET the rate constant 
for deprotonation of tyrosine (pKa = 10) to H2O is very small: ~10 s–1. 19 
We now consider a reversible PCET with proton transfer to a single H2O: 
 
where A = [Mn+]–TyrOH and B = [M(n-1)+]–TyrO•. The observed rate law for this equilibrium 
reaction is: 
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assuming that [H3O+] is constant throughout the reaction. The observed rate constant, kobs = kf  +  
kb[H3O+],  gives a slope of –1 in the log(kobs) vs pH plot in the region where kb[H3O+] >> kf, and 
a slope of zero in the other limit. Note that the slope would never be positive, as observed 
experimentally.  
The mechanistic treatment above does not explain the pH dependence of kobs observed for 
RuY and RuesterY in the absence of buffer and at low buffer concentrations. The pH-dependence 
of the rate constant cannot be explained by a single molecular species as proton acceptor for the 
CEP reaction in a rate-determining step. We therefore assign the observed slope of ca. 0.5 in the 
ln(kobs) vs. pH plot as arising from CEP reaction with proton transfer to the solvent that is 
affected by the bulk pH.8,9 For stronger oxidants, as in Re(P-Y) the pH independence of kw is 
consistent with an ETPT mechanism. In RuesterY, with intermediate oxidant strength, kw is first 
pH-independent but becomes pH-dependent at high pH when the CEP mechanism dominates9 
(see data at pH 9.9 in Figure 5.2). ETPT has lower reorganization energy compared to CEP;9,20 
thus the ETPT rate increases more steeply with increasing –ΔG0 and can out-compete CEP for 
stronger oxidants.9 The higher kinetic isotope effect (kH/kD) for the CEP reactions (RuY and 
RuesterY, pH 10, Table 5.1) compared to the pure ETPT reactions with tyrosine (RuesterY, pH 7 
and Re(P-Y), Table 5.1) or ET from tyrosinate8 support these mechanistic assignments. 
5.4.2 Buffer Dependence of kobs  
At higher phosphate buffer concentrations (>10 mM) the rate is first order in [HPO42–] 
indicating a buffer-assisted PCET. Several mechanisms were considered within the framework of 
Scheme 5.1: 
PTET with proton transfer to buffer 
We first consider PTET with a rate limiting ET:  
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 with a diffusion-controlled deprotonation of the buffer by TyrO–, k–PT ≈ 1 × 1010 M–1 s–1, and an 
equilibrium constant (kPT / k–PT) of 10–ΔpKa where ΔpKa = pKa(TyrOH) – pKa(H2PO4–) = 2.8. A 
rate-limiting ET requires that kET << k–PT [HB+]. As k–PT [HB+] ≈ 1 × 107 s–1 and kET ≥ 5 × 107 s–1  
(kET2 in Table 5.1) this condition does not apply for any of the systems studied. 
Secondly, for PTET with a rate limiting deprotonation, the observed rate constant is equal to 
kPT = 1.6 × 107 M–1 s–1 (assuming k–PT ≈ 1 × 1010 M–1 s–1), which is comparable to the values of 
kb that we measure for Re(P-Y) and RuesterY. For the imidazoles and pyridine instead, the 
predicted values of kPT are much lower than the observed values of kb (Table 5.2). For 4-Me-Im, 
with ΔpKa = 2.55, would give kPT ≈ 3×107 M–1 s–1 while we observe kb = 2.4 × 108 M–1 s–1. For 
4-Br-Im we predict kPT ≈ 5 × 103 M–1 s–1 while the observed rate kb = 3 × 106 M–1 s–1. This 
excludes the PTET mechanism for the imidazole or pyridine as proton acceptor and suggests that 
the buffer-assisted PCET reaction is a CEP, with proton transfer to these bases. 
PTET within a H-bond complex 
We furthermore consider the reaction scheme in which PCET occurs within a hydrogen 
bonded complex as depicted in Scheme 5.1. For PTET (pathway 2), the steady-state 
approximation can be used to derive an expression of the rate constant for the reaction:  
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 (2) 
The diffusion controlled complexation rate, kd = 1 × 1010 M–1 s–1, and association constant, 
KC = 0.5 s–1 (Table 5.2) gives a dissociation rate k–d = 2 × 1010 s–1. The protonation rate of 
tyrosine within the complex (k–PT2) cannot be faster than the collision frequency factor of 6 × 
1012 s–1, given by absolute rate theory. Assuming that ΔpKa = 2.8 does not change within the 
complex (given the weak association constant, we expect the hydrogen bond to be weak and not 
significantly shift the pKa of the phenol or the base), this gives the rate of deprotonation kPT2 = 
1·1010 s–1, and finally kET2 = 5 × 107 s–1 for RuY. Using these values for the rate constants in the 
equation above, kb is estimated to 4 × 104 M–1s–1 which is two orders of magnitude slower than 
the observed rate of 3 × 106 M–1s–1 for RuY. Due to the similar behavior of the three systems 
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studied, RuY, RuYester and Re(P-Y), we have no reason to believe that the mechanism for PCET 
within a complex between Y and B would be different for the three systems. 
We therefore assign the buffer-assisted PCET to a CEP mechanism with electron transfer to 
metal oxidant and proton transfer to basic form of the buffer. For Re(P-Y) and RuesterY we only 
have limiting values for kPTET, but we measure kinetic isotope effects that are larger than 
expected for a PTET reaction as ΔpKa was found to be the same in H2O and D2O. The driving 
force for the primary PCET step is increased with a buffer molecule as the proton acceptor 
compared to a single water molecule (pKa(H3O+) ≈ –1.5), or to ET oxidation forming Y•+ 
(E0(Y•+/Y) = 1.46 V vs. NHE9). Hydrogen bonding bases may also further enhance the rate of 
CEP reactions in aqueous media by increasing the proton vibrational wavefunction overlap 
and/or by decreasing the reorganization energy for CEP.20  
5.5 Conclusions 
We have revealed a pattern of reactivity in the RuY, RuesterY, and Re(P-Y) series with at 
least three competing PCET mechanisms: (1) CEP with the solvent as proton acceptor, which 
does indeed show a pH-dependent rate that is independent of buffer; (2) pH-independent ETPT; 
(3) a buffer-assisted CEP that is a general phenomenon at higher buffer concentrations (Figures 
5.2 and 5.3). The pH-dependence of (3) follows the titration of the buffer. The relative 
importance of (2) increases systematically with oxidant strength. 
The pH-dependence of CEP with proton transfer to water, identified for the first time for 
RuY,8 has been questioned on theoretical grounds,11,21 and proposed to arise from reactions with 
the buffer.5 Here we experimentally confirm that the pH-dependence is genuine and cannot be 
explained by buffer-assisted reactions or simple reaction schemes with first-order dependencies 
on OH– or H3O+. While the rate-dependence on pH phenomenologically follows the Marcus 
equation for pure electron transfer,8,9 a microscopic model to explain this type of CEP reaction 
remains to be developed. The free energy of the overall PCET process may depend on a 
weighted average of microconfigurations, the distribution of which is pH dependent. It remains 
to be seen if the driving force dependence is coincidental or if the factors determining the rate-
dependence on pH are directly connected to the free energy of the overall process. Our results 
underpin the mechanistic richness of PCET one may encounter and serve as a model for 
discussion of PCET reactions in more complex radical enzymes such as ribonucleotide 
reductase.  
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5.6 Experimental Section 
Materials. RuY,8 RuesterY,9 and Re(P–Y),10 were available from previous studies. 
Potassium phosphate buffer (Mallinkrodt) was used as received. Pyridine (Sigma Aldrich) was 
distilled from and stored over KOH. Imidazoles (Sigma Aldrich) were purified by sublimation. 
Time Resolved Emission and Transient Absorption Spectroscopies. Time resolved 
emission experiments with solutions of Re(P–Y) were performed as described in Chapter IV. 
Transient absorption experiments with RuY and RuesterY were performed as previously 
described. 8, 9 
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 Chapter VI 
 
 
Unnatural Fluorotyrosine Amino Acids as Probes of PCET 
Mechanism in Reactions of Tyrosyl Radicals 
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6.1 Motivation 
We wish to develop methods for probing the mechanisms of PCET reactions of tyrosyl 
radicals in enzymes. Furthermore, we wish to distinguish between radical hops along the 
Y356→Y731→Y730 pathway in RNR. For these reasons, we have synthesized a series of 
fluorotyrosine unnatural amino acids, FnY, and studied the effect of fluorination on both the 
pKa of the phenolic proton and the reduction potential of the oxidized radical. This chapter 
describes density functional theory calculations that explain the trends in reduction potential 
of these radicals. Additionally, FnYs are incorporated into dipeptides with benzophenone to 
characterize the transient absorption spectrum of each fluorotyrosyl radical. Finally, the FnYs 
are appended to the Re(bpy)(CO)3CN complex for a Marcus-type driving force analysis of 
charge separation and recombination reactions involving the deprotonated, FnY–. These data 
show that FnY can be used to vary the driving force for both the proton and the electron part 
of PCET reactions involving tyrosyl radical, that the spectra of FnY• are significantly shifted 
to distinguish it from Y•, and that ET reactions involving FnY– are well described by Marcus’ 
theory for ET. 
6.2 Background 
Of the amino acid radicals participating in biological charge transfer processes, tyrosyl 
radical (Y•) is pre-eminent.1- 4 Nature employs tyrosine to fulfill two enzymatic criteria: (1) 
as a charge transport relay and (2) to transport both a proton and an electron for the activation 
of substrates at an enzyme active site. This one-electron, protein-based oxidant has been 
identified as both a stable cofactor in deoxynucleotide biosynthesis (ribonucleotide 
reductase)5 and as a transient intermediate with directed reactivity in photosynthetic O2 
evolution (Photosystem II),6 prostaglandin biosynthesis (prostaglandin synthase),7 alcohol 
oxidation (galactose oxidase)8 and reduction of oxygen to water (cytochrome c oxidase) (see 
Chapter I).9  Despite extensive knowledge about the structure of the Y•s in these systems, the 
precise mechanism of their formation and reactivity at a functional biological level has, for 
the most, part remained unknown. However, at a mechanistic level, it is well established that 
oxidation of tyrosine under physiological conditions requires the loss of both a proton and an 
electron, implicating proton-coupled electron transfer (PCET) in the radical forming 
mechanism.4,6,10 Therefore, the study of tyrosine radicals in the initiation and propagation of 
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charge in biology will necessarily demand that new tools are needed to control both the 
electron and proton for Y• formation within the enzyme. This is especially pertinent to our 
studies of class I ribonucleotide reductase (RNR).4,11 Radical migration over the 
unprecedented distance between the β2 •Y122 cofactor and the α2 active site has been 
suggested to involve a radical hopping pathway spanning both subunits with three other 
tyrosine residues, Y356 (β2), 731 (α2) and 730 (α2), as discussed in Chapter I. Moreover, the 
mechanism of formation of the stable Y122•, which involves a putative di-iron, FeIII/FeIV 
intermediate as the oxidant, also remains unknown.12- 16 
Substitution of tyrosine with other redox active amino acids can provide insight into the 
mechanism of charge transport in enzymes. However, only the natural amino acids of 
tryptophan and cysteine have reduction potentials close to that of tyrosine, and they are poor 
structural analogues. For this reason, we have turned our attention to unnatural amino acids, 
specifically, fluorotyrosines because they offer minimal structural perturbations compared to 
tyrosine. They are isosteric with 
tyrosine and the van der Waals 
radius of fluorine is only 0.15 Å 
larger than that of hydrogen,17 thus 
representing the most conservative 
substitution barring isotopic 
replacement. Fluorination at various 
points on the phenol ring affects a 
large range of pKa values for the 
unprotected amino acid (FnYs).18 A 
similar variation in the tyrosyl 
radical reduction potentials upon 
fluorine substitution would provide a 
systematic variation in ΔG°ET and 
ΔG°PT, the factors that control the 
thermodynamics of PCET reactions.  
Table 6.1. Fluorotyrosine derivatives studied here 
and their physical properties. 
 
Fluorotyrosine pKa Ep(Y•/Y–) / mV 
Ac-Y-NH2 9.9 642 
Ac-3,5-F2Y-NH2 7.2 755 
Ac-2,3-F2Y-NH2 7.8 810 
Ac-2,3,5-F3Y-NH2 6.4 853 
Ac-2,3,6-F3Y-NH2 7.0 911 
Ac-F4Y-NH2 5.6 968 
The synthesis and physical characterization of the N-acetyl and C-amide protected 
fluorotyrosines, Ac-FnY-NH2s, shown in Table 6.1 have been reported from our labs.19 The 
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methodologies for determining the ΔG°ET and ΔG°PT for the half of the PCET reaction 
involving fluorotyrosine oxidation have been determined by measuring both the reduction 
potentials for the radicals, Ep(FnY•/FnY) , and the pKa of the phenolic protons for Ac-FnY-
NH2s. The pKa varies from 5.6 to 8.4  and the reduction potential varies over 320 mV in the 
pH region accessible to most proteins, as shown by the plot of Ep(FnY•/FnY) vs. pH in Figure 
6.1.19 The utility of FnYs in providing insight into the mechanism of tyrosine oxidation in 
biological systems were also demonstrated in our labs by incorporating them site-specifically 
at position 356 in the β2 subunit of E. coli RNR and correlating RNR activity to pKa and 
reduction potentials of the Ac-FnY-NH2s presented here.20 
This chapter describes density functional theory calculations that explain the trends in 
reduction potential of these radicals. 
The UV/Vis absorbance spectra of the 
FnY•s in dipeptides is also presented 
using transient laser absorption 
spectroscopy with benzophenone as 
the photo-oxidant. The kinetics for 
photogeneration of FnY• attached to a 
ReI polypyridyl complex and the 
lifetime of the radical in the charge 
separated state are also described. The 
excited state of Re(bpy)(CO)3CN is 
shown to directly oxidize deprotonated 
FnY–, and the kinetics for charge 
separation are in the normal Marcus 
regime whereas charge recombination 
occurs in the inverted region. 
 
Figure 6.1. Reduction potential vs. NHE as a 
function of pH for Ac-FnY-NH2 derivatives of Table 
1: (▬) Ac-Y-NH2, (▬) Ac-3-FY-NH2, (▬) Ac-3,5-
F2Y-NH2, (▬) Ac-2,3-F2Y-NH2, (▬) Ac-2,3,5-F3Y-
NH2, (▬) Ac-2,3,6-F3Y-NH2 and (▬) Ac-F4Y-NH2. 
6.3 Results and Discussion 
6.3.1 Electronic Structure Calculations of Ac-FnY-NH2s.  
The Ac-FnY•-NH2/Ac-FnY–-NH2 redox couple was found to generally increase with the 
number of fluorine substituents on the phenol ring (Table 6.1 and Figure 6.1). Within the 
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 Figure 6.2. (Left) Plot of EP(Ac-FnY•-NH2/Ac-FnY–-NH2) vs. E(Ac-FnY•-NH2) – E(Ac-FnY–-
NH2), the total bonding energy difference between Ac-FnY•-NH2 and Ac-FnY–-NH2 as 
calculated by DFT, with linear fit (▬). (Bottom) Plot of –ln(Ka) vs. E(Ac-FnY–-NH2) – E(Ac-
FnY-NH2), the total bonding energy difference between Ac-FnY–-NH2 and Ac-FnY-NH2 as 
calculated by DFT, with linear fit (▬). Color coded points correspond to data for (●) Ac-Y-
NH2, (●) Ac-3-FY-NH2, (●) Ac-3,5-F2Y-NH2, (●) Ac-2,3-F2Y-NH2, (●) Ac-2,3,5-F3Y-NH2, (●) 
Ac-2,3,6-F3Y-NH2, (●) Ac-F4Y-NH2. 
series of di- and trifluorotyrosines, the couples follow a trend: Ac-2,3-F2Y-NH2 > Ac-3,5-
F2Y-NH2 and Ac-2,3,6-F3Y-NH2 > Ac-2,3,5-F3Y-NH2 that is captured computationally. 
Geometry optimizations on Ac-FnY-NH2, Ac-FnY•-NH2, and Ac-FnY–-NH2 were performed 
while keeping the amino acid backbone in the same conformation.  
Figure 6.2 (left) compares the difference in total bonding energy between the Ac-FnY•-
NH2 and Ac-FnY–-NH2 redox states as calculated by DFT to the experimentally determined 
Eps (Ac-FnY•-NH2/Ac-FnY–-NH2). The linear correlation between observed and calculated 
results validates the quality of the computation.  The electronic structure calculation 
summarized in Figure 6.3 shows that the observed trend in the reduction potential arises 
primarily from stabilization of the HOMO and HOMO-1 orbitals of the phenolate with 
increasing fluorination of the aromatic ring of tyrosine. This stabilization of HOMO and 
HOMO-1 levels is most pronounced for Ac-FnY–-NH2; these levels exhibit only a modest 
shift for Ac-FnY•-NH2 (and Ac-FnY-NH2). The Kohn-Sham representations of the frontier 
molecular orbitals, shown for tyrosinate in Figure 6.3, reveals that the HOMO orbital carries 
significant π-electron density at the 3 and 5 positions of the aromatic ring whereas the 
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HOMO-1 has π-electron density localized on the orbital of the oxygen of the phenol, in an in-
plane antibonding interaction with the aromatic ring. The interaction of the HOMO and 
HOMO-1 ring orbitals with the pπ-orbitals of the fluorine atom substituents allows subtle 
variations in the reduction potential among members of the phenolate series to be understood. 
For instance, substitution of fluorine at the 2,3 vs 3,5 ring positions results in a 55 mV 
increase in the reduction potential of the radical. The HOMO, which is presented in the 
framed box of Figure 6.3, exhibits an antibonding interaction between the π-orbitals of the 
fluorine atoms and the 3,5-carbon pπ orbitals of the aromatic ring. By moving a fluorine from 
a 5- to a 2-position, this antibonding interaction is relaxed significantly, resulting in 
stabilization of the HOMO. A similar effect is observed for 2,3,5- and 2,3,6- 
trifluorotyrosines.  
 
Figure 6.3. Energy level diagram for frontier molecular orbitals of the phenolates: (▬) Ac-
Y–-NH2, (▬) Ac-3-FY–-NH2, (▬) Ac-3,5-F2Y–-NH2, (▬) Ac-2,3-F2Y–-NH2, (▬) Ac-2,3,5-
F3Y–-NH2, (▬) Ac-2,3,6-F3Y–-NH2 and (▬) Ac-F4Y–-NH2. Selected Kohn-Sham 
representations of orbitals for the tyrosine analog are shown at the 95% probability level. 
The Kohn-Sham representation of the HOMO orbital for Ac-3,5-F2Y–-NH2 is presented in the 
frame. 
A parallel calculation was performed to assess the difference between the observed ln(Ka) 
and the total bonding energy difference of protonated and deprotonated Ac-FnY-NH2s. The 
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calculation predicts the general trend that increasing the number of fluorine substituents 
decreases the pKa of the phenolic proton (Figure 6.2, right), however a poorer correlation is 
observed as compared to that for the reduction potentials. The anomaly is most obvious for 
Ac-2,3-F2Y-NH2 and Ac-3,5-F2Y-NH2, which are calculated to have similar pKas despite an 
observed difference of 0.6 pKa units. We believe that such deviations arise from the 
deficiency of gas phase DFT calculations in modeling specific hydrogen bonding interactions 
that are important in determining the overall pKa of the fluorotyrosines.21- 23 
6.3.2 Spectroscopic Characterization of FnY•.  
As presented in Chapter III, the triplet excited state of benzophenone in the BPA-Y-OMe 
dipeptide is competent for oxidation of tyrosine, rapidly forming the •BPA-Y•-OMe diradical 
state which persists for hundreds of nanoseconds. The absorption spectrum of the 
benzophenone ketyl radical, produced upon tyrosine photo-oxidation, does not significantly 
overlap with that of the fluorotyrosyl radical analogue. Therefore, the BPA photo-oxidant 
provides an excellent means for measuring the absorption spectra of the fluorotyrosyl radical 
analogues when photolyzed in the BPA-FnY-OMe dipeptides. 
Figure 6.4 shows the TA spectra obtained 100 ns after 300 nm excitation of each of the 
BPA-FnY-OMe dipeptides. The amount of BPA•-FnY•-OMe produced in each experiment 
varies due to changes in pump-probe beam overlap and sample concentration.  Therefore, to 
allow for comparison of the FnY• absorption maxima between experiments, the spectra in 
 
Figure 6.4. The transient absorption spectrum of (▬) BPA-Y-OMe, (▬) BPA-3-FY-OMe, 
(▬) BPA-3,5-F2Y-OMe, (▬) BPA-2,3-F2Y-OMe, (▬) BPA-2,3,5-F3Y-OMe, (▬) BPA-2,3,6-
F3Y-OMe and (▬) BPA-F4Y-OMe normalized to the peak at 547 nm obtained 100 ns after 
excitation of ~500 μM solutions of each dipeptide buffered to pH 4.0 with 20 mM succinic 
acid. 
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Figure 6.5 are normalized to the 547 nm peak of the BPA• ketyl radical. The feature is 
invariant for each of the dipeptides whereas the absorption band of each FnY• species varies 
in its maximum between 395 and 415 nm. An interesting comparison can be made between 
the FnY•s and Y• absorbance features. The 3-FY•, 2,3-F2Y•, 2,3,6-F3Y• and F4Y• all have the 
familiar double hump absorbance feature of Y•, though they are slightly broader and red-
shifted. Of particular note are the single peaks at 395 and 400 nm for 3,5-F2Y• and 2,3,5-
F3Y•, respectively, which are significantly blue-shifted from the larger 407 nm absorbance 
peak of Y•. 
6.3.3 Marcus Analysis of ET in [Re]-FnY. 
The complex, Re(bpy)(CO)3CN (= [Re]), is a powerful excited state oxidant (E°(ReI*/ 0) = 
1.6 V vs. NHE). When the native 
amino acid, Y, is appended to the 
bpy ligand in [Re]–Y (n = 0, 
Chart 6.1), excited state 
quenching ensues and Y• forms if 
the tyrosine phenol is 
deprotonated.24 We prepared the 
series of [Re]–FnY presented in 
Chart 6.1 to determine how variation in the FnY•/FnY– reduction potential affects the rate of 
radical formation and charge recombination. The compounds were obtained by coupling the 
previously reported series of 
fluorotyrosine methyl esters with Re(bpy-
COOH)(CO)3CN using standard amide 
bond peptide coupling chemistry in 
modest yield (25 - 50%). In the course of 
this work, single crystals of Re(bpy-
COOH)(CO)3CN were obtained. The 
solution of the X-ray crystal structure is 
presented in Figure 6.5; this is the first 
reported structure of a mononuclear 
Re(bpy)(CO)3CN complex. Of note, the weaker field CN– ligand results in a longer Re—C 
 
Chart 6.1. Structure of [Re]–FnY complexes.
 
Figure 6.5. X-Ray structure and atom labeling 
scheme for Re(bpy-COOH)(CO)3CN•MeOH; 
solvent molecule not shown. 
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bond length of 2.17 Å compared to the shorter Re—C bond lengths of the stronger field, 
facial CO ligands (1.92 - 1.95 Å). 
Ultrafast time-resolved emission and nanosecond transient absorption spectroscopies were 
undertaken on [Re]–FnY– complexes to characterize kinetically any photoinduced electron 
transfer. For each [Re]–FnY–, the excited state [Re] emission was quenched compared to Re–
Y at pH 7 and could be fit to a single exponential decay function. The emission quenching is 
due to electron transfer24 to the excited Re complex from FnY– and the rate of charge 
separation, kCS, could be determined from: 
  kCS=τ–1([Re]–FnY–)–τ–1([Re]–Y)  (6.1) 
where τ([Re]–FnY–) is the emission lifetime of the quenched complex at pH 12 and τ([Re]–Y) 
is the lifetime of the unquenched control at pH 7. These data are presented in Table 6.2; kCS 
varies from 89.2 - 2.15 × 107 s–1 depending on the FnY employed. 
Nanosecond transient absorption spectroscopy confirms that the emission quenching is 
due to electron transfer in the [Re]–FnY–. Figure 6.6 shows the transient spectra observed 
following 355 nm (FWHM = 3 ns) excitation of [Re]–2,3,6-F3Y–. The peak at 520 nm 
corresponds to the reduced bpy•– ligand24 and the peak at 418 nm corresponds to the 
absorption feature for 2,3,6-F3Y•. The spectra at 15 and 65 ns are somewhat different, 
however, as the ratio of the 520/480 nm peaks change slightly. These dynamics are due to the 
decay of the quenched 3MLCT state which occurs with a time constant of 14.5 ns obtained 
from the ultrafast emission quenching described above. As such, the single wavelength 
kinetics trace obtained at 520 nm in the inset of Figure 6.6 (and for the other FnY– with n > 2) 
Table 6.2. Emission quenching and charge recombination kinetics 
data for [Re]-FnY complexes 
Compound τ([Re]-FnY) 
(ns) 
kET 
(107 s–1) 
kCR  
(107 s–1) 
[Re]–Y 1.10 89.2 2.17 
[Re]–3-FY 1.84 52.7 1.96 
[Re]–3,5-F2Y 3.7 25.3 1.79 
[Re]–2,3-F2Y 6.3 14.2 1.89 
[Re]–2,3,5-F3Y 11.1 7.31 1.67 
[Re]–2,3,6-F3Y 14.5 5.20 1.69 
[Re]–F4Y 26.0 2.15 1.54 
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was fit starting at 20 ns with a sum of 
two exponentials: a fast growth 
component whose time constant was 
fixed to that obtained in the ultrafast 
emission experiment and a slow decay 
component. The latter component 
corresponds to charge recombination 
(CR), the rate constants for which, kCR, 
are presented in Table 6.2. For FnY– with 
n < 2, the quenched 3MLCT state 
decayed within the instrument response 
and thus the 520-nm traces could be fit to 
 single exponential.  a
With the rates for charge separation 
and recombination in [Re]–FnY– in hand, we next chose to analyze the driving force 
dependence of these rates within the Marcus-Levich framework for ET described by eq. 6.2:25 
 
Figure 6.6. Transient absorption spectra of [Re]–
2,3,6-F3Y– observed (▬) 15, (▬) 65, (▬) 115 and 
(▬) 215 ns and following 355 nm, 3 ns laser 
irradiation. The Y• absorbance feature of the 15 ns 
trace is magnified. Inset: Single wavelength 
kinetics trace (○) obtained at 520 nm with bi-
exponential fit (▬). 
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where HAB is the electronic coupling, λ is the reorganization energy, and ΔG° is the free 
energy driving force for the electron transfer. The driving force for the CS and CR reactions, 
ΔGCS° and ΔGCR°, were derived from eqs. 6.3 and 6.4, respectively, 
 –ΔGCS° = E°(ReI*/ 0) – EP(FnY•/FnY–) (6.3) 
 ΔGCR° = E°(ReI / 0) – EP(FnY•/FnY–) (6.4) 
where E°(ReI*/ 0) and E°(ReI / 0) are the excited and ground state ReI reduction potentials24 and 
EP(FnY•/FnY–) is the peak potential for the FnY•/FnY– couple (Table 6.1). Figure 6.7 (left) 
plots ln(kCS) vs. –ΔGCS°, and shows that the data are well fit by both a linear and parabolic 
Marcus relation. These data indicate that CS is strongly activated and occurs in the normal 
region for Marcus’ ET. In the limit that 4λ >> ΔG°2, eq. 2 predicts that the ln(kCS) vs. –ΔGCS° 
plot should be linear with a slope of 0.5/(kBT). From the linear fit in Figure 6.7 (left), we 
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Figure 6.7. Left: ln(kCS) vs. –ΔGCS° plot with linear (▬) and parabolic (▬) fit. Right: ln(kCR) 
vs. –ΔGCR° plot with linear (▬) fit. 
obtain 0.3/(kBT). The parabolic fit (eq. 2) yields an approximate value of λ for this system of 
1.9 eV, indicating that 4λ is about an order of magnitude larger than ΔG°2.  
The lack of curvature in the plot in Figure 6.7 (left) introduces a large degree of error in 
the calculation of λ from eq. 6.2 for CS. To provide a more accurate measurement of λ, the 
temperature dependence of kCS for [Re]-3,5-F2Y and [Re]-F4Y was measured. The data were 
analyzed as ln(kCS•T1/2) vs. T–1 plots (Figure 6.8) and fit to eq. 6.5: 25 
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–)•ln( Δ=  (6.5) 
where ΔG‡ is the activation energy, A is a pre-factor, and kB is the Boltzmann constant. The 
reorganization energy, λ, could then be 
calculated with eq. 6.6:25 
 
λ
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G
4
)( 2CS‡ °Δ+=Δ  (6.6) 
The calculated values of ΔG‡ and 
λ are listed below in Table 6.3. The 
calculated values of λ from the 
temperature dependence experiments are 
in agreement with the value calculated 
from the driving force plot in Figure 6.8 
(left). 
 
Figure 6.8. Temperature dependence of the rate of 
charge separation in [Re]-3,5-F2Y– and [Re]-F4Y– 
(○) with linear fit (▬). 
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Figure 6.7 (right) plots ln(kCR) 
ΔGCR° and, in contrast to CS, 
shows that CR is weakly 
dependent on driving force and 
occurs in the inverted region for 
Marcus’ ET. Previous work has 
shown that inverted region ET often does not exhibit the predicted parabolic dependence on 
driving force due to electron coupling to vibrational modes that assist the reaction (see 
Chapter I).
vs. –
Table 6.3. Experimental Activation Energies and 
Calculated Reorganization Energies and Driving 
Forces for Charge Seperation 
Compound ΔG‡ / eV λ / eV ΔG°CS / eVa 
[Re]–3,5-F2Y– 0.16 2.0 -0.85 
[Re]–F4Y– 0.23 2.0 -0.63 
26 Under such conditions, a modest linear decrease in ln(kCR) with –ΔGCR° is 
predicted by the energy gap law.26 The scatter in these data is likely due to experimental 
precision (2 ns error shown in plot) and small differences in electronic coupling and/or 
frequency of the accepting vibrational modes for each of the FnYs.  
6.4 Conclusions 
The mechanistic complexity arising from the coupling of electron and proton transfers in 
charge transport processes involving amino acid radicals requires the development of new 
tools and methods for their study. The results reported and discussed herein show that FnYs 
will be useful in the study of biological charge transport mechanisms involving tyrosine for 
the following reasons. (1) They provide a range of pKas for the phenolic proton and Eps for 
the Y•/Y couple, which allows for tuning of the ΔG°PT and ΔG°ET for the PCET reaction. UV-
Vis and DPV analysis illustrate that the Ac-FnY-NH2s offer a range of almost 5 units in pKa 
and 320 mV in redox potential within the pH range of 6-9 where proteins can be studied.19 (2) 
The oxidized forms of FnY•s possess unique spectral signals allowing a distinction between 
Y• and FnY• in the same system. The time-resolved absorption spectra of BPA-FnY-OMe 
dipeptides show that the λmax for FnY• absorption can be shifted by ~10 nm relative to Y•. (3) 
The variation in Eps for the FnY•/FnY– couple directly correlates to the rate of electron 
transfer in reactions involving FnY• as predicted by the driving force dependence of ET from 
Marcus Theory. The correlation between ET rate and driving force also validates the DPV 
method of measuring the reduction potentials for FnY•. 
The FnYs will be useful for a variety of mechanistic studies in biology, in which tyrosine 
is integral to radical initiation and transport. We have demonstrated one example of this utility 
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by site-specifically replacing Y356 of R2 with the FnYs presented here.20 A study of the pH 
dependent activity of each of these new semi-synthetic enzymes cast with the backdrop of the 
Ac-FnY-NH2s pKa and Ac-FnY•-NH2s reduction potential data discussed above have allowed 
for mechanistic details of the PCET reactivity at this site to be unveiled. 
Furthermore, with the basic characterization of FnY• and the of electron transfer reactions 
in [Re]–FnY in hand, we can now focus on incorporation of this system into RNR for the 
study of photoinitiated radical transport. Radical transport in the enzyme likely occurs via a 
PCET mechanism as amino acid oxidation is coupled to changes in protonation state. Upon 
substituting FnY for Y, we can now predict what affect this will have on the ET part of the 
reaction, allowing us to gauge the degree of proton coupling to the radical transport process. 
The ability to phototrigger radical formation is a powerful tool for the study of radical 
based enzymes. Previous methods to generate the radicals by metal complexes have relied on 
indirect bimolecular methods (flash-quench10) owing to insufficient oxidizing power of the 
direct excited state. As we show here, this is not the case for ReI polypyridyl excited states. 
Transient spectroscopic results show that tyrosyl radical is generated promptly upon 
photoexcitation and it is of sufficient lifetime to promote the investigation of radical transport. 
One important reason for the prompt photogeneration is that the non-natural FnY amino acids 
are deprotonated at physiological pHs so that radical initiation occurs by simple electron 
transfer. Using previously described peptide methods,20 the [Re]–FnY constructs may be 
incorporated into the PCET network of RNR, thus allowing the kinetics for radical transport 
to be probed.  
6.5 Experimental Section 
Materials. N-acetyl-L-tryosinamide, 3-fluoro-L-tyrosine, trifluoroacetic acid (TFA), 
thionyl chloride, 1-(3-dimethylamino-propyl)-3-ethylcarbodiimide hydrochloride (WSC•HCl) 
and N-methylmorpholine (NMM) were purchased from Sigma-Aldrich. L-Tyrosine methyl 
ester hydrochloride (Y-OMe•HCl) and 4-benzoyl-N-[(1,1-dimethylethoxy) carbonyl]-L-
phenylalanine (Boc-BPA-OH) were from Advanced ChemTech. 1-Hydroxybenzotriazole 
(HOBt) was obtained from NovaBiochem. All chemicals were used as received. 
Fluorotyrosines (FnYs)19 and rhenium(I)(4-methyl-2,2´-bipyridine-4´-carboxylic 
acid)tricarbonyl cyanide (Re(bpy-COOH)(CO)3CN) 24 were prepared as previously described.  
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Fn-Tyrosine Methyl Ester Hydrochloride (FnY-OMe·HCl). In a typical synthesis, the 
diammonium salt of the FnY (0.6 mmol) was combined with 20 mL of methanol in a 50 mL 
round bottom flask. Thionyl chloride (400 μL, 5.5 mmol) was added dropwise and the 
solution was stirred for three days at room temperature. The solvent was removed in vacuo 
and the resulting white solid was dissolved in a minimal amount of methanol. Ether was 
added dropwise to precipitate NH4Cl, which was removed by filtration. Further dropwise 
addition of ether induced crystallization of the title compound. After cooling to –20°C, the 
white crystals were isolated by filtration and dried in vacuo providing product in 70 - 88% 
yield.  
3-FY-OMe•HCl: 1H NMR (300 MHz, (CD3)2SO, 25 oC) δ = 3.02 (m, 2H, Cβ-H), 3.68 (s, 
3H, -OCH3), 4.22 (m, 1H, Cα-H), 6.80 (m, 1H, arom. C-H), 6.90 (m, 1H, arom. C-H), 7.02 
(m, 1H, arom. C-H), 8.56 (b.s., 3H, -NH3+), 9.88 (b.s., 1H, PhO-H). 19F NMR (300 MHz, 
(CD3)2SO, 25 oC) δ = 27.3 (t, 1F, 11.1 Hz).  
3,5-F2Y-OMe·HCl: 1H NMR (300 MHz, (CD3)2SO, 25 oC) δ = 3.05 (m, 2H, Cβ-H), 3.70 
(s, 3H, -OCH3), 4.27 (m, 1H, Cα-H), 6.94 (d, 2H, arom. C-H, 8.8 Hz), 8.63 (b.s., 3H, -NH3+), 
10.15 (s, 1H, PhO-H). 19F NMR (300 MHz, (CD3)2SO, 25 oC) δ = 32.1 (d, 2F,11.1 Hz).  
2,3-F2Y-OMe•HCl: 1H NMR (300 MHz, (CD3)2SO, 25 oC) δ = 3.09 (m, 2H, Cβ-H), 3.65 
(s, 3H, -OCH3), 4.14 (m, 1H, Cα-H), 6.78 (m, 1H, arom. C-H), 6.89 (m, 1H, arom. C-H), 8.64 
(b.s., 3H, -NH3+), 10.51 (s, 1H, PhO-H). 19F NMR (300 MHz, (CD3)2SO, 25 oC) δ = –0.5 (d, 
1F, 22.2 Hz), δ = 19.5 (d, 1F, 22.2 Hz). 
2,3,5-F3Y•HCl: 1H NMR (300 MHz, (CD3)2SO, 25 oC) δ = 3.12 (m, 2H, Cβ-H), 3.69 (s, 
3H, -OCH3), 4.22 (m, 1H, Cα-H), 7.10 (m, 1H, arom. C-H), 8.70 (b.s., 3H, -NH3+), 10.83 
(b.s., 1H, PhO-H). 19F NMR (300 MHz, (CD3)2SO, 25 oC) δ = 5.5 (d, 1F, 16.7 Hz), 15.8, (s, 
1F), 24.5 (s, 1F).  
2,3,6-F3Y•HCl: 1H NMR (300 MHz, (CD3)2SO, 25 oC) δ = 3.07 (m, 2H, Cβ-H), 3.64 (s, 
3H, -OCH3), 4.07 (m, 1H, Cα-H), 6.73 (m, 1H, arom. C-H), 8.70 (b.s., 3H, -NH3+), 11.13 (s, 
1H, PhO-H). 19F NMR (300 MHz, (CD3)2SO, 25 oC) δ = –4.8 (s, 1F), 22.3, (d, 1F, 22.2 Hz), 
40.9 (m, 1F).  
2,3,5,6-F4Y•HCl: 1H NMR (300 MHz, (CD3)2SO, 25 oC) δ = 3.16 (m, 2H, Cβ-H), 3.66 (s, 
3H, -OCH3), 4.14 (m, 1H, Cα-H), 8.75 (b.s., 3H, -NH3+), 11.56 (b.s., 1H, PhO-H). 19F NMR 
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(300 MHz, (CD3)2SO, 25 oC) δ = –0.6 (d, 2F, 16.7 Hz), 16.2, (d, 1F, 22.2 Hz), δ = 40.9 (m, 
1F) 
4-Benzoyl-L-Phenylalanyl-FnY Methyl Ester Trifluoroacetic Acid (BPA-FnY-OMe• 
CF3COOH). The compounds were prepared as described in Chapter 3 for BPA-Y-OMe• 
CF3COOH, except that FnY-OMe•HCl was used instead of Y-OMe (45-65% yield). 
BPA-3-FY-OMe•CF3COOH: 1H NMR (300 MHz, (CD3)2CO, 25 oC) δ = 2.90 - 3.20 (m, 
2H, Cβ-H), 3.32-3.48 (m, 2H, Cβ-H), 3.69 (s, 3H, -OCH3), 4.63 (m, 1H, Cα-H), 4.96 (m, 1H, 
Cα-H), 6.85 - 7.04 (m, 2H, phenol-H), 7.14 (m, 1H, phenol-H), 7.32 (m, 2H, C6H4OC6H5), 
7.50 - 7.82 (m, 7H, C6H4OC6H5) 19F NMR (300 MHz, (CD3)2CO, 25 oC) δ = 27.17 (m, 1F), 
89.76 (s, 3F). 
BPA-3,5-F2Y-OMe•CF3COOH: 1H NMR (300 MHz, (CD3)2CO, 25 oC) δ = 2.89-3.25 (m, 
2H, Cβ-H), 3.38 (m, 2H, Cβ-H), 3.70 (s, 3H, -OCH3), 4.65 (m, 1H, Cα-H), 4.95 (m, 1H, Cα-
H), 7.03 (m, 2H, phenol-H), 7.33 (d, 2H, C6H4OC6H5, 8.3 Hz), 7.56 (m, 2H, C6H4OC6H5), 
7.62-7.85 (m, 5H, C6H4OC6H5). 19F NMR (300 MHz, (CD3)2CO, 25 oC) δ = 26.6 (s, 2F), 85.6 
(s, 3F).  
BPA-2,3-F2Y-OMe•CF3COOH: 1H NMR (300 MHz, (CD3)2CO, 25 oC) δ = 2.93 - 3.49 
(m, 4H, Cβ-H), 3.69 (s, 3H, -OCH3), 4.68 (m, 1H, Cα-H), 4.95 (m, 1H, Cα-H), 6.80 (m, 1H, 
phenol-H), 7.01 (m, 1H, phenol-H), 7.39 (d, 2H, C6H4OC6H5, 7.7 Hz), 7.56 (m, 2H, 
C6H4OC6H5), 7.63 - 7.86 (m, 5H, C6H4OC6H5). 19F NMR (300 MHz, (CD3)2CO, 25 oC) δ = –
1.7 (m, 1F), 18.3 (m, 1F), 85.6 (s, 3F). 
BPA-2,3,5-F3Y-OMe•CF3COOH: 1H NMR (300 MHz, (CD3)2CO, 25 oC) δ = 2.93-3.51 
(m, 4H, Cβ-H), 3.70 (s, 3H, -OCH3), 4.68 (m, 1H, Cα-H, 5.04 (m, 1H, Cα-H), 7.11 (m, 1H, 
phenol-H), 7.41 (d, 2H, C6H4OC6H5, 7.7 Hz), 7.55 (m, 2H, C6H4OC6H5), 7.62 - 7.85 (m, 5H, 
C6H4OC6H5). 19F NMR (300 MHz, (CD3)2CO, 25 oC) δ = 7.93 (d, 1F, 22.2 Hz), 18.56 (m, 
1F), 26.1 (s, 1F), 89.9 (s, 3F).  
BPA-2,3,6-F3Y-OMe•CF3COOH: 1H NMR (300 MHz, (CD3)2CO, 25 oC) δ = 3.00-3.26 
(m, 2H, Cβ-H), 3.44 (m, 2H, Cβ-H), 3.67 (s, 3H, -OCH3), 4.66 (m, 1H, Cα-H), 5.12 (m, 1H, 
Cα-H), 6.76 (m, 1H, phenol-H), 7.41-7.85 (m, 9H, C6H4OC6H5). 19F NMR (300 MHz, 
(CD3)2CO, 25 oC) δ = –1.86 (m, 1F), 25.2 (d, 1F, 22.2 Hz), 44.1 (m, 1F), 90.0 (s, 3F).  
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BPA-2,3,5,6-F4Y-OMe•CF3COOH: 1H NMR (300 MHz, (CD3)2CO, 25 oC) δ = 3.10 - 
3.52 (m, 4H, Cβ-H), 3.68 (s, 3H, -OCH3), 4.65 (m, 1H, Cα-H), 5.05 (m, 1H, Cα-H), 7.46 - 7.85 
(m, 9H, C6H4OC6H5). 19F NMR (300 MHz, (CD3)2CO, 25 oC) δ = –2.42 (d, 2F, 22.2 Hz), 14.6 
(d, 2F, 22.2 Hz), 85.6 (s, 3F). 
[Re]–FnY. In a typical synthesis Re(bpy-COOH)(CO)3CN (195 mg, 0.383 mmol, 1 eq), 
FnY–COOMe•HCl (1 eq), WSC•HCl (147 mg, 0.766 mmol, 2 eq), and HOBt (104 mg, 0.766 
mmol, 2 eq) were combined in a 50 mL round bottom flask with 20 mL of 
dimethylformamide. NMM (255 μL, 2.30 mmol, 6 eq) was added and the solution stirred for 
2.5 hours at room temperature. Upon addition of NMM in the synthesis of [Re]-2,3-F2Y, the 
reaction mixture initially turned green, but changed back to yellow as the reaction progressed. 
The solvent was removed in vacuo and the residual yellow/orange oil was dissolved in 75 mL 
of CH2Cl2. The organics were washed with 2 × 30 mL of water and dried over MgSO4. The 
solvent was removed in vacuo and the resulting yellow solid was dissolved in a few mLs of 
5% MeOH/CH2Cl2 and loaded onto a silica gel Chromatotron plate (2 mm). The product 
eluted as a yellow band with 5% MeOH/CH2Cl2 and the solvent was removed in vacuo 
yielding a yellow solid that was triturated with ether and isolated by filtration (25 - 50 % 
yield). 
[Re]–Y: 1H NMR (300 MHz, (CD3)2CO, 25 oC) δ = 2.67 (d, 3H, bpy-CH3), 3.02 - 3.27 
(m, 2H, Cβ-H2), 3.72 (d, 3H, Y-OCH3), 4.88 (m, 1H, Cα-H), 6.77 (m, 2H, phenol C-H), 7.16 
(m, 2H, phenol C-H), 7.66 (m, 1H, bpy-H), 8.03 (m, 1H, bpy-H,), 8.25 (s, 1H, phenol O-H), 
8.53 (m, 1H, amide N-H), 8.66 (m, 1H, bpy-H), 8.85 (m, 1H, bpy-H), 8.97 (d, 1H, bpy-H), 
9.24 (m, 1H, bpy-H).  
[Re]–3-FY: 1H NMR (300 MHz, (CD3)2CO, 25 oC) δ = 2.65 (d, 3H, bpy-CH3), 3.05-3.30 
(m, 2H, Cβ-H2), 3.74 (d, 3H, Y-OCH3), 4.91 (m, 1H, Cα-H), 6.94 (m, 2H, phenol C-H), 7.12 
(m, 1H, phenol C-H), 7.66 (m, 1H, bpy-H), 8.03 (m, 1H, bpy-H,), 8.58 (m, 2H, phenol O-H, 
amide N-H), 8.65 (m, 1H, bpy-H), 8.84 (m, 1H, bpy-H), 8.98 (d, 1H, bpy-H), 9.25 (m, 1H, 
bpy-H). 19F NMR (300 MHz, (CD3)2CO, 25 oC) δ = 23.25 (m, 1F). 
[Re]–3,5-F2Y: 1H NMR (300 MHz, (CD3)2CO, 25 oC) δ = 2.65 (d, 3H, bpy-CH3), 3.08-
3.30 (m, 2H, Cβ-H2), 3.74 (d, 3H, Y-OCH3), 4.95 (m, 1H, Cα-H), 7.01 (m, 1H, phenol C-H), 
7.66 (m, 1H, bpy-H), 8.03 (m, 1H, bpy-H,), 8.63 (m, 2H, amide N-H, bpy-H), 8.86 (m, 2H, 
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bpy-H, phenol O-H), 8.98 (d, 1H, bpy-H), 9.26 (m, 1H, bpy-H). 19F NMR (300 MHz, 
(CD3)2CO, 25 oC) δ = 26.85 (d, 1F). 
[Re]–2,3-F2Y: 1H NMR (300 MHz, (CD3)2CO, 25 oC) δ = 2.67 (s, 3H, bpy-CH3), 3.10-
3.42 (m, 2H, Cβ-H2), 3.74 (s, 3H, Y-OCH3), 4.97 (m, 1H, Cα-H), 6.75 (m, 1H, phenol C-H), 
6.99 (m, 1H, phenol C-H), 7.67 (m, 1H, bpy-H), 8.04 (m, 1H, bpy-H,), 8.65 (m, 2H, amide N-
H, bpy-H), 8.88 (m, 1H bpy-H), 8.97 (d, 1H, bpy-H), 9.06 (s, phenol O-H), 9.24 (m, 1H, bpy-
H). 19F NMR (300 MHz, (CD3)2CO, 25 oC) δ = –1.52 (m, 1F), 18.40 (m, 1F). 
[Re]–2,3,5-F3Y: 1H NMR (300 MHz, (CD3)2CO, 25 oC) δ = 2.64 (d, 3H, bpy-CH3), 3.05-
3.44 (m, 2H, Cβ-H2), 3.76 (d, 3H, Y-OCH3), 4.97 (m, 1H, Cα-H), 7.05 (m, 1H, phenol C-H), 
7.66 (m, 1H, bpy-H), 8.05 (m, 1H, bpy-H,), 8.68 (m, 2H, amide N-H, bpy-H), 8.89 (m, 1H 
bpy-H), 8.98 (m, 1H, bpy-H), 9.26 (m, 1H, bpy-H), 9.42 (s, 1H, phenol O-H). 19F NMR (300 
MHz, (CD3)2CO, 25 oC) δ = 8.00 (m, 1F), 18.67 (m, 1F), 26.26 (m, 1F). 
[Re]–2,3,6-F3Y: 1H NMR (300 MHz, (CD3)2CO, 25 oC) δ = 2.66 (s, 3H, bpy-CH3), 3.17-
3.44 (m, 2H, Cβ-H2), 3.74 (d, 3H, Y-OCH3), 4.91 (m, 1H, Cα-H), 6.60 (m, 1H, phenol C-H), 
7.65 (m, 1H, bpy-H), 8.06 (m, 1H, bpy-H,), 8.65 (m, 1H, bpy-H), 8.74 (m, 1H, amide N-H), 
8.90 (m, 1H bpy-H), 8.98 (m, 1H, bpy-H), 9.27 (m, 1H, bpy-H), 9.63 (s, 1H, phenol O-H). 19F 
NMR (300 MHz, (CD3)2CO, 25 oC) δ = –1.59 (m, 1F), 25.34 (m, 1F), 44.13 (m, 1F). 
[Re]–F4Y: 1H NMR (300 MHz, (CD3)2CO, 25 oC) δ = 2.66 (s, 3H, bpy-CH3), 3.26-3.48 
(m, 2H, Cβ-H2), 3.76 (d, 3H, Y-OCH3), 4.99 (m, 1H, Cα-H), 7.67 (m, 1H, bpy-H), 8.05 (m, 
1H, bpy-H,), 8.64 (m, 1H, bpy-H), 8.73 (m, 1H, amide N-H), 8.88 (m, 1H bpy-H), 8.98 (m, 
1H, bpy-H), 9.26 (m, 1H, bpy-H), 10.0 (bs, 1H, phenol O-H). 19F NMR (300 MHz, (CD3)2CO, 
25 oC) δ = –2.30 (d, 2F), 14.75 (d, 2F). 
NMR Methods. 1H and 19F NMR spectra were recorded on a Varian 300 MHz NMR at 
the MIT Department of Chemistry Instrumentation Facility (DCIF). Aqueous samples for 1H 
NMR and 19F NMR were carried out in D2O with 3-(trimethylsilyl)-propionic acid-d4 (TSP) 
as an internal standard and CFCl3 as an external standard, respectively. Nonaqueous 1H and 
19F NMR were externally referenced to tetramethylsilane and CFCl3, respectively.  
X-Ray Crystal Structure of Re(bpy-COOH)(CO)3CN•MeOH. Single crystals of the 
complex were grown by slow evaporation of a saturated solution in methanol. X-ray 
diffraction data were collected at 100 K on a Siemens diffractometer equipped with a CCD 
 153
detector, using the Mo Kα radiation. The data were integrated to hkl-intensity and the unit 
cell calculated using the SAINT v.4.050 program from Siemens. Solution and refinement 
were performed by direct methods (SHELXTL v.6.10, Sheldrick, G. M., and Siemens 
Industrial Automation, Inc., 2000). The structures were solved by the Patterson method, non-
hydrogen atoms were refined anisotropically, and hydrogen atoms were placed at calculated 
positions. Details regarding the refined data, cell parameters and results of the solution are 
presented at the end of this chapter (Table 6.4). 
Computational Methods. Density functional theory calculations (DFT) were performed 
using the Amsterdam Density Functional (ADF2002.02) program27,28 a home-built Linux 
cluster comprising 60 Intel processors organized in groups of 12 running in parallel. The 
generalized gradient approximation was used as implemented in ADF by the Becke-88 
functional for exchange,29 and the Perdew-Wang-91 functional for correlation.30 A basis set 
of triple-ζ  Slater-type functions augmented by a polarization set (TZP) was used for all 
atoms; spin restriction was lifted for all Ac-FnY•-NH2 radicals. Energies reported are gas-
phase internal energies at 0 K, without zero-point vibrational energy, of the geometry 
optimized structure. Each structure was optimized from the same amino acid backbone 
configuration, which was kept nearly constant throughout the calculation.  
Transient Absorption (TA) Spectroscopy. Laser radiation (400 nm, ~100 fs) was used 
as the pump source in the time-resolved emission experiments and the data were collected on 
a streak camera as previously described.24 TA measurements were performed with pump light 
provided by an Infinity Nd:YAG laser (Coherent) running at 20 Hz, slightly modified from 
that described in Chapter II. For studies with [Re]-FnY, the third harmonic (355 nm) provided 
a convenient pump source, however due to low absorption of BPA-FnY-OMe at 355 nm, 300 
nm pump light was used for excitation as described in Chapter III. Aqueous BPA-FnY-OMe 
samples were prepared at 200-500 μM concentrations in deionized water buffered to pH 4 
with 20 mM succinic acid. All TA measurements were performed in a 2 mm quartz optical 
cell. For BPA-3-FY-OMe, 266 nm pump light was used as described in Chapter II and the 
sample was flowed through a 2 mm cell to ensure fresh sample for each laser shot. For [Re]-
FnY, all samples were dissolved in aqueous solutions of 10 mM KOH (pH 12) in the 
concentration range of 50 - 100 μM and freeze-pump-thaw degassed to 10–5 torr on a high-vac 
line. 
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Temperature Dependent Time-Resolved Emission Spectroscopy. The emission 
lifetime of [Re]-3,5-F2Y– and [Re]-F4Y– were measured in 10 mM KOH as a function of 
temperature over the range 320-260 K.  The emission lifetime of the control complex, [Re]-Y-
COOH,24 ([Re]-Y with a free carboxylic acid) was also measured in 20 mM Tris buffer at pH 
7.5 over the same temperature range. At this pH the tyrosine phenol is protonated and tyrosine 
oxidation does not occur, thus allowing for measurement of the intrinsic temperature 
dependence of the 3MLCT excited state. Each sample was freeze-pump-thaw degassed to 10–5 
torr in a glass vial to remove traces of dissolved oxygen. The samples were then sealed in the 
glass vial under vacuum and placed in a modular cryostat system31 equipped with glass 
windows to allow for excitation of the sample and collection of the emitted light.  The [Re]-
Y-COOH control complex was excited with 355 nm, nanosecond laser light and the emitted 
light monitored with a photomultiplier tube. The [Re]-3,5-F2Y and [Re]-F4Y complexes were 
excited with 400 nm, ~100 femtosecond laser light and the emitted light collected with a 
streak scope. Data were collected at 5 K intervals and the sample was allowed to equilibrate 
for 15 minutes at the set temperature before collection. 
The overall photochemical sequence of events is: 
[ReI]–FnY– [ReI]*–FnY– (= [ReIIbpy–
•]*–FnY–)  [Re0]–FnY•⎯⎯⎯ →⎯ MLCT)(hν ⎯→⎯CSk ⎯→⎯CRk [ReI]–FnY– 
Rate constants for charge separation at a given temperature were calculated with the eq. 6.7: 
 kCS(Τ)   =   τ–1([Re]–FnY–)(T)   –  τ  – 1([Re]–Y-COOH)(T) (6.7) 
where τ  ([Re]–FnY–)(T) and τ  ([Re]–Y-COOH)(T) are the emission lifetimes of the [Re]-
FnY– and [Re]-Y-COOH at a given temperature. 
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 Table 6.4. Crystal data and structure refinement for Re(bpy-COOH)(CO)3CN. 
Empirical formula C17H14N3O6Re 
Formula weight 542.51 
T (K) 100(2) 
λ (Å) 0.71073  
Crystal system Triclinic 
Space group 1P  
a (Å) 8.3707(5) 
b (Å) 10.4102(6) 
c (Å) 11.8772(7) 
α (º) 104.8670(10) 
β (º) 96.5250(10) 
γ (º) 106.2030(10) 
V (Å3) 941.28(10) 
Z 2 
ρcalcd (Mg/m3) 1.914 
Abs. coeff (mm–1) 6.493 
θ range for data collection (°) 1.81 to 28.29 
Index ranges –11 ≤ h ≤ 4, –13 ≤ k ≤ 13, –14 ≤ ℓ ≤ 
15 
Reflections collected 5964 
Independent reflns (Rint) 4430 (0.0221) 
Completeness to θmax 94.9% 
Data/restraints/parameters 4430 / 0 / 260 
GOFa on F2 1.055 
R1b 0.0297 
wR2c 0.0743 
Largest diff. peak, hole 1.928, –1.457 eÅ–3 
 a GOF = (Σ w(Fo2 – Fc2)2/(n – p))1/2 where n is the number of data and p is the 
number of parameters refined. b R1 = Σ||Fo – |Fc||/Σ|Fo|. c wR2 = (Σ(w(Fo2 – 
Fc2)2)/Σ(w(Fo2)2))1/2.  
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 Chapter VII 
 
 
PhotoRNRs with Benzophenone and Anthraquinone 
Excited States as Radical Generators 
 
 
 
 
 
 
 
 
 
 
 
Parts of this Chapter have been published: 
Reece, S. Y; Seyedsayamdost, M. R.; Stubbe, J.; Nocera, D. G. “Photoactive Peptides for 
Light Initiated Tyrosyl Radical Generation and Transport into Ribonucleotide Reductase” 
J. Am. Chem. Soc. 2007, in press. 
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7.1 Motivation and Background 
Having developed methods for photochemical Y• generation (Chapters III and IV), a basic 
understanding of PCET mechanisms of Y• formation (Chapter V), and tools to probe the 
PCET reactions involving Y• in enzymes (Chapter VI), we decided to apply these 
methodologies to the study of PCET 
in RNR. This chapter presents 
photochemical RNR systems based 
on the benzophenone and 
anthraquinone (Figure 7.1) excited 
state oxidants of Y•. These molecules 
can be excited with UV light of 
wavelengths outside of the protein absorption envelope and their corresponding excited states 
are competent for rapid (sub-ns) tyrosine oxidation (see Chapter III). We now append these 
photooxidants to the end of the Y–R2C19 peptide (see Chapter I, Figure 1.14), bind them to 
the α2 subunit, and photolyze them in the presence of RNR substrate and effector. The RNR 
turnover data obtained, in comparison to that for the Y730F-α2 variant, provide insight into 
the mechanism of radical transport in α2. 
 
Figure 7.1. Molecular structures of photooxidants 
used in this chapter. 
7.2 Results 
Synthesis. Chromophore-(F/Y)-R2C19 peptides were synthesized by extending the Fmoc-
R2C19-PEG-PS resin bound peptide, first with Fmoc-(F/Y)-OH, followed by the appropriate 
Table 7.1. Characterization of Peptides 
Peptide 
tR 
(min)a 
MW Calcd
(m/z) 
MW Found 
(m/z)b 
IC50c 
(μM) 
Ac-BPA-Y-R2C19 16.7 2563 2564 15 
Ac-BPA-F-R2C19 18.3 2547 2548 30 
Anq-Y-R2C19 17.1 2504 2507 4 
Anq-F-R2C19 19.9 2488 2489 7 
aRetention time (tR) from analytical HPLC trace. bMALDI-TOF MS in 
negative ion mode. cConcentration of peptide at 50% RNR inhibition. 
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carboxylic acid containing chromophore (Fmoc-BPA-COOH or Anq-COOH) using standard 
Fmoc-SPPS conditions. Table 7.1 lists the analytical HPLC retention times and MALDI-TOF 
mass spectral data for each of the peptides synthesized.  
Time-resolved Spectroscopy. The BPA and Anq dipeptides and full-length peptides were 
weakly emissive or non-emissive in aqueous solutions. Accordingly, the formation and 
reaction of the chromophore excited states and photoproducts were characterized by transient 
absorption spectroscopy. The BPA-Y-OMe dipeptide produces the •BPA-Y•-OMe diradical 
state upon excitation with λexc = 300 nm. 
Radical recombination occurs with a rate 
constant of 5.6 × 106 s–1 (Chapter III).1 The 
transient absorption and kinetics traces 
shown in Figure 7.2 establish a similar 
photochemistry for the full length peptide, 
Ac-BPA-Y-R2C19. Transient absorption 
features at 337, 410 and 550 nm, obtained 65 
ns following 300 nm excitation, are 
consistent with the formation of Y• (ε410 nm = 
2750 ± 200)2 and the benzophenone ketyl 
radical (ε330 nm = 22000 M–1 cm–1 and ε540 nm 
= 2800 M–1 cm–1).3 The overall absorption 
profile does not change over the time course 
of 415 ns, 1 μs and 10 μs. Time-evolved 
absorption kinetics obtained at 410 and 550 nm (inset of Figure 7.2) can both be fit to a mono-
exponential decay function with a time constant of 490 ± 20 ns, thus yielding a rate constant 
for radical recombination of 2.0 ± 0.1 × 106 s–1. The direct and concomitant return of the 
transient signals of •BPA and •Y to baseline indicates that radical recombination proceeds 
without the production of additional intermediates. Moreover, the similarity of the transient 
data for the dipeptide and full-length peptide indicates that the BPA reacts solely with Y and 
not other residues on the R2C19 peptide. 
 
Figure 7.2. Transient absorption spectra of 
BPA-Y-R2C19 obtained 65 (▬), 415 ns, 1, 
and 10 μs (▬) following 300 nm excitation. 
Insets: Time-evolved absorbance data (○) with 
mono-exponential decay fit (▬) obtained at 
410 and 550 nm.
We next investigated the photochemistry of the Anq chromophore appended to the Y-
R2C19 peptide against the backdrop of the dipeptide results already discussed in Chapter III. 
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Figure 7.3. Left panel: Transient absorption spectra of Anq-Y-R2C19 obtained 115 ns 
(▬), 1, and 10 μs (▬) following 355 nm excitation. Left and right insets: Single 
wavelength kinetics traces (○) with bi-exponential decay fit (▬). Middle inset: Plot of 
ΔΔOD obtained by subtracting the normalized transients observed for Anq-Y-R2C19 and 
Anq-F-R2C19 at 100 ns. Bottom panel: Transient absorption spectra of Anq-F-R2C19 
obtained 115 ns (▬), 1, 10, and 100 μs (▬) following 355 nm excitation. 
Figure 7.3 (left) shows the transients obtained 100 ns, 1 μs and 10 μs after excitation of Anq-
Y-R2C19 with 355 nm laser pulse. The spectra are similar to those observed for the Anq-Y-
OH dipeptide and are ascribed to the Anq•–-Y•-R2C19 diradical state of the peptide. Single 
wavelength kinetics obtained at 410 nm and 520 nm (Figure 7.3, left and right insets) could be 
fit to a bi-exponential decay with short, major and long, minor components similar to that for 
Anq-Y-OH (Chapter III): 410 nm, τ1 = 540 ± 30 ns (80%), τ2 = 2.1 ± 0.3 μs (20%); 510 nm, τ1 
= 630 ± 70 ns (80%), τ2 = 2.1 ± 0.3 μs (20%). The shorter components are the same within the 
error of the measurement, and, as with Anq-Y-OH, are attributed to radical recombination 
between Anq•– and Y• on the peptide with a rate constant of 1.7 ± 0.3 × 106 s–1. As with Anq-
Y-OH, we attribute the slower component to the decay of the Anq-solvent photoproduct. 
To further confirm Y• formation in Anq-Y-R2C19, the control peptide Anq-F-R2C19 (as 
with the dipeptides) was examined in an effort to uncover photochemical reactivity arising 
from that other than Y356 as a number of other residues are potential reductants of 3Anq. 
3AQS has been shown to oxidize the carboxylate-containing residues of glycyl-glycine 
dipeptides leading to the formation of the AQS•– semiquinone anion radical and the 
decarboxylated amidomethylene radical.4,5 There are five carboxylic acid containing Asp/Glu 
residues on the R2C19 peptide. In addition, 3Anq has also been shown to oxidize alcohols;6 
both hydroxyl-containing Ser and Thr residues are present on R2C19 as well. The right panel 
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of Figure 7.3 shows the transients observed upon excitation of the Anq-F-R2C19 peptide with 
355 nm excitation at 100 ns, 1, 10, and 100 μs. These transients observed at 100 ns do not 
resemble that for Anq-F-OH (Chapter III, Figure 3.8, left panel). The peaks at 410 and 520 
nm resemble that of Anq•–. The decay of the signals at 410 and 520 nm in the right panel of 
Figure 7.3 are complex, decaying on both the hundreds of nanoseconds and microsecond 
timescales, with a Anq•– remaining after 100 μs. Because Anq•– should be the only absorbing 
species in the 375 - 450 nm spectral region upon excitation of Anq-F-R2C19, this spectrum 
may be used for the normalization and subtraction of the transients following excitation of 
Anq-Y-R2C19 and Anq-F-R2C19 at 100 ns. The inset in the left of Figure 7.3 (middle inset) 
plots the ΔΔOD for this subtraction. The distinctive Y• absorption profile, with at peak at 410 
nm and a shoulder to the blue (for reference, compare to Figure 7.2 with the Ac-BPA-Y-
R2C19 system), is obtained. This difference spectrum further supports the contention that Y• 
is produced promptly after excitation of Anq-Y-R2C19.  
Peptide Binding to α2. To study PCET in the photochemical RNR system, the 
chromophore-(Y/F)-R2C19 peptides need to bind to α2. A protocol has been developed by 
Climent and coworkers7,8 to asses binding of β2 C-terminal tail peptides of various lengths to 
α2. These studies found that (1) the C-terminal peptide tail of β2 accounts for most of the 
binding interaction between this subunit and α2; (2) these peptides are inhibitors of RNR 
activity by competing with β2 for binding to α2; (3) addition of an N-terminal tyrosine to Ac-
R2C19 to form Ac-Y-R2C19 results in stronger binding by a factor of 2 (Ki = 40.0 and 20.0 
μM, respectively); and (4) further addition of residues at the N-terminus, up to R2C37, did not 
significantly enhance binding. We were interested to know if the addition of a chromophore to 
the N-terminus of Y-R2C19 significantly perturbs binding from that of the native peptide 
studies of Climent. To address this issue, we used Climent’s methods7 to asses binding of the 
Ac-BPA- and Anq-containing peptides.  
α2 and β2 (0.1 and 0.2 μM, respectively) were combined and the relative RNR activity 
was measured as the peptide concentration was increased from 0 to 80 μM. Under these 
conditions, the peptide concentrations at 50% inhibition, IC50, can be used to approximate Ki.7 
IC50s were estimated from the plots of relative RNR activity vs. peptide concentration shown 
in Figure 7.4 and are listed in Table 7.1. These data show that the presence of the 
chromophore does not weaken binding. In fact, the Anq-containing peptides bind more 
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Figure 7.4. Plots of relative RNR activity vs. peptide concentration in the competitive 
inhibition binding assay for Ac-BPA-Y-R2C19 (■), Ac-BPA-F-R2C19 (□), Anq-Y-R2C19 
(●), and Anq-F-R2C19 (○) peptides. 
strongly by a factor of ~4 compared to the BPA containing peptides suggesting a hydrophobic 
interaction between the planar aromatic chromophore and the surface of α2. Furthermore, 
replacement of the F residue for Y at position 356 on peptides of the same length results in a 
doubling of the binding strength, suggesting a specific interaction between the hydroxyl group 
of Y356 and residues in α2.  
Photoinitiated Nucleotide Reduction. Having established the Y• photogeneration and α2 
binding, light-initiated nucleotide reduction assays were examined to test whether charge 
transport occurs across the non-covalent peptide/α2 complex. To quantitate the maximum 
amount of dCDP that could be formed under single turnover conditions, α2 was incubated 
with β2 and CDP substrate for 10 min. To determine if the peptide deactivates the enzyme in 
the dark, α2 was also incubated with the Ac-BPA-Y-R2C19 peptide in the dark for 2 min, 
followed by 10 min incubation with β2 and CDP substrate. Both experiments resulted in 2.1 
eq of dC per dimer of α2 (Table 7.2); the photoassay data are therefore reported as a percent 
turnover per eq of monomer, α. 
Photoinitiated nucleotide reduction was performed under conditions where all the α2 was 
bound to peptide. The calculation of the percent α2 bound treats the α2 dimer as two separate 
monomers, with each binding one peptide with the same Kd. By following the protocol of 
Climent and coworkers,7 the IC50 values in Table 7.1 may be used to approximate Kd for the 
peptide-α2 complex. Under the conditions of the single turnover assays for photoinitiated 
CDP reduction, α2 is 92% and 98% bound by Ac-BPA-Y-R2C19 and Anq-Y-R2C19 
peptides, respectively.  
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The results of the photo-assay for α2:Ac-BPA-Y-R2C19 and α2:Anq-Y-R2C19 
protein:peptide complexes are presented in Figure 7.5 and in Table 7.2. Turnover for wt-α2 
was complete by the time the first data point was collected (2 minutes), and therefore data 
collected at subsequent times (i.e., 5 and 10 minutes) were invariant. Accordingly, the data for 
wt-α2 correspond to the average of 9 data points (3 × 2, 5, and 10 minutes). The Ac-BPA-Y-
R2C19 and Anq-Y-R2C19 peptides turnover α2 under irradiation at 12.0 ± 0.6 % and 13.1 ± 
0.6 %, respectively (indicated by the open bars in Figure 7.2), which are well above the 
background turnover (grey bars) that arises from β2 contamination and radiochemical 
Table 7.2. Single Turnover Photo-initiated CDP Reduction Assay Data. 
Sample Condition Counts / cpma dC / % per α  
Chromophore and Y356 Dependence 
Ac-BPA-Y-R2C19 + α2 hν 367 + 17 12.0 + 0.6 
Anq-Y-R2C19 + α2 hν 395 + 16 13.1 + 0.6 
α2 Pathway Dependence 
Ac-BPA-Y-R2C19 + Y730F-α2 hν 55 + 2 0.4 + 0.1 
Controls 
Ac-BPA-Y-R2C19 + α2 dark 57 + 4 0.5 + 0.1 
Anq-Y-R2C19 + α2 dark 60 + 3 0.6 + 0.1 
Ac-BPA-Y-R2C19 + Y730F-α2 dark 46 + 1 0.1 + 0.1 
α2 dark 57 + 2 0.4 + 0.1 
Quantitation of Total  α2 Turnovers 
α2 + β2 dark 5887b  103 (2.1 eq / α2) 
Inactivation of  α2 c 
Ac-BPA-Y-R2C19 +  α2 dark 3341d 106 (2.1 eq /  α2) 
Ac-BPA-Y-R2C19 +  α2 hν 133.5d 2.9 
aUsing [14C]-CDP with activity of 5455 cpm/nmol unless otherwise noted. bUsing [3H]-
CDP with activity of 11100 cpm/nmol. cα2 incubated with peptide for 2 min, followed 
by incubation with β2 and CDP for 10 min. dUsing [14C]-CDP with activity of 6330 
cpm/nmol. 
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impurities. In an attempt to understand why 
turnover was limited to ~13%, the activity of 
α2 was assayed before and after photolysis 
with the Ac-BPA-Y-R2C19 peptide. At 2 
minutes, α2 photolyzed in the presence of 
peptide was found to be completely inactive 
for nucleotide reduction with β2 (Table 7.2), 
whereas the α2 from the dark reaction 
maintained activity up to the final time point 
of 10 minutes. SDS gels of the dark and light 
reactions (Figure 7.6) reveal that the α2 band 
from the light reaction smeared compared to 
the dark control, consistent with multiple 
cross-links of the peptide to α2 and 
degradation of the protein. These data indicate that either the 3BPA or radical photo-products 
can deactivate the enzyme by direct reaction with α2.  
 
Figure 7.5. Light initiated, single turnover 
assays with Ac-BPA-(Y)-R2C19:α2, Anq-Y-
R2C19:α2 and Ac-BPA-Y-R2C19:Y730F-α2. 
The bars refer to light (□) reactions and dark 
(■) controls. For 100% turnover, each dimer 
of α2 would produce 2 molecules of dCDP. 
The photoactivity of the α2:Ac-BPA-Y-R2C19 protein:peptide complex is perturbed 
significantly by the replacement of Y730 
with phenylalanine. Assuming that the Kd 
for the Y730F-α2 peptide complex is the 
same as with wt-α2, Y730F-α2 is 80% 
bound by the Ac-BPA-Y-R2C19 peptide 
under the conditions of the assay. 
However, the turnover measured for 
Y730F-α2 bound by Ac-BPA-Y-R2C19 
after 2 minutes of photolysis is within the 
background levels of the assay (see Figure 
7.5), indicating that the mutant is inactive 
towards photoinitiated dCDP production. 
 
Figure 7.6. SDS gel with molecular weight 
markers (lanes 1 & 5), α2 + Ac-BPA-Y-R219 in 
the dark at 2, 5, and 10 minutes (lanes 2-4), and 
in the light (lanes 6-8). 
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7.3 Discussion 
 The excited states of BPA and Anq are rapid (> 108 s–1) phototriggers of Y• when 
appended to the 20-mer peptide C-terminus of β2. The modified Y-R2C19 peptides bind to α2 
with comparable or larger affinity than Y-R2C19 itself, suggesting a hydrophobic interaction 
between the chromophore and α2. Light excitation of the α2:X-Y-R2C19 (X = Ac-BPA or 
Anq) complex triggers RNR activity, as determined by single turnover assays of α2 in the 
presence of substrate and effector. In this way, the entire β2 subunit of the Class I enzyme can 
be replaced by a small, redox active peptide for •C439 radical generation in the active site, in 
much the same way as β2 is replaced by the small adenosylcobalamin cofactor in the Class II 
RNR enzyme.9  
The BPA and Anq add to the growing repertoire of Y• phototrigggers of RNR. 
Tryptophan may also effect light-initiated activity of RNR,10 however, the process does not 
occur through a discrete excited state. W• radicals are obtained through irreversible photo-
ionization of W, which leads to peptide decomposition.11 The TA spectra shown in Figures 
7.2 and 7.3 establish that Y• is transiently generated in BPA- and Anq-containing peptides 
and that the radical decays (τ ~ 500 ns) via charge recombination to reform the ground state 
products. Thus, in the absence of α2, the peptide is stable to excitation. However, we note that 
benzophenone is commonly used as a photoactive cross-linker for peptide and protein 
ligation.12 Peptide crosslinking to α2 would compete with Y oxidation on Y-R2C19 and may 
provide an explanation for the limiting turnover of 12 - 13%.  
Radical transport from Y356 to C439 in the active site of α2 has been proposed to occur 
through Y731 and Y730 residues.13 The crystal structure of α2 (Figure 1.13) shows the Y731-
Y730-C439 triad to be within hydrogen bonding contact distances, with Y731 at the surface 
of α2.14 Site directed mutagenesis studies showed the Y730F and Y731F-α2 variants to be 
catalytically inactive and structural studies15 of these mutants revealed that the π –π 
interaction was maintained upon mutation of either of the Y residues to F; thus the hydrogen 
bond network between Y730-Y731-C439 was proposed to be critical for radical transport in 
α2.16 Work with W as the photochemical radical generator on the Y-R2C19 peptide bound to 
α2 supported this contention, however turnover yields were too low for further analysis of the 
radical transport mechanism.10 
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The peptide region of β2 containing Y356 is particularly mobile in that it is not located in 
the crystal structure of β2 nor in the structure of α2 with the Y-R2C19 peptide bound. Thus 
the photo-oxidant or a mobile 
•Y356 residue photo-generated 
on the BPA/Anq-Y-R2C19 
peptide bound to α2 could, in 
theory, interact with Y731. In 
either case, we can probe the 
mechanism of radical transport 
along the Y731-Y730-C439 
pathway.  
We consider three distinct 
mechanisms for radical transport 
in α2; these are summarized in 
Figure 7.7: (1) direct ET 
tunneling via superexchange 
coupling between C439 and 
•Y731; (2) ET hopping in which 
the electron hole tunnels from •Y731→ Y730→C439, forming the protonated Y730•+ radical 
cation as an intermediate; and (3) PCET hopping, in which both an electron and a proton 
tunnel between the •Y731→Y730→C439 residues, forming the neutral •Y730 radical as an 
intermediate. The Y730F-α2 variant provides a convenient way to evaluate these potential 
mechanisms by independently tuning the electron and proton transfer distances. As described 
above, the X-ray crystal structure of the Y730F-α2 variant (Figure 7.7)15 reveals that the 
mutation breaks the hydrogen bond network between Y731 and C439 while maintaining the 
protein fold and the distance among the π-systems of the aromatic rings.  
 
Figure 7.7. The crystal structure of the Y730F- α215 
variant shows that mutation of Y730 to F730 interrupts 
the hydrogen bond network in α2 and significantly 
increases the proton tunneling distance. Y356 on the 
R2C20 peptide is not located in the structure and is 
represented here for illustrative purposes. 
The results of the Y730F-α2 mutant discount Mechanism (1) as a possibility for radical 
transport. We argue that the superexchange mechanism for ET between C439 and •Y731 
should be mediated by the π-π interaction between the aromatic Y731-Y730 residues, rather 
than via the hydrogen bond network as the latter provide a poor conductor of electronic 
coupling.17,18 The disruption of the proton transfer network should do little then to perturb the 
 168
superexchange coupling since the distance between the aromatic residues is preserved. 
Accordingly, the rates for radical transport, and consequently turnover, would not be expected 
to differ greatly in wt-α2 or Y730F-α2. However, Figure 7.5 clearly shows that photoinitiated 
turnover (and thus radical transport) is perturbed in the mutant.  
Mechanism (2) relies on ET hopping among aromatic residues, which can prevail for long 
distance charge transfer in proteins19,20 and DNA.21 For this case, the “hop” in the Y730F 
mutant entails ET tunneling from C439 to Y731. The hopping distance increases by ~2.5 Å 
with the replacement of Y730 with phenylalanine. Using a β = 1.1 Å–1 for tunneling through a 
3-ring pathway,22 the increased distance in Y730F-α2 should reduce the rate to ~6% that of 
wild type (assuming all parameters equal except for distance). Based on this ET-hopping 
radical transport rate, an overall activity of 0.8% would be expected. From the data in Figure 
7.5 and Table 7.2, turnover with Y730F-α2 is 0.4 + 0.1%, which is less than that expected for 
a direct tunneling or hopping pathway. We note that the 0.1% error is the lower limit of our 
detection. As can be seen from the data for the α2 dark control experiment, the 0.4% activity 
includes counts from contaminating background radiation (most likely due to radiological 
impurities in CDP). If the activity is normalized to this background, the Y730F-α2 mutant is 
essentially inactive.  
Of relevance to radical transport by Mechanism (3), the self-exchange reaction between 
phenoxyl radical and phenol has recently been studied computationally.23,24 The reaction 
occurs within a hydrogen bonded complex and proceeds via a PCET mechanism in which the 
electron is transferred between orbitals of π symmetry on the phenol and the proton is 
transferred between distinct orbitals of σ(O–H) symmetry.23,24 As has been discussed, since 
the electron and proton transport is of different origins, the PCET is not derived from a 
genuine hydrogen atom transfer but rather from the coupling between the electron and 
proton.25 Inasmuch as the electron and proton tunnel for such transfers, the reaction rates are 
predicted to be highly dependent on tunneling distance24 and, as has been emphasized, the 
decoupling of electron transfer and proton transfer distances is crucial to probing PCET 
mechanisms.25,26 The Y730F mutation increases the tunneling distance for the proton, 
assuming that non-crystallographically identified water molecules are not present in the 
structure, while maintaining the electron transfer distance. The O---S distance from Y731 to 
C439 is 5.9 Å in Y730F-α2, while in wt-α2 the longest distance between phenol-O and thiol-S 
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atoms is 3.4 Å. The attenuation of turnover is consistent with the interruption of the proton 
transfer pathway, as indicated in Figure 7.7. 
The foregoing analysis points toward a proton-dependent hopping mechanism for radical 
transport in α2. Higher turnover numbers with wt-α2 compared to that for Y730F-α2 will be 
critical to further distinguishing between ET (Mechanism (2)) and PCET (Mechanism (3)) 
hopping mechanisms. We note that the active RNR complex may be an asymmetric dimer, 
27,28 and hence the activity of the peptide-α2 may be limited to 50% owing to half-site 
reactivity in α2. To overcome this complication, we will next focus on direct spectroscopic 
detection of radicals along the pathway in α2. To this end, the current BPA and Anq 
containing peptides set a benchmark inasmuch as Y• may be generated with excitation light 
that lies to the red spectral side of the protein absorption envelope, and, for BPA, the Y• 
absorption feature can be clearly detected. The disadvantages of the BPA and Anq 
chromophores lie in their complicated photochemistry and propensity towards protein 
crosslinking/degradation. Future experiments will take advantage of the lower energy metal-
to-ligand charge transfer excited states of metal complexes discussed in Chapter IV that are 
competent for radical generation in conjunction with fluorotyrosine unnatural amino acids 
(Chapter VI).  
7.4 Experimental Section 
Materials. Anthraquinone-2-carboxylic acid (Anq-COOH), reduced β-nicotinamide 
adenine dinucleotide phosphate (NADPH), N-hydroxyurea, deoxycytidine (dC), cytidine-5´-
diphosphate (CDP), trifluoroacetic acid (TFA), adenosine 5´-triphosphate (ATP), 1-(3-
dimethylamino-propyl)-3-ethylcarbodiimide hydrochloride (EDC•HCl), piperidine, 
diisopropylethylamine (DIPEA), triisopropylsilane and N-methylmorpholine (NMM) were 
purchased from Sigma-Aldrich. 4-Benzoyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-
phenylalanine (Fmoc-BPA-COOH) and L-phenylalanine tert-butyl ester hydrochloride (F-
OtBu•HCl) were from Advanced ChemTech. 1-Hydroxybenzotriazole (HOBt) and L-tyrosine 
tert-butyl ester (Y-OtBu) were obtained from NovaBiochem. O-(7-azobenzotriazol-1-yl)-
1,1,3,3-tetramethyluronium hexafluorophosphate (HATU), O-(1,1-dimethylethyl)-N-[(9H-
fluoren-9-ylmethoxy)carbonyl]-L-tyrosine (Fmoc-Y(tBu)-OH), and N-[(9H-fluoren-9-
ylmethoxy)-carbonyl]-L-phenylalanine (Fmoc-F-OH) were purchased from Applied 
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Biosystems. [2-14C]-CDP was purchased from Moravek Biochemicals and diluted to a 
specific activity of 5455 cpm/nmol. Calf-intestine alkaline phosphatase (20 U/μL) was 
purchased from Roche. All chemicals were used as received, except for piperidine, which was 
freshly distilled from KOH under N2 prior to use. 4-Benzoyl-L-phenylalanyl-tyrosine methyl 
ester trifluoroacetic acid (BPA-Y-OMe•TFA) was available from a previous study.29 E. coli 
thioredoxin (TR, SA of 40 U/mg), E. coli thioredoxin reductase (TRR, SA of 1800 U/mg) 
and E. coli β2 (SA of 6800 nmol/min mg) were isolated as previously described.30   
Synthesis of Chromophore-(Y/F)LVGQIDSEVDTDDLSNFQL [Chromophore-
(Y/F)-R2C19]. Solid phase peptide synthesis (SPPS) using Fmoc-protected amino acids was 
employed to extend the Fmoc-R2C19-PEG-PS resin bound peptide, which was available from 
a previous study.31 For the syntheses of the chromophore-(Y/F)-R2C19 peptides, typically 
125 mg of the Fmoc-R2C19-PEG-PS resin bound peptide (0.2 mmol/g) was loaded into a 10 
mL Bio-Rad Poly-Prep column containing a porous 30 μm polyethylene bed in the bottom to 
hold the resin. The N-terminal Fmoc protecting group was cleaved by shaking the resin in a 
solution of 1.8 mL 0.1 M HOBt in 20% piperidine/DMF for 3 × 8 min using a 
FisherScientific Vortex Genie 2 (VWR). The resin was then washed with 3 × 2 mL of DMF 
and CH2Cl2. Fmoc-Y(tBu)-OH/ Fmoc-F-OH was then coupled to the free N-terminus by 
shaking the resin for 2 × 70 - 80 min in a solution of 0.5 M amino acid, 0.45 M HATU and 1 
M DIPEA; the volume was adjusted accordingly such that the amino acid was in 6 - 8 fold 
excess. The chromophore-COOH (chromophore = Anq and Fmoc-BPA) compounds were 
then coupled in a similar manner with the following modifications. In the case of the Anq 
chromophore, the coupling solution consisted of 4 eq of Anq-COOH suspended/dissolved in 
300 - 600 μL of DMF containing 0.45 M HATU and 1 M DIPEA due to limited solubility of 
the chromophore. In the case of Fmoc-BPA, after chromophore coupling, the Fmoc protecting 
group was cleaved as described above and the N-terminus acetylated by shaking the resin in a 
0.5 M acetic anhydride, 0.5 M DIPEA in DMF for 1 hour. Cleavage of the peptide from the 
resin was carried out by shaking in 2.5 mL of 95% TFA, 2.5% triisopropylsilane, 2.5% water 
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for 4 h. The resin was then washed for 2 × 1 min with 2 mL of TFA. The cleavage cocktail 
and washings were combined, evaporated under a stream of N2, and taken up in 15 mL of 
ether to precipitate the crude peptide, which was pelleted in a centrifuge and the ether 
decanted. The precipitate was dissolved in 0.1 M ammonium bicarbonate HPLC buffer via 
sonication over several minutes. 
Peptide Purification and Characterization. Peptides were purified by reversed phase 
HPLC as previously described.10 The HPLC system consisted of a Waters 600 controller and 
a Waters 996 photodiode array detector, which were interfaced to and controlled by a 
computer using Waters’ Millenium 32 software. Samples were manually injected onto a semi-
preparative Waters XTerra MS C-18 column (19 × 100 mm), which had been previously 
equilibrated with 10% acetonitrile/0.1 M ammonium bicarbonate (pH 8). A linear gradient of 
10 → 65 % acetonitrile vs. ammonium bicarbonate over 45 min at a flow rate of 5 mL/min 
was used to elute the peptides. The eluant absorbance was monitored at the λmax of the 
chromophore and at 210 nm, where the peptide amide bond absorbs. Fractions were collected 
by hand, lyophilized, taken up in 50 mM Tris buffer at pH 7.5, combined, and stored at –80 
°C. Analytical HPLC was employed to confirm the purity of the peptides. The samples were 
manually injected onto an analytical Waters XTerra MS C-8 (4.6 × 100 mm) column and 
eluted with the same gradient used for purification at a flow rate of 1 mL/min. The molecular 
weight (MW) of the peptide was characterized by MALDI-TOF mass spectrometry as 
described below. The HPLC retention times (tR) and MALDI-TOF m/z ratios for each peptide 
are listed in Table 7.1. Analytical HPLC traces for each peptide were recorded at 210 nm to 
confirm purity. 
Isolation, Purification and Pre-reduction of α2. E. coli α2 was isolated by standard 
procedures.30 To remove contaminating β2, it was further purified using a POROS HQ/20 
anion exchange column (Applied Biosystems) on a BIOCAD Sprint Perfusion 
Chromatography System (Applied Biosystems). The column was loaded with α2 (10 - 15 mg) 
and washed with Tris buffer (50 mM, pH 7.6) for 5 min. α2 was eluted with a linear gradient 
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of 0 - 700 mM NaCl over 30 min at a flow rate of 4 mL/min. Fractions were collected by 
hand and concentrated on a YM-30 membrane (Millipore). This procedure reduced 
background turnover of CDP 7 - 8 fold. To pre-reduce α2, ~30 mg were incubated with 30 
mM DTT for 30 min at room temperature. Hydroxyurea, ATP and CDP were added to final 
concentrations of 30 mM, 3 mM and 1 mM, respectively, and the incubation continued for an 
additional 20 min. Another 10 mM DTT was added, and the mixture incubated for 10 min and 
desalted on a G-25 Sephadex column (~35 mL, 1.5 × 23 cm) pre-equilibrated in 50 mM Tris, 
15 mM MgSO4, pH 7.6. 
 α2 Activity Assay and Competitive Inhibition Assay for Binding of Peptide to α2. α2 
(0.1 μM, specific activity = 1900 nmol min–1 mg–1), β2 (0.2 μM, specific activity = 6800 nmol 
min–1 mg–1), TR (30 μM), TRR (0.5 μM), NADPH (0.2 mM), CDP (1 mM), and ATP (1.6 
mM) were combined in 50 mM HEPES, 15 mM MgSO4, 1 mM EDTA buffer at pH 7.6. 
Enzyme activity was measured by the consumption of NADPH, which was monitored by the 
decrease in absorbance at 340 nm. This was then repeated with peptide concentrations ranging 
from 2 - 80 μM. 
Single Turnover Assays for Photoinitiated Nucleotide Reduction in Peptide-α2 
Complexes. The assays were performed by a method modified from that previously 
reported.10 FPLC purified, pre-reduced α2 (20 μM, specific activity = 1800 nmol min–1 mg–1), 
peptide (200 μM), ATP (3.0 mM), and [2-14C]-CDP (1.0 mM, 5445 cpm nmol–1) in 50 mM 
Tris, ~7 mM MgSO4 buffer at pH 7.5 were added to a 1 cm quartz micro-cuvette with total 
solution volume of 200 μL. Care should be taken in preparation of the peptide stock solutions 
as they are sensitive to the concentration of MgSO4 and the peptide can precipitate upon 
addition of solid MgSO4 to the solutions. Typically, the peptide stock solutions were prepared 
in 50 mM Tris buffer (pH 7.5) and diluted into the reaction mixture containing millimolar 
concentrations of Mg2+. The reaction was initiated by the addition of [2-14C]-CDP (97 mM), 
quickly mixed, spun down in a minicentrifuge (< 10 s, 2000 g) to consolidate the liquid, and 
pipetted into the cuvette. Samples were irradiated at room temperature with the focused light 
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from a 1000 W Xe arc lamp equipped with a 299 nm long pass and IR filters. Fractions (60 
μL) were removed at 2, 5 and 10 min intervals and immediately quenched by heating in a 
boiling water bath for 2 min. The precipitated protein was then spun down for 10 min in a 
minicentrifuge at 20,000 g. The supernatant (50 of the 60 μL) was transferred to a new 
Eppendorf tube, diluted with 14 units of alkaline phosphatase and 120 nmol of carrier dC to a 
final volume of 170 μL, and incubated at 37 °C for 2 h in a sealed Eppendorf vial. dC was 
then separated from C and quantitated as previously described.32,33 Each reaction was 
repeated twice along with a dark α2 control and a dark α2-peptide control to quantify 
background counts arising from contaminating β2 that co-purifies with α2 and from 
radiochemical impurities in the stock [2-14C]-CDP that elute with the product. Background 
counts were low in these experiments, as shown in Table 7.2. For reactions involving the 
Y730F-α2 mutant, 90 μM peptide and 20 μM protein were used, with all other conditions the 
sam
re 
ana
e as for wt-α2. 
Physical Measurements. 1H NMR spectra were recorded on a Varian Mercury 300 MHz 
NMR at the MIT Department of Chemistry Instrumentation Facility (DCIF) and externally 
referenced to tetramethylsilane. ESI-FT mass spectrometry was performed with a Brüker 
Daltonics APEXII instrument housed in the DCIF. MALDI-TOF mass spectrometry was 
performed with a Brüker Omniflex instrument in the DCIF using α-cyano-4-hydroxycinnamic 
acid as the matrix. The instrument was calibrated in positive ion mode with a quadratic 
polynomial using a mixture of angiotensin II (1046.5423), P14R synthetic peptide 
(1533.8582), and ACTH fragment 18-39 (2465.1989) (Sigma). All peptides synthesized we
lyzed in negative ion mode due to the large number of carboxylate containing residues.  
UV-vis absorption spectra were recorded on a Cary 17D modified by On-Line Instrument 
Systems (OLIS) to include computer control or a Spectral Instruments 440 spectrophotometer. 
TA measurements were made with pump light provided by the third harmonic (355 nm) of an 
Infinity Nd:YAG laser (Coherent) running at 20 Hz as previously described.34 In the case of 
the BPA, 300 nm pump light was used as previously described owing to the lack of 
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absorption at 355 nm for this chromophore.29 Transient absorption experiments for all 
compounds were performed in a 2 mm cuvette in 20 mM Tris buffer at pH 7.5 at 350 μM for 
Anq dipeptides/Y(F)-R2C19 peptides and 500 μM for the BPA dipeptides/Y-R2C19 peptide. 
Sample volumes of 200 μL were employed for all the peptide spectroscopy experiments 
reported herein. All experiments were performed under ambient conditions. 
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8.1 Motivation and Background 
The experiments with the anthraquinone and benzophenone based photochemical RNRs 
prompt the question of whether the photooxidant on the Y-R2C19 peptide can interact with 
Y731 in α2 directly. To test this hypothesis, we repeated the photochemical RNR experiments 
with the (Ac-BPA/Anq)–F-R2C19 peptides, keeping in mind that these photooxidants can 
accept both a proton and an electron. We also developed peptides that could oxidize Y731 
directly, but could only accept an electron. Pyrene (Py) functionalized peptides are ideal for 
this application, as this chromophore has a large molar absorptivity in the near UV/vis 
spectral region (to the red of the protein absorption envelope) and, under certain conditions, is 
capable of oxidizing Y. This chapter presents experiments with the BPA, Anq, and Py-
modified R2C19 peptides that either contain F or the photooxidant itself in the place of 
“Y356” on the peptide. Photochemical assay results are presented for these peptides in 
complex with α2 in the presence of RNR substrate and effector, along with initial transient 
absorption (TA) experiments to investigate radical transport in the Py-R2C19:α2 complex. 
8.2 Results 
8.2.1 BPA and Anq Based Systems 
We first wished to characterize the products 
produced upon photolysis of the (Ac-
BPA/Anq)-F-R2C19 peptides. In Chapter VII 
we performed this experiment for the Anq-F-
R2C19 peptide and found that the 3Anq excited 
state is capable of oxidizing other residues on 
the peptide, forming the •Anq– semiquinone 
radical anion. For the Ac-BPA-F-R2C19 
peptide, photolysis with 300 nm initiates an 
irreversible photo-reaction that depletes the 
starting material; therefore a fresh sample of 
peptide was required for each experiment. 
Figure 8.1 shows the transient absorbance trace 
obtained immediately following (50 ns) the nanosecond laser pulse.  The feature at 525 nm is 
 
 
Figure 8.1. TA Spectrum obtained 
following excitation of a solution of Ac-
BPA-F-R2C19 with pulsed, 300 nm laser 
light. Inset: Single wavelength absorbance 
kinetics trace monitored at 530 nm. 
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consistent with that previously observed for the 
triplet excited state of benzophenone 
(ε520nm(3BP) = 5800 + 400 M–1 cm–1).1 Single 
wavelength kinetics obtained at this wavelength 
(Figure 8.1, inset) can be fit to a single 
exponential decay with a time constant of 1.2 μs, 
which is similar to the observed lifetime of 
triplet benzophenone in water.2  
As discussed in Chapter VII, the (Ac-
BPA/Anq)-F-R2C19 peptides were observed to 
bind to α2 with micromolar affinities, thus 
allowing for formation of a peptide:α2 complex 
for photochemical RNR studies. Photoinitiated nucleotide reduction was therefore performed 
under identical conditions to that reported for the (Ac-BPA/Anq)-Y-R2C19 systems in 
Chapter VII: α2 was photolysed in the presence of 10-fold excess of peptide, 3mM ATP 
effector, and 1 mM [2-14C]-CDP substrate. Figure 8.2 plots the percent of deoxycytidine that 
was formed in these experiments per α subunit. For the Ac-BPA-F-R2C19:α2 system, 
turnover was complete after 2 minutes with 7.5 + 0.5 % dC formed per α. Photolysis of the 
Anq-F-R2C19:α2 system resulted in a time-dependent turnover that generated up to 7.7 + 0.3 
% dC per α after 10 minutes. The counts measured for radioactive dC product in these 
photolysis experiments was well above the background limit of detection, as determined by 
the Ac-BPA-F-R2C19:α2 and Anq-F-R2C19:α2 dark controls (0.2 + 0.1 and 0.1 + 0.1 % dC 
per α, respectively). Thus the Ac-BPA-F-R2C19:α2 and Anq-F-R2C19:α2 systems are 
competent for photochemical RNR turnover, although not as efficient as their Y-containing 
counterparts. 
 
Figure 8.2. Light initiated, single turnover 
assays with Ac-BPA-F-R2C19:α2 and 
Anq-F-R2C19:α2. The bars refer to light 
(□) reactions and dark (■) controls. For 
100% turnover, each dimer of α2 would 
produce 2 molecules of dCDP. 
8.2.2 Pyrene Based Systems 
Synthesis. Py-R2C19 and Py-Y-R2C19 peptides were generated using solid-phase peptide 
synthesis to extend the Fmoc-R2C19-PEG-PS resin bound peptide with Fmoc-Y-OH (in the 
case of the latter) and pyrene-1-carboxylic acid as described for the Anq- and BPA-containing 
peptides in Chapter VII. The full length peptide was stable to the peptide cleavage and 
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purification conditions. Table 1 
presents the analytical HPLC 
retention time and MALDI-TOF 
mass spectrometry characterization 
data for these peptides. 
Spectroscopy. Py-Y-R2C19 
was synthesized in hopes of 
characterizing photochemical Y• 
formation on the full length peptide using pyrene as the excited photooxidant. The 
fluorescence decay of Py-R2C19 (control peptide without tyrosine) was single exponential 
with τ(Py-R2C19) = 14.7 ns, while a biexponential function was needed to fit the 
fluorescence decay of Py-Y-R2C19, with τ1(Py-Y-R2C19) = 4.3 ns (65 %) and τ2(Py-Y-
R2C19)= 9.3 ns (45 %). Both lifetime components are quenched compared to the Py-R2C19 
control peptide; the shorter component is similar to the lifetime of the Py-Y dipeptide reported 
in Chapter III. We assign the biexponential emission lifetime of the Py-Y-R2C19 sample to 
two different conformations of the peptide in solution. 
Table 8.1. Characterization of Pyrene Peptides 
Peptide tR 
(min)a 
MW Calc’d 
(m/z) 
MW Found 
(m/z)b 
Py-Y-R2C19 19.3 2498 2501 
Py-R2C19 20.1 2334 2338 
aRetention time (tR) from analytical HPLC trace. bMALDI-
TOF MS in negative ion mode
Transient absorption experiments of Py-Y-R2C19 were performed to probe the nature of 
the emission quenching in this peptide. Nanosecond TA required the use of low laser powers 
(50 μJ per pulse, 355 nm) to avoid the formation of eximer excited states.  Under these 
conditions, only weak absorptions 
corresponding to unquenched 3Py-Y-R2C19 
(not shown) were observed following laser 
excitation, similar to that obtained for 3Py-Y-
OH. Therefore, as with the Py-Y dipeptide, no 
products of the fluorescence quenching could be 
observed on the nanosecond timescale. 
RNR binding. The competitive inhibition 
assay described in Chapter VII was used to 
characterize binding of the Py-R2C19 and Py-
Y-R2C19 peptides to α2. Figure 8.3 plots the 
relative RNR activity vs. concentration of 
 
Figure 8.3. Plots of relative RNR activity 
vs. peptide concentration in the 
competitive inhibition binding assay for 
Py-Y-R2C19 (■) and Py-R2C19 (●). 
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peptide for the assay experiment with both Py-
R2C19 and Py-Y-R2C19 peptides. We again 
observe an approximate two-fold increase in 
binding with the “Y356”-containing peptide (Py-
Y-R2C19, IC50 ≈ 3 μM) compared to the peptide 
without this residue (Py-R2C19, IC50 ≈ 6 μM). As 
with the Anq-containing peptides in Chapter VII, 
the hydrophobic pyrene moiety results in a ~4 
fold stronger binding affinity of the peptide to α2 
compared to peptides without this 
chromophore.3,4 Steady-state emission 
spectroscopy was also used to characterize binding of a pyrene-containing peptide to α2. 
Figure 8.4 plots the normalized emission spectrum of a 3 μM solution of Py-R2C19 in the 
presence and absence of 30 μM α2. In the absence of α2 the spectrum is broad and lacks the 
vibrational fine structure observed for the simpler “dipeptides” (Figure 3.4). Upon binding to 
α2, the vibrational fine structure reappears. Pyrene emission is known to be sensitive to 
environment polarity and, as such, has found application as a probe of protein-protein 
interactions.5 We therefore attribute the dynamics 
in Figure 8.4 to an ordering of the peptide 
structure upon binding to α2. 
Photoinitiated Nucleotide Reduction. Since 
we could not observe Y• photoproducts in the 
nanosecond transient absorption experiments with 
Py-Y-R2C19, we decided to generate the pyrene 
cation radical on Py-R2C19 and use this species 
as the radical initiator in the photochemical RNR 
experiment. As characterized by Figure 3.5, the 
Py•+ radical can be formed upon pyrene excitation 
in the presence of a sacrificial electron acceptor. 
We used methyl viologen, MV2+, as the acceptor 
for the photoinitiated deoxynucleotide production. 
 
Figure 8.4. Steady-state emission 
spectra of Py-R2C19 (3 μM) in the 
presence (▬) and absence (▬) of α2 (30 
μM). 
 
Figure 8.5. Light initiated, single 
turnover assays with Py-R2C19 (200 
μM), MV2+ (10 mM) and α2 (20 μM). 
The bars refer to light (□) reactions and 
dark (■) controls. For 100% turnover, 
each dimer of α2 would produce 2 
molecules of dCDP. 
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Figure 8.5 plots the percent dC formed per α monomer for both light and dark reactions of Py-
R2C19:α2 with 10 mM MV2+. The samples turned blue during photolysis indication the 
presence of the reduced MV•+ radical. For the light induced reaction, we measured 14.5 + 1.0 
% turnover per α, which is well above the activity of the dark, control experiments (1.3 + 0.7 
% for Py-R2C19:α2 and 0.5 + 0.1 % for α2 alone). This activity is also in the range of that 
measured for the Anq-(Y/F)-R2C19 and Ac-BPA-(Y/F)-R2C19 peptides. 
 
Figure 8.6. Transient absorption spectra of a solution of 100 μM Py-R2C19 and 25 mM 
MV2+ in the absence (left) and presence (right) of 100 μM α2 obtained 235 ns (▬), 1 (▬), 
and 10 (▬) μs after a 355 nm ns-laser flash. . Left and right insets for each panel correspond 
to single wavelength absorbance kinetics data (○) and exponential fit (▬) monitored at 396 
and 455 nm, respectively. 
TA Studies of the Py-R2C19:α2 complex. Nanosecond transient absorption spectroscopy 
was used to characterize the reaction of •Py-R2C19+ bound to α2.  These experiments were 
conducted in 20 mM Tris buffer at pH 7.5 with 100 μM concentration of Py-R2C19 and α2, 1 
mM CDP, 3 mM ATP, and 25 mM MV2+ as the sacrificial electron acceptor.   
The left panel of Figure 8.6 plots the absorbance traces obtained 230 ns, 1, and 10 μs after 
the 355 nm nanosecond laser pulse in 20 mM Tris buffer at pH 7.5 with 100 μM of Py-
R2C19, 25 mM MV2+, 1 mM CDP, and 3 mM ATP. The spectra show features at 396 and 455 
nm, which are assigned to the electron transfer products MV•+ (ε396 nm = 42100 + 800)6 and 
Py•+ (see Figure 3.5), respectively.  The broad absorbance cut off at the red edge in this 
spectrum also corresponds to MV•+ (ε606 nm = 13700 + 300).6 Single wavelengths kinetics 
recorded at 396 and 455 nm (Figure 8.6, left panel insets) can be fit to a single exponential 
decay with commensurate time constants (8.4 and 11.8 μs, respectively); this decay is 
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therefore assigned to charge recombination between MV•+ and Py•+. The right panel of Figure 
8.6 plots the absorbance traces for the same experiment, but in the presence of 100 μM α2.  
Again, absorption peaks corresponding to the MV•+ and Py•+ are observed; however these 
features do not decay concomitantly (Figure 8.6, right panel insets).  The 455 nm, Py•+ time-
evolved absorbance can be fit to a bi-exponential decay with time constants, τ1 = 2.5 μs (58 
%) and τ2 = 10.5 μs (42 %), while the MV•+ time-evolved absorbance decays on a much 
slower timescale with bi-exponential time constants, τ1 = 19 μs (54 %) and τ2 ~ 160 μs (46 
%).  
8.3 Discussion 
The results of Figure 8.2 show that the excited states of both BPA and Anq are capable of 
turning over α2 directly, without the participation of “Y356” on the peptide. We therefore 
propose that the BPA and Anq excited states oxidize Y731 directly in the α2; experiments 
with the Y731F-α2 variant will be needed to confirm this hypothesis. The 3BPA excited state 
persists into the microsecond time regime, as shown by Figure 8.1, thus allowing this excited 
state plenty of time to oxidize Y731. For the Anq-F-R2C19 peptide, however, the •Anq– 
semiquinone radical anion is formed within the nanosecond laser pulse via oxidation of 
another, unidentified, residue on the peptide (Chapter VII). Therefore, oxidation of Y731 in 
α2 by 3Anq must compete with this intra-peptide photochemistry (and reaction of 3Anq with 
solvent) in order for this peptide to turnover α2. These competitive rates may account for the 
time-dependent turnover observed for this system (see Figure 8.2). The crystal structure α2 
was obtained with the Y-R2C20 peptide bound, and shows significant ordering of the peptide 
for residues 360-375; however, the region containing Y356 is not located in the structure and 
is proposed to be thermally labile.7 From these observations we propose that the C-terminus 
of the (Ac-BPA/Anq)-F-R2C19 peptides bound to α2 are also thermally labile, and that 
intimate interaction of the photooxidant with Y731 may occur, at least transiently. Thus these 
excited states should be able to accept both a proton and an electron in forming •Y731. 
However, this process is not as efficient as oxidation of the proximate “Y356” in the (Ac-
BPA/Anq)-Y-R2C19 peptides, as these systems generated higher percent turnover (Figure 
7.5) than the F-containing constructs. 
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In contrast to Anq and BPA, the pyrene cation radical, •Py+-R2C19, can only accept an 
electron upon oxidation of amino acid residues. Nonetheless, Figure 8.5 shows that this 
oxidant is competent for initiating nucleotide reduction. These data are consistent with the 
conclusion based on work with FnY356-β2s that a proton is not required for radical transport 
at position 356 in β2.8 The TA studies in Figure 8.6 (left) show that •Py+-R2C19 is formed 
within the nanosecond laser flash in the presence of 25 mM MV2+ and persists into the tens of 
microseconds timescale, allowing this species plenty of time to oxidize residues in α2. The 
results of Figure 8.2 (right) confirm that the •Py+-R2C19 species is formed and decays much 
more rapidly when bound to α2, as compared to the species in free solution. We attribute this 
faster decay to oxidation of some residue in α2, however we cannot distinguish which one. 
Unfortunately, the absorption of reduced MV•+ radical overlaps the region where Y• would 
absorb (390-415 nm), and we do not observe buildup of any protein-based radicals. This 
complication, combined with the relatively low turnover for this construct, motivated us to 
search for other excited state oxidants that could turnover α2 at higher percent yields and 
would allow us to directly observe protein based radicals upon flash photolysis. The triplet 
MLCT excited states of Re(bpy)(CO)3CN, when combined with the fluorotyrosine unnatural 
amino acids (Chapter VI), seemed to provide a reasonable construct for achieving these goals. 
8.4 Experimental Section 
Materials. Pyrene-1-carboxylic acid (Py-COOH), methyl viologen dichloride hydrate 
(MV2+), trifluoroacetic acid (TFA), adenosine 5’-triphosphate (disodium salt from bacteria, 
ATP), cytidine 5’-diphosphate (sodium salt from yeast, CDP), piperidine, methyl viologen 
dichloride (MV2+) and diisopropylethylamine (DIPEA), were purchased from Sigma-Aldrich. 
O-(7-Azobenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HATU) and O-
(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine (Fmoc-Y(tBu)-OH) 
were purchased from Applied Biosystems. [2-14C]-CDP was purchased from Moravek 
Biochemicals and diluted to a specific activity of 5455 cpm/nmol.  All chemicals were used 
as received, except for piperidine, which was freshly distilled from KOH under N2 prior to 
use. Ac-BPA-F-R2C19 and Anq-F-R2C19 were prepared as described in Chapter VII. E. coli 
thioredoxin (TR, SA of 40 U/mg), E. coli thioredoxin reductase (TRR, SA of 1800 U/mg) 
and E. coli β2 (SA of 6800 nmol/min mg) were isolated as previously described.9 
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Synthesis of Pyrene-(Y)LVGQIDSEVDTDDLSNFQL [Py-(Y)-R2C19]. The pyrene-
containing peptides were synthesized in a manner similar to the other R2C19 peptides 
described in Chapter VII. Briefly, solid phase peptide synthesis (SPPS) using Fmoc-protected 
amino acids was employed to extend the Fmoc-R2C19-PEG-PS resin bound peptide, which 
was available from a previous study.10 For the synthesis of the Py-Y-R2C19 peptide, the 
Fmoc-Y(tBu)-OH was coupled to the resin-bound peptide as described in Chapter VII. The 
pyrene chromophore was incorporated into the peptide using pyrene-1-carboxylic acid. Py-
COOH (25 mg, 4 eq) was combined with 125 mg of resin containing the free N-terminal, 
(Y(tBu))-R2C19 peptide, HATU (51 mg), DIPEA (53 μL), and 1.5 mL of DMF. The reaction 
mixture was shaken in a FisherScientific Vortex Genie 2 (VWR) for 80 min. The resin was 
rinsed with 2 mL of DMF (4 × 1 min) and the coupling step was repeated. The resin was then 
rinsed with 2 mL DMF (4 × 1 min) and 2 mL CH2Cl2 (3 × 1 min) and dried in vacuo. The 
peptide was cleaved from the resin and worked up using the standard peptide cleavage 
cocktail and procedure described in Chapter VII.  
Peptide Purification and Characterization. Both Py-R2C19 and Py-Y-R2C19 were 
purified and analyzed by reversed phase HPLC using methods similar to those described in 
Chapter VII. The molecular weight (MW) of the peptide was characterized by MALDI-TOF 
mass spectrometry as described in Chapter VII. The HPLC retention times (tR) and MALDI-
TOF m/z ratios for each peptide are listed in Table 8.1. Analytical HPLC traces for each 
peptide were recorded at 210 nm to confirm purity. 
Isolation, Purification and Pre-reduction of α2. E. coli α2 was isolated by standard 
procedures.9 To remove contaminating β2, it was further purified by the procedure described 
in Chapter VII. To pre-reduce α2, ~30 mg were incubated with 30 mM DTT for 30 min at 
room temperature. Hydroxyurea, ATP and CDP were added to final concentrations of 30 mM, 
3 mM and 1 mM, respectively, and the incubation continued for an additional 20 min. 
Another 10 mM DTT was added, and the mixture incubated for 10 min and desalted on a G-
25 Sephadex column (~35 mL, 1.5 × 23 cm) pre-equilibrated in 50 mM Tris, 15 mM MgSO4, 
pH 7.6. 
 α2 Activity Assay and Competitive Inhibition Assay for Binding of Peptide to α2. α2 
(0.1 μM, specific activity = 1900 nmol min–1 mg–1), β2 (0.2 μM, specific activity = 6800 nmol 
min–1 mg–1), TR (30 μM), TRR (0.5 μM), NADPH (0.2 mM), CDP (1 mM), and ATP (1.6 
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mM) were combined in 50 mM HEPES, 15 mM MgSO4, 1 mM EDTA buffer at pH 7.6. 
Enzyme activity was measured by the consumption of NADPH, which was monitored by the 
decrease in absorbance at 340 nm. This was then repeated with peptide concentrations ranging 
from 1 - 40 μM. 
Single Turnover Assays for Photoinitiated Nucleotide Reduction in Peptide-α2 
Complexes. The assays were performed by the method described in Chapter VII, except that 
samples were irradiated at room temperature with the focused light from a 1000 W Xe arc 
lamp equipped with a 299 nm (BPA and Anq peptides) or 338 nm (pyrene peptides) long pass 
and IR filters. dC was then separated from C and quantitated as previously described.11,12  
Physical Measurements. MALDI-TOF mass spectrometry was performed with a Brüker 
Omniflex instrument in the DCIF using α-cyano-4-hydroxycinnamic acid as the matrix. The 
instrument was calibrated in positive ion mode with a quadratic polynomial using a mixture of 
angiotensin II (1046.5423), P14R synthetic peptide (1533.8582), and ACTH fragment 18-39 
(2465.1989) (Sigma). All peptides synthesized were analyzed in negative ion mode due to the 
large number of carboxylate containing residues.  
UV-vis absorption spectra were recorded on a Spectral Instruments 440 
spectrophotometer. TA measurements were made with pump light provided by the third 
harmonic (355 nm) of an Infinity Nd:YAG laser (Coherent) running at 20 Hz as previously 
described.13 In the case of the BPA, 300 nm pump light was used as previously described 
owing to the lack of absorption at 355 nm for this chromophore.Error! Bookmark not defined. 
Transient absorption experiments for all compounds were performed in a 2 mm cuvette in 20 
mM Tris buffer at pH 7.5. Sample volumes of 200 μL were employed for all the peptide 
spectroscopy experiments reported herein. All experiments were performed under ambient 
conditions. 
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 Chapter IX 
 
 
The Search For Intermediates in Photochemical RNRs 
with Re(bpy)CO3CN as the Radical Initiator  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parts of this chapter have been submitted for publication: 
Reece, S. Y.; Seyedsayamdost, M. R.; Stubbe, J.; Nocera, D. G. “Direct Observation of a 
Transient Tyrosine Radical Competent for Initiating Turnover in a Photochemical 
Ribonucleotide Reductase” submitted. 
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9.1 Motivation and Background 
Re(bpy)(CO)3CN exhibits an excited state that is a competent oxidant of Y– (Chapter IV). 
Tyrosinate oxidation occurs within the nanosecond laser pulse, the Re(bpy•–)(CO)3CN and Y• 
intermediates could be distinguished by transient absorption spectroscopy, and this charge 
separated state persisted into the hundreds of nanoseconds timescale. This photochemistry 
was extended in Chapter VI to fluorotyrosine unnatural amino acids; these tyrosine analogues 
exhibit significantly lower pKas allowing us to generate FnY• from FnY– in the pH range 
where RNR is active (6-8.5). The confluence of these results led us to synthesize [Re]-FnY-
R2C19 peptides ([Re] = Re(bpy)(CO)3CN) for application to the photochemical RNR system 
([Re]-3,5-F2Y-R2C19 peptide is shown in Figure 9.1). 
The absorption spectra of FnY• are significantly shifted 
from that of Y• to allow for visualization of the 
•FnY356→Y731 radical hop from the peptide into α2. 
Furthermore, the 3[Re]* excited should be selective for 
FnY– oxidation; thus allowing us to avoid protein 
decomposition via spurious photochemical reactions. 
We now describe the synthesis of these peptides, a 
thorough characterization of the peptide based 
photochemistry via time-resolved emission and transient absorption (TA) spectroscopies, 
photoinitiated deoxynucleotide production in the photochemical RNR, and investigation of 
the radical generation and transport process in the peptide:α2 complex via nanosecond TA. 
 
Figure 9.1. Chemical structure of 
[Re]-3,5-F2Y-R2C19. 
9.2 Results 
Synthesis. The [Re]-(F/Y/3,5-F2Y)-R2C19 peptides were made by extending the Fmoc-
R2C19-PEG-PS resin bound peptide, first with Fmoc-(F/Y/3,5-F2Y)-OH, followed by the 
carboxylic acid containing Re complex, Re(bpy–COOH)(CO)3CN using Fmoc solid-phase 
peptide synthesis conditions similar to those previously described.1 New HPLC methods were 
required to purify the [Re]-3,5-F2Y-R2C19 peptide: the crude reaction product was separated 
by preparative reversed-phase HPLC using 10 mM KPi buffer at pH 6 with a 10→ 65% 
acetonitrile gradient over 45 minutes. The purified peptides were characterized by analytical 
HPLC and mass spectrometry. MALDI-TOF MS was the most convenient MS technique for 
peptide characterization, however, as is commonly observed for Re(bpy)(CO)3X complexes, 
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the [Re] chromophore loses its cyanide ligand during laser ablation and positive ion analysis. 
The full length peptide with CN– ligand intact can be characterized by ESI-FT MS. Table 9.1 
lists the analytical HPLC retention times and mass spectral data for each of the peptides 
synthesized. 
Table 9.1. Characterization of Peptides 
Peptide 
tR 
(min)a 
MW Calcd
(m/z) 
MW Found 
(m/z) 
IC50d 
(μM) 
[Re]-F-R2C19 25.5 2748 2721b - 
[Re]-Y-R2C19 23.8 2764 2737b 8 
[Re]-3,5-F2Y-R2C19 19.5 2800 1399c,  2772b - 
aRetention time (tR) from analytical HPLC trace. b[M-CN]+ ion from 
MALDI-TOF MS. c[M-2H]2– ion from ESI-FT MS.  dConcentration of 
peptide at 50% RNR inhibition. 
Photophysics and Photochemistry. Steady 
state emission spectroscopy was used to 
investigate quenching of the 3[Re]* excited state 
in the [Re]-3,5-F2Y-R2C19 peptide. Figure 9.2 
plots the emission spectra obtained as the pH of 
the solution is titrated from 4.5 to 11.5. Between 
pH 4.5-5.0 the emission red-shifts and decreases 
in intensity. We attribute this spectral shift to a 
change in the peptide conformation as the 
carboxylic side groups of Asp and Glu residues 
are deprotonated. Between pH 5 and 11.5, the 
emission energy and band shape does not 
change, however we observe a decrease in overall intensity. This emission quenching is 
consistent with deprotonation of the 3,5-F2Y phenolic proton (pKa = 7.2 for the Ac-3,5-F2Y-
NH2 model compound)13, which induces electron transfer from 3,5-F2Y– to the proximate 
3[Re]* excited state (see Chapter VI). By titrating the 3[Re]* emission intensity with pH, we 
obtain a pKa value of 3,5-F2Y on the peptide of 7.3 + 0.1.  
 
Figure 9.2. Emission spectra of [Re]-3,5-
F2Y-R2C19 as a function of pH, which was 
titrated from 4.5 to 11.5. Inset: pH 
Titration curve of integrated emission 
intensity. 
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We next used time-resolved emission and transient absorption spectroscopy to 
characterize the excited states produced in the [Re]-(F/Y/3,5-F2Y)-R2C19 peptides. The 
emission decay of [Re]-3,5-F2Y-R2C19 at pH 10 could be fit to a bi-exponential decay 
function with τ1 = 1.9 ns (66%) and τ2 = 10.7 ns (34%). Similarly, the [Re]-Y-R2C19 
emission decay at pH 12 exhibited bi-exponential behavior (τ1 = 0.5 ns (86%) and τ2 = 3.0  ns 
(14%). Both lifetime components for both peptides are quenched compared to the emission 
lifetime of [Re]-F-R2C19 at all pHs or [Re]-Y-R2C19 at pH < 10 (τ = 50 + 2 ns or 62 + 2 ns 
in 20% glycerol). As with the Py-Y-R2C19 peptide (Chapter VIII), we attribute the bi-
exponential emission decay to two separate conformations of the R2C19 peptide in solution. 
 
Figure 9.3. TA spectra of 100 μM solutions of [Re]-F-R2C19 (left) and [Re]-Y-R2C19 (right) 
in 50 mM Tris buffer (pH 7.6), 20% glycerol, 1 mM CDP, 3 mM ATP, and 15 mM MgSO4 
recorded at 65, 115, and 215 ns following a 355 nm laser pulse. Insets: Single wavelength 
kinetics traces (○) with single exponential fit (▬) recorded at 480 nm. 
Nanosecond TA spectroscopy was used to characterize the products of the emission 
quenching. Figure 9.3 plots the TA spectra recorded 65, 115, and 215 ns following excitation 
of 100 μM solutions of [Re]-F-R2C19 (left) and [Re]-Y-R2C19 (right). The spectra contain 
features at 380 and 480 nm, which decay with a time constant (64 + 1 ns) identical to that of 
the excited state emission decay. Moreover, the spectra resemble that previously assigned for 
the 3[Re]* MLCT excited state in model complexes with Y and F amino acids.14 We therefore 
attribute these spectra to the 3[Re]* MLCT excited state on the peptide. Figure 9.4 presents the 
TA spectra of 100 μM solutions of [Re]-3,5-F2Y-R2C19. The left panel shows the spectrum 
obtained for a pH 8.5 solution (deprotonated 3,5-F2Y–), and exhibits features at 395 and ~525 
nm following the 355 nm laser pulse. This spectrum resembles that of the •[Re]–-3,5-F2Y• 
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charge separated state previously reported for the [Re]-3,5-F2Y-OMe model compound.2,14 
The left inset plots the single wavelength absorbance kinetics obtained at 525 nm; the 
spectrum decays with a time constant of 70 ns, corresponding to a rate of 1.7 × 107 s–1 for 
charge recombination on the full length peptide. The 3,5-F2Y• radical can be trapped by 
oxidizing the •[Re]–-3,5-F2Y• charge separated state in a bimolecular fashion with a reagent in 
solution. The right panel of Figure 9.4 plots the TA spectrum following 355 nm excitation of 
a solution of [Re]-3,5-F2Y-R2C19 at pH 8.5 in the presence of 10 mM Ru(III)(NH3)63+ 
quencher. A clear “double-hump” feature is present with λmax = 395 nm, which is 
characteristic of the absorption spectrum of 3,5-F2Y•.13 The spectrum decays with a time 
constant of 9.6 μs, as determined by the single wavelength absorbance kinetics at 395 nm 
(Figure 9.4, right inset). Thus by using the Ru(III) quencher, we can extend the lifetime of the 
3,5-F2Y• on the peptide well into the microsecond time regime. 
 
Figure 9.4. (Left) TA spectra of 100 μM [Re]-3,5-F2Y-R2C19 obtained 65 and 215 ns after a 
355 ns flash. (Right) TA spectrum of 100 μM [Re]-3,5-F2Y-R2C19 in presence of 10 mM 
Ru(III)(NH3)63+ obtained 65 ns after the 355 nm laser flash. Conditions: 50 mM Tris buffer 
(pH 8.5), 20% glycerol, 1 mM CDP, 3 mM ATP, and 15 mM MgSO4. Insets: Single 
wavelength kinetics traces (○) with single exponential fit (▬) recorded at the wavelength 
indicated. 
Binding to the α2 subunit of RNR. Binding of the [Re]-Y-R2C19 peptide to α2 was first 
probed by the standard competitive inhibition assay.3- 5 Figure 9.5 plots the relative RNR 
activity vs. the concentration of peptide competitive inhibitor in solution. From these data, we 
estimated that the peptide binds to α2 with an approximate IC50 of 8 μM. Under these 
conditions the IC50 can be used to approximated the dissociation equilibrium constant, KD. 
Thus, the larger [Re] complex does not inhibit binding of the peptide to α2; in fact, the 
binding is of comparable strength to other hydrophobic pyrene- and anthraquinone-terminated 
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peptides used in this thesis (Chapters VII and VIII) and is 
stronger than the Y-R2C19 peptide alone. 
Since the [Re] chromophore is emissive and 3MLCT 
excited states are sensitive to solvent and environment 
polarity, we can use the emission from the 3[Re]* excited 
state as a probe of peptide binding to α2. Figure 9.6 plots 
the emission spectra of a 5 μM solution of the [Re]-Y-
R2C19 peptide as the α2 concentration is increased from 
0→50 μM. Upon binding to α2, the emission band blue 
shifts and increases in intensity. This is consistent with the exclusion of water from the 
coordination sphere of the [Re] chromophore upon binding to a hydrophobic region of the 
protein.6,7 The emission maxima were plotted as a function of α2 concentration (Figure 9.6, 
inset) and fit to the binding model in eq 2, yielding a dissociation constant, KD, of 4 μM, 
which, given the error associated with the emission measurement, is comparable to the value 
obtained with the competitive inhibition binding assay. Time resolved emission was then used 
to further probe the homogeneity of the peptide:α2 binding interaction. For this experiment, 5 
μM peptide and 20 μM α2 (with 3mM ATP and at pH 7.5) were used to ensure that most of 
the peptide was bound. Under all conditions investigated, the time resolved 3[Re]* emission 
recorded at 600 nm was best fit with a bi-exponential 
decay function. One emission decay component was set 
equal to that of the free peptide while the other emission 
component was allowed to vary. In 20% glycerol, we 
obtained decay components of 60 ns (75%) and ~200 ns 
(25%), which did not change upon addition of 1 mM 
CDP substrate. These data reveal that the conformation 
of the peptide bound to α2 is heterogeneous, with at 
least two major binding modes. For one binding mode, 
the [Re] chromophore is solvated similar to that in free 
solution, while the other binding mode partially 
desolvates the [Re] chromophore resulting in a blue-
shifted emission energy with longer emission lifetime. 
 
Figure 9.5. Competitive inhibition 
binding assay of [Re]-Y-R2C19 to 
α2. 
 
Figure 9.6. Emission spectra of 
[Re]-Y-R2C19 (5 μM)  at pH 7.5 as 
the α2 concentration is increased 
from 0→50 μM. Inset: Emission 
maximum as a function of α2 
concentration (○) with fit (▬) to 
binding model in eq 2. 
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We next used the [Re] emission as a probe of the 
pKa of the 3,5-F2Y on the peptide bound to α2. 
Figure 9.7 plots the emission intensity of a 5 μM 
solution of [Re]-3,5,-F2Y-R2C19 in the presence of 
20 μM α2 as the pH is increased from 6.3 to 9.0. The 
red spectra in the figure correspond to the emission of 
5 μM [Re]-3,5,-F2Y-R2C19 in the absence of α2 at 
pH 6.3 (lower spectrum) and 9.0 (upper spectrum). 
These spectra illustrate that binding of 5 μM peptide 
to 20 μM α2 causes as blue shift and an increase in 
the 3[Re]* emission intensity, both at pH 6.3 and 9.0. 
As the pH is titrated from 9.0 to 6.3 for the solution 
containing the bound peptide, the 3[Re]* emission 
intensity decreases with an apparent pKa of 7.3 + 0.1. 
The same pKa was obtained whether the integrated emission or emission maximum (at 600 or 
650 nm) was plotted vs. pH. As was observed in Figure 9.2, deprotonation of the phenol of 
3,5-F2Y initiates electron transfer between 3,5-F2Y– and 3[Re]* resulting in a decrease in 
emission intensity. We thus attribute the emission quenching in Figure 9.7 to electron transfer 
between 3[Re]* and 3,5-F2Y– on the peptide bound 
to α2. Thus the pKa of the bound 3,5-F2Y does not 
shift significantly from that of the peptide in free 
solution. These data show that we should be able to 
make 3,5-F2Y• radicals bound to α2 to 
photochemically initiate deoxynucleotide 
production. 
 
Figure 9.7. Emission spectra of [Re]-
3,5-F2Y-R2C19 (5 μM) and α2 (20 
μM) as the pH is titrated from 9.0 to 
6.3. The red spectra were recorded at 
pH 6.3 (lower spectrum) and pH 9.0 
(upper spectrum) in the absence of 
α2. Inset: Integrated emission 
intensity as a function of pH (○) with 
fit (▬) to monoprotic titration curve. 
Stability of α2 under photolysis conditions and 
Inactivation of α2 with Ru(III)(NH3)63+. We 
veloped new photolysis conditions for the 
hotochemical RNRs reported in this chapter, 
herefore we wanted to test the stability of α2 
during the experiment. We also considered using 
de
p
t
 
Figure 9.8. Amount of dCDP produced 
per α2 under single turnover 
conditions after incubation with the 
labeled conditions. Photolysis was 
performed with λ>299 nm in a 
temperature controlled (25°C)  bath. 
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Ru(III)(NH3)63+ as a bimolecular oxidant of the •[Re]–-3,5-F2Y• charge separated state on the 
peptide bound to α2, and therefore we investigated the stability of α2 to this compound. 
Figure 9.8 plots the number of equivalents of dCDP produced after incubation of α2 with 3 
mM ATP and 0.75 mM [2-14C]-CDP under the labeled conditions, followed by incubation 
with β2 for 10 minutes. The bars represent an average of two data points, one obtained at 2 
and one at 5 minutes. α2 incubated in the dark produces 2.0 equivalents of dCDP per dimer, 
which decreases slightly under photolysis conditions (1.8 eq per α2). Incubation of α2 with 25 
mM Ru(III)(NH3)3+ results in further decrease in α2 turnover (1.5 eq) which is enhanced 
under photolysis (1.0 eq). The ammonia ligands of Ru(III)(NH3)3+ are somewhat labile8 and 
may exchange for thiolates of cysteine residues in α2. Binding of active site thiolates in α2 to 
Ru(III) would prevent nucleotide reduction and effectively inactivate α2. 
 
Figure 9.9. Single turnover assays for α2 with [Re]-(F/Y/3,5-F2Y)-R2C19 
peptides in 20% glycerol. Data was collected after 2, 5, and 10 minutes of 
photolysis with light of λ > 348 nm. Red and blue bars are at pH 8.2 and 7.5, 
respectively. 
Photochemical RNR turnover. Figure 9.9 plots the turnover achieved upon photolysis of 
200 μM [Re]-(F/Y/3,5-F2Y)-R2C19 peptide with 20 μM α2 at pH 7.5 and 8.2 in 20% glycerol 
in the presence of 0.75 mM [5-3H]-CDP substrate and 3 mM ATP effector under single 
turnover conditions. Data were collected after 2, 5, and 10 minutes using light of λ > 348 nm 
and are an average of two separate experiments. The data were also corrected for background 
counts from radiochemical impurities, which were assessed by [Re]-F-R2C19 + α2 dark 
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controls. From the plot in Figure 9.8, we see that the [Re]-F-R2C19:α2 system is essentially 
inactive towards photochemical nucleotide reduction. The [Re]-Y-R2C19:α2 and [Re]-3,5-
F2Y-R2C19:α2 systems, however, exhibit a time-dependent photochemical RNR activity. 
Higher percent turnover was measured at pH 7.5 compared to pH 8.2 for both systems. The 
[Re]-3,5-F2Y-R2C19:α2 construct approaches 30% turnover at 10 minutes, which is the 
highest turnover recorded for any photochemical RNR to date. Adding glycerol to the solution 
increased the overall turnover yield, along with the reproducibility of the experiment. 
Transient Spectroscopy of the Peptide:α2 Complex. Since the [Re]-Y-R2C19 peptide is 
active for photochemical deoxynucleotide reduction, we wondered if we could observe the 
[Re]0-Y• charge separated state upon binding this peptide to α2, instead of the 3[Re]* excited 
state observed for the peptide free in solution (Figure 9.3). Figure 9.10 plots the TA spectra 
recorded for 100 μM solutions of [Re]-F-R2C19 (left) and [Re]-Y-R2C19 (right) in the 
presence of 135 μM α2, 1 mM CDP, and 3 mM ATP in 20% glycerol at pH 7.5. The spectra 
in both panels resemble those of the 3[Re]* excited state (see Figure 9.3). For both peptides, 
the absorbance decay at 480 nm could be fit to a bi-exponential decay function with τ1 ≡ 62 ns 
(55 %) and τ2 = 150 ns (45 %) for the [Re]-F-R2C19:α2 system and τ1 ≡ 62 ns (62 %) and τ2 
= 185 ns (38 %). These data are consistent with previous results discussed above that suggest 
the peptide binds to α2 in a heterogeneous fashion. In search for a signals corresponding to Y• 
and bpy•– that would be formed in the event of radical formation on the [Re]-Y-R2C19 
 
Figure 9.10. TA spectra recorded for 100 μM solutions of [Re]-F-R2C19 (left) and [Re]-Y-
R2C19 (right) in the presence of 135 μM α2, 1 mM CDP, and 3 mM ATP in 20% glycerol at 
pH 7.5. Spectra are recorded at 65, 115, 215, and 415 ns (left) and at 115, 215, and 415 ns 
(right).  Insets: Single wavelength absorbance kinetics data measured at 480 nm. 
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peptide, the spectra for both peptides at a 
common time point were normalized and the 
signal for [Re]-F-R2C19 subtracted from that 
of [Re]-Y-R2C19. In no case could a clear 
absorption feature be distinguished between 
380 and 420 nm (Y•) or at 525 nm (bpy•–). 
We next investigated the [Re]-3,5-F2Y-
R2C19 peptide bound to variants of α2 by TA 
spectroscopy. The Y731F-α2 variant provides 
a control with which we can isolate the 
photochemistry to the peptide (radical 
transport from the peptide into α2 should not 
occur with F at position 731). Figure 9.11 plots 
the TA spectra recorded for a 100 μM solution 
of [Re]-3,5-F2Y-R2C19 in the presence of 140 μM Y731F-α2, 1 mM CDP, and 3 mM ATP in 
20% glycerol at  pH 8.2. Under these conditions ~87% of the peptide should be bound to 
Y731F-α2, assuming a KD = 8 μM. The spectrum at the earliest time point (65 ns) resembles 
an admixture of the 3[Re]* excited state and the [Re]0–3,5-F2Y• charge separated state (see 
Figures 9.3 and 9.4, respectively), with a peak at 380 nm (3[Re]*) and a shoulder at 395 nm 
(3,5-F2Y•). Single wavelength kinetics 
recorded at 395 nm could be fit to a single 
exponential decay function with a lifetime of 
91 ns.  
 
Figure 9.11 TA spectra of a 100 μM 
solution of [Re]-3,5-F2Y-R2C19 in the 
presence of 140 μM Y731F-α2, 1 mM 
CDP, and 3 mM ATP in 20% glycerol at  
pH 8.2. Spectra were recorded at 65, 115, 
and 215 ns. Inset: Single wavelength 
absorbance kinetics recorded at 395 nm. 
By relieving the Y731F mutation, we 
wondered if we would see a disappearance of 
the 395 nm signal (3,5-F2Y•) and an increase 
in signal corresponding to Y• (~410 nm), as 
would be the result for radical injection into 
α2. Figure 9.12 plots the TA spectra obtained 
upon excitation of a 100 μM solution of [Re]-
3,5-F2Y-R2C19 in the presence of 216 μM α2, 
 
Figure 9.12 TA spectra of a 100 μM 
solution of [Re]-3,5-F2Y-R2C19 in the 
presence of 216 μM α2, 1 mM CDP, and 3 
mM ATP at pH 8.3. Spectra were recorded 
at (▬) 65, (▬) 215, and (▬) 415 ns.  
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1 mM CDP, and 3 mM ATP. As with the Y731F-α2 variant, the spectrum at the earliest time 
point (65 ns) resembles an admixture of the 3[Re]* excited state and the [Re]0–3,5-F2Y• 
charge separated state, except that the peaks at 380 and 480 nm (3[Re]*) are more 
pronounced, the 525 nm (bpy•–) and 395 nm (3,5-F2Y•) features are decreased in intensity. 
These data are consistent with inefficient quenching of the 3[Re]* excited state by the 3,5-F2Y 
residue upon binding of the peptide to α2. This effect is more pronounced for wt-α2 than for 
Y731F-α2. 
To simplify the spectra and maximize our ability to visualize 3,5-F2Y•→Y731 radical 
transport, we decided to use a bimolecular quencher to oxidize both the unquenched 3[Re]* 
excited state and the [Re]0 species in the [Re]0-3,5-F2Y• charge separated state. Oxidation of 
3[Re]* would produce [ReII]+, which is a strong oxidant14 and should rapidly oxidize 3,5-F2Y. 
Also, by mutating Y730 to F and C439 to S, we wondered if the 3,5-F2Y• produced on the 
 
Figure 9.13 TA spectra of a 100 μM solution of [Re]-3,5-F2Y-R2C19 with 10 mM 
Ru(III)(NH3)63+ (upper left) and 200 μM α2 (upper right), 175 μM Y730F-α2 (lower left), or 
175 μM C439S-α2 (lower right). Conditions: 1 mM CDP, 3 mM ATP, 15 mM MgSO4 and 50 
mM Tris buffer at pH 8.3. Spectra were recorded at (▬) 415 ns, (▬) 1, (▬) 2, and (▬) 10 
μs.  
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peptide would oxidize Y731 and become 
trapped in α2. Figure 9.13 displays the spectra 
produced upon excitation of a 100 μM solution 
of [Re]-3,5-F2Y-R2C19 with 10 mM 
Ru(III)(NH3)63+ (upper left) and 200 μM α2 
(upper right), 175 μM Y730F-α2 (lower left), or 
175 μM C439S-α2 (lower right). In all cases, 
the spectra resemble that of the 3,5-F2Y• radical 
displayed in Figure 9.4 (right) with a peak at 
395 nm. We next compared the spectra obtained 
at the earliest time point (415 ns) for each of the 
systems. Figure 9.14 presents an overlay of 
these spectra normalized to the peak at 395 nm. 
The band shape of the peak is the same for 
every peptide:α2 system, and in no case do we observe a shoulder to the red, as would be 
expected for observation of a tyrosyl radical in α2. 
 
Figure 9.14 Normalized TA spectra of 100 
μM solutions of [Re]-3,5-F2Y-R2C19 
containing 10 mM Ru(III)NH33+ (▬) and 
200 μM α2 (▬), 175 μM Y730F-α2 (▬), or 
175 μM C439S-α2 (▬). 
9.3 Discussion 
The results described above show that the [Re]-Y-R2C19 peptide binds to α2 with 
micromolar affinity, but that the peptide:α2 
complex is heterogeneous in solution with at 
least two different binding modes of the peptide 
to the protein. Binding of the peptide inhibits 
RNR activity (Figure 9.5) and affects the steady 
state emission of the 3[Re]* excited state 
(Figure 9.6), however, analysis of the 3[Re]* 
time-resolved emission reveals at least two 
environments of the chromophore with 
different solvation/polarity. The X-ray structure 
of α2 (Figure 9.15)9 was obtained with the Y-
R2C19 peptide bound, however the C-terminal 
residues (356-360) were not located in the 
 
Figure 9.15 X-Ray structure of α2 with 
R2C20 peptide bound from ref[9]. 
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structure. Together, these data support a model in which the C-terminus of the bound peptide 
is thermally labile. However, there must be transient interactions between the “Y356” residue 
on the peptide with α2 that result in the stronger binding of Y-R2C19 peptides compared to F-
R2C19 (see Chapter VII). 
The photochemical RNR assays with the [Re]-(F/Y/3,5-F2Y)-R2C19 peptides reveal that 
radical generation on the peptide is required for turnover in systems based on the [Re] 
chromophore. The [Re]-F-R2C19 peptide is inactive towards deoxynucleotide production, 
which is in contrast to the Ac-BPA-, Anq-, and Py•+-based peptides described in Chapter 
VIII. Both the Py•+ and 3[Re]* oxidants can only accept an electron in oxidation of Y, 
however the 3[Re]* lifetime only persists into the hundreds of nanoseconds timescale when 
bound to α2, compared to Py•+ which lasts into the microsecond timescale. We therefore 
surmise that the relatively short lifetime of the 3[Re]*, in combination with its ability to serve 
as only an ET oxidant, prevent the excited 3[Re]*-F-R2C19 peptide from oxidizing Y731 
directly and turning over α2. 
The fact that the [Re]-Y-R2C19 peptide is competent for photochemical RNR turnover is 
somewhat surprising, given that we see no evidence for [Re]0-Y• formation in the TA studies 
of the peptide free in solution (Figure 9.3) or bound to α2 (Figure 9.10). Either a small amount 
of [Re]0-Y• is formed upon excitation of [Re]-Y-R2C19 in solution, or a proton acceptor 
exists in one of the binding modes of the peptide:α2 complex that is hydrogen bonded to 
Y356, thereby facilitating its oxidation as observed in Chapter V with buffers bound to Y in 
solution. In either case, the concentration of this species is too small to be detected by the 
spectroscopic methods employed above. 
Excitation of the [Re]-3,5-F2Y-R2C19:α2 complex results in ~30% deoxynucleotide 
formation per α. The active RNR complex has been proposed to be an asymmetric dimer10,11 
and hence the activity of the peptide:α2 complex may be limited to 50% owing to half-site 
reactivity in α2. If this is indeed the case, then we are approaching the single turnover limits 
with the [Re]-3,5-F2Y-R2C19 peptide. This chromophore-fluorotyrosine combination also 
allows us to visualize, for the first time, a tyrosyl radical on the peptide bound to α2 with TA 
spectroscopy (Figures 9.11 and 9.13). To visualize radical injection into α2, we would expect 
to see a decrease in the TA signal at 395 nm (3,5-F2Y•), concomitant with an increase in the 
signal at ~410 nm (•Y731 or •Y730). The Y730F and C439S mutants were designed to 
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prevent further radical transport and deoxynucleotide production, therein trapping the radical 
at Y731. Unfortunately, as evidenced by Figures 9.13 and 9.14, we see no evidence for a 
shoulder at 410 nm on the 395 nm, 3,5-F2Y• peak. Even at longer times (10 μs), after decay of 
most of the 3,5-F2Y• on the peptide in Figure 9.13, a clear feature at 410 nm for trapped 
•Y731 in the Y730F and C439S mutants cannot be resolved. From these data, we conclude 
that the conformation of the peptide:α2 complex that supports photochemical RNR activity is 
in equilibrium with other, non-productive peptide:α2 conformations. Under steady state 
photolysis, this conformation may be sampled many times for RNR turnover, but in the single 
laser-pulse TA experiment, the concentration of the productive conformation is too low for 
visualization of radical transport using our current TA methods. 
9.4 Experimental Section 
Materials. Trifluoroacetic acid (TFA), adenosine 5’-triphosphate (disodium salt from 
bacteria, ATP), cytidine 5’-diphosphate (sodium salt from yeast, CDP), piperidine, and 
diisopropylethylamine (DIPEA), were purchased from Sigma-Aldrich. O-(7-Azobenzotriazol-
1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HATU), N-[(9H-fluoren-9-
ylmethoxy)-carbonyl]-L-phenylalanine (Fmoc-F-OH) and O-(1,1-dimethylethyl)-N-[(9H-
fluoren-9-ylmethoxy)carbonyl]-L-tyrosine (Fmoc-Y(tBu)-OH) were purchased from Applied 
Biosystems. 1-Hydroxybenzotriazole (HOBt) was obtained from NovaBiochem. [5-3H]-
Cytidine diphosphate was purchased from Amersham and purified as described below. Calf-
intestine alkaline phosphatase (10 U/μL) was purchased from New England Biolabs. [2-14C]-
CDP was purchased from Moravek Biochemicals and diluted to a specific activity of 6330 
cpm/nmol. Piperidine was freshly distilled from KOH under N2 prior to use. Fmoc-3,5-F2Y 
was made in two steps from 2,6-difluorophenol, pyruvate, and ammonia using pyruvate 
formate lyase as previously described.12,13 Re(bpy-COOH)(CO)3CN was prepared as 
described in Chapter IV.14 
Purification of [5-3H]-CDP.  250 μCi of [5-3H]-CDP (Amersham, 24 μCi/nmol, 97.9% 
radiochemical purity) was diluted to a specific activity of ~0.018 μCi/nmol with cold cytidine 
diphosphate (Sigma). The diluted stock solution was then purified over a diethylaminoethyl 
(DEAE)-Sephadex A25 column. The resin was purchased in the chloride form from Sigma-
Aldrich, swelled in 10 mM triethylammonium bicarbonate (TEAB) solution, and poured into 
a 60 mL column. The resin was washed with 5 column volumes of 1M TEAB solution, 
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followed by five column volumes of deionized 
water. The stock [5-3H]-CDP solution was then 
slowly loaded onto the column and eluted with a 
0→600 mM TEAB gradient (450 mL × 450 mL). 
Fractions (400 drops) were collected automatically 
by a fraction collector and every other fraction 
analyzed by a 96 well plate UV-vis absorption 
spectrometer at 260 and 280 nm. Figure 9.16 plots 
the absorption trace for this column separation; 
fractions were pooled between the two horizontal 
lines (49-56). The solvent and TEAB were removed 
in vacuo, and the resulting product dissolved in deionized water. The entire column separation 
procedure was repeated, yielding a 20 mM stock solution with 11,100 Cpm/nmol (99.95 % 
radiochemical purity as assayed by the C/dC ion exchange separation procedure15,16). 
 
Figure 9.16 DEAE ion exchange 
purification of [5-3H]-CDP. Fractions 
between the vertical lines were 
collected and pooled. 
Synthesis of [Re]-(F/Y/3,5-F2Y)LVGQIDSEVDTDDLSNFQL [[Re]-(F/Y/3,5-F2Y)-
R2C19]. Solid phase peptide synthesis (SPPS) using Fmoc-protected amino acids was 
employed to extend the Fmoc-R2C19-PEG-PS resin bound peptide, which was available from 
a previous study.17 For the syntheses of the [Re]-(F/Y/3,5-F2Y)-R2C19 peptides, typically 
250 mg of the Fmoc-R2C19-PEG-PS resin bound peptide (0.2 mmol/g) was loaded into a 10 
mL Bio-Rad Poly-Prep column containing a porous 30 μm polyethylene bed in the bottom to 
hold the resin. The N-terminal Fmoc protecting group was cleaved by shaking the resin in a 
solution of 3.6 mL 0.1 M HOBt in 20% piperidine/DMF for 3 × 8 min using a 
FisherScientific Vortex Genie 2 (VWR). The resin was then washed with 3 × 4 mL of DMF 
and CH2Cl2. Fmoc-F-OH/ Fmoc-Y(tBu)-OH/ Fmoc-3,5-F2Y was then coupled to the free 
N-terminus by shaking the resin for 2 × 70 - 80 min in a solution of 0.5 M amino acid, 0.45 M 
HATU and 1 M DIPEA; the volume was adjusted accordingly such that the amino acid was in 
6 - 8 fold excess. The Re(bpy-COOH)(CO)3CN chromophore was then coupled in a similar 
manner with some modifications: the coupling solution consisted of 27 mg of Re(bpy-
COOH)(CO)3CN in 1.5 mL DMF with 77 mg of HATU and 100 μL of DIPEA due to limited 
solubility of the chromophore. The coupling reaction was repeated to ensure high yields of the 
desired product. Cleavage of the peptide from the resin was carried out by shaking in 5 mL of 
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95% TFA, 2.5% triisopropylsilane, 2.5% water for 4 h. The resin was then washed for 2 × 1 
min with 2 mL of TFA. The cleavage cocktail and washings were combined, evaporated 
under a stream of N2, and taken up in 15 mL of ether to precipitate the crude peptide, which 
was pelleted in a centrifuge and the ether decanted. The precipitate was dissolved in 0.1 M 
ammonium bicarbonate HPLC buffer via sonication over several minutes. 
Peptide Purification and Characterization. Peptides were purified by reversed phase 
HPLC using the system described in Chapter VII. Samples were manually injected onto a 
preparative Waters XTerra MS C-8 column (30 × 100 mm), which had been previously 
equilibrated with 10% acetonitrile/10 mM potassium phosphate buffer (pH 6). A linear 
gradient of 10 → 50 % acetonitrile vs. phosphate buffer over 50 min at a flow rate of 10 
mL/min was used to elute the peptides. The eluant absorbance was monitored at 355 and 210 
nm, where the [Re] chromophore and peptide amide bond absorb, respectively. Fractions 
containing the desired product were collected by hand, pooled, and reinjected onto the C-8 
prep column which had been equilibrated with 0.1 M ammonium bicarbonate. The loaded 
column was rinsed with 5 column volumes of ammonium bicarbonate buffer, and the peptide 
eluted with 1:1 acetonitrile/ 0.1 M ammonium bicarbonate. The eluant was collected by hand, 
lyophilized, taken up in 50 mM Tris buffer at pH 7.5, combined, and stored at –80 °C. 
Analytical HPLC was employed to confirm the purity of the peptides. The samples were 
manually injected onto an analytical Waters XTerra MS C-8 (4.6 × 100 mm) column and 
eluted with a 10 → 65 % acetonitrile vs. 10 mM phosphate buffer (pH 6) over 45 minutes at a 
flow rate of 1 mL/min. The molecular weight (MW) of the peptide was characterized by 
MALDI-TOF mass spectrometry as described below. The HPLC retention times (tR) and 
MALDI-TOF m/z ratios for each peptide are listed in Table 8.1. Analytical HPLC traces for 
each peptide were recorded at 210 nm to confirm purity. The concentration of each peptide 
stock solution was estimated by UV-vis absorbance using the known ε355 nm = 5300 M–1 cm–1 
for the  [Re]-3,5-F2Y-OMe dipeptide. 
Isolation, Purification and Pre-reduction of α2. E. coli α2,18 Y730F/Y731F-α2,19 and 
C439S-α220 were isolated by standard procedures.  To remove contaminating β2, these 
proteins were further purified using a POROS HQ/20 anion exchange column (Applied 
Biosystems) on a BIOCAD Sprint Perfusion Chromatography System (Applied Biosystems). 
The column was loaded with α2 (10 - 15 mg) and washed with Tris buffer (50 mM, pH 7.6) 
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for 5 min. α2 was eluted with a linear gradient of 0 - 700 mM NaCl over 30 min at a flow rate 
of 4 mL/min. Fractions were collected by hand and concentrated on a YM-30 membrane 
(Millipore). This procedure reduced background turnover of CDP 7 - 8 fold. To pre-reduce 
α2, ~30 mg were incubated with 30 mM DTT for 30 min at room temperature. Hydroxyurea, 
ATP and CDP were added to final concentrations of 30 mM, 3 mM and 1 mM, respectively, 
and the incubation continued for an additional 20 min. Another 10 mM DTT was added, and 
the mixture incubated for 10 min and desalted on a G-25 Sephadex column (~35 mL, 1.5 × 23 
cm) pre-equilibrated in 50 mM Tris, 15 mM MgSO4, pH 7.6. 
α2 Activity Assay and Competitive Inhibition Assay for Binding of Peptide to α2. α2 
(0.1 μM, specific activity = 1900 nmol min–1 mg–1), β2 (0.2 μM, specific activity = 6800 nmol 
min–1 mg–1), TR (30 μM), TRR (0.5 μM), NADPH (0.2 mM), CDP (1 mM), and ATP (1.6 
mM) were combined in 50 mM HEPES, 15 mM MgSO4, 1 mM EDTA buffer at pH 7.6. 
Enzyme activity was measured by the consumption of NADPH, which was monitored by the 
decrease in absorbance at 340 nm. This was then repeated with peptide concentrations ranging 
from 1 - 150 μM. 
Single Turnover Assays for Photoinitiated Nucleotide Reduction in Peptide-α2 
Complexes. The assays were performed by a method modified from that described in Chapter 
VII. For the data in Figure 9.8 and 9.9, [2-14C]-CDP (0.75 mM, 6330 cpm nmol–1) or [5-3H]-
CDP (0.75 mM, 11,100 Cpm/nmol) substrate was used, respectively. FPLC purified, pre-
reduced α2 (20 μM, specific activity = 1800 nmol min–1 mg–1), peptide (200 μM), ATP (3.0 
mM), and labeled-CDP in 50 mM Tris, 15 mM MgSO4 buffer (pH 7.5 unless otherwise 
indicated) were added to a 1 cm quartz micro-cuvette with total solution volume of 200 μL. 
The data in Figure 9.8 and 9.9 were also collected with samples containing 25 mM 
Ru(III)(NH3)63+ or 20% glycerol, respectively. The reaction was initiated by the addition of 
CDP, quickly mixed, spun down in a minicentrifuge (< 10 s, 2000 g) to consolidate the liquid, 
and pipetted into the cuvette. Samples were irradiated at room temperature with the focused 
light from a 1000 W Xe arc lamp equipped with a 299 (Figure 9.8) or 348 nm (Figure 9.9) 
long pass filters. The cuvette was contained in a pyrex beaker filled with water at 25 °C to 
regulate the temperature during photolysis. Fractions (60 μL) were removed at 2, 5 and 10 
min intervals and immediately quenched by heating in a boiling water bath for 2 min. The 
precipitated protein was then spun down for 10 min in a minicentrifuge at 20,000 g. The 
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supernatant (50 of the 60 μL) was transferred to a new Eppendorf tube, diluted with 14 units 
of alkaline phosphatase and 120 nmol of carrier dC to a final volume of 170 μL, and 
incubated at 37 °C for 2 h in a sealed Eppendorf vial. dC was then separated from C and 
quantitated as previously described.15,21  
Analysis of [Re]-Y-R2C19 binding to α2. Figure 9.6 plots the binding of the [Re]-Y-
R2C19 peptide to α2 as monitored by steady state emission spectroscopy. Solutions of 5 μM 
peptide were titrated with α2 from concentrations of 0→65 μM. Emission from [Re] did not 
significantly change at higher concentrations of α2; thus at 65 μM we concluded that each 
molecule of α2 was bound to two [Re]-Y-R2C19 peptide. The fraction of bound peptide as a 
function of α2 concentration, χbound(α2), was then calculated from the equation: 
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where I600nm  is the emission intensity at 600 nm. The inset of Figure 9.6 plots χbound(α2) vs. 
[α2]. The data were fit to the following kinetic model: 
  
where P = [Re]-Y-R2C19. This treatment does not imply that two peptides bind to α2 
simultaneously. From this model we can derive an expression for χbound:22 
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assuming that KD is the same for binding of the first and second peptide, as previously 
discussed.3 Thus by plotting χbound vs. [α2] and fitting the data to eq. 2, we can derive KD. 
Physical Measurements. ESI-FT mass spectrometry was performed with a Brüker 
Daltonics APEXII instrument housed in the DCIF. MALDI-TOF mass spectrometry was 
performed with a Brüker Omniflex instrument in the DCIF using α-cyano-4-hydroxycinnamic 
acid as the matrix. The instrument was calibrated in positive ion mode with a quadratic 
polynomial using a mixture of angiotensin II (1046.5423), P14R synthetic peptide 
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(1533.8582), and ACTH fragment 18-39 (2465.1989) (Sigma). All peptides synthesized were 
analyzed in positive ion mode as the [M-CN]+ ion. 
UV-vis absorption spectra were recorded on a Spectral Instruments 440 
spectrophotometer. Steady state emission spectra were recorded on an automated Photon 
Technology International (PTI) QM 4 fluorimeter equipped with a 150-W Xe arc lamp and a 
Hamamatsu R928 photomultiplier tube. Samples were excited at 330 nm in a 2 mm × 1 cm 
cuvette with four polished windows. Time resolved emission measurements on the <20 ns 
timescale were made with the frequency doubled (400 nm) pump light provided by a 
Ti:sapphire laser system (100 fs pulsewidth) and collected on a Hamamatsu C4334 Streak 
Scope streak camera as previously described.23 Time resolved emission measurments on the 
>20 ns timescale were made with pump light provided by the third harmonic (355 nm) of an 
Infinity Nd:YAG laser (Coherent) running at 20 Hz.24 
Nanosecond transient absorption (TA) measurements were made with the same laser 
running at 10 Hz. Thus system was extensively modified from that previously described.24 
Probe light was provided by a pulsed 75 W Xe-arc lamp (Photon Technologies Incorporated). 
The lamp was pulsed with 5 A current (1 ms pulse width) and triggered externally at 10 Hz. 
The signal light passed through a Triax 320 spectrometer, where it was dispersed by a 300 × 
500 blazed grating and collected with either an intensified gated CCD camera (ICCD, CCD 
30-11, Andor Technology, 1024 × 256 pixels, 26 μm2) for TA spectra or a photomultiplier 
tube (PMT) for TA kinetics at a single wavelength. PMT outputs were collected and averaged 
with a 1 GHz oscilloscope (LeCroy 9384CM)A TTL pulse synchronized with the Q-switch of 
Infinity laser was delayed 99 ms before triggering the pulser for the probe light. All electronic 
delays were created with SRS DG535 delay generators (Stanford Research Systems). 
Electronic shutters (Uniblitz) were used to create the pulse sequence illustrated in Figure 9.17. 
To produce a TA spectrum, the series of four spectra were taken: IF (pump on/probe off), I 
 
Figure 9.17 Timing of the nanosecond TA instrument running at 10 Hz.  
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(pump on/probe on), IB (pump off/probe off), and I0 (pump off/probe on). Transient spectra 
were corrected for fluorescence and background light using these spectra by the calculation: 
ΔOD = log[(I0 – IB)/(I – IF)]. For experiments involving α2, the spectra reported are an 
average of 125 of the four-spectra sequences. Sample sizes were typically 200 μL in a 2 × 10 
mm cuvette containing a Teflon-coated mini-stirbar. Both the white light and pump beams 
were focused and overlapped to pass through the 2mm-wide window of the cuvette, providing 
a total pathlength of 1 cm. To provide optimal beam overlap, the pump beam was reflected off 
a small mirror in front of the collimating lense for the probe beam after the sample, as 
illustrated in Figure 9.18. 
 
Figure 9.18 Diagram of the nanosecond TA instrument running at 10 Hz.  
 
 
 210
 211
9.5 References 
 
 1.  Yee, C. S.; Seyedsayamdost, M. R.; Chang, M. C. Y.; Nocera, D. G.; Stubbe, J. 
Biochemistry 2003, 42, 14541. 
 2.  Reece, S. Y.; Seyedsayamdost, M. R.; Stubbe, J.; Nocera, D. G. J. Am. Chem. Soc. 
2006, 128, 13654. 
 3. Climent, I.; Sjöberg, B.-M.; Huang, C. Y. Biochemistry 1991, 30, 5164. 
 4. Climent, I.; Sjöberg, B.-M.; Huang, C. Y. Biochemistry 1992, 31, 4801. 
 5.  Reece, S. Y.; Seyedsayamdost, M. R.; Stubbe, J.; Nocera, D. G. J. Am. Chem. Soc. 
2007, in press. 
 6. Chen, P.; Meyer, T. J. Chem. Rev. 1998, 98, 1439. 
 7. Blanco-Rodriguez, A. M.; Busby, M.; Gradinaru, C.; Crane, B. R.; Di Bilio, A. J.; 
Matousek, P.; Towrie, M.; Leigh, B. S.; Richards, J. H.; Vlcek, A., Jr.; Gray, H. B. J. 
Am. Chem. Soc. 2006, 128; 4365. 
 8.  Taube, H. Chem. Rev. 1952, 50, 69. 
 9. Eriksson, M.; Uhlin, U.; Ramaswamy, S.; Ekberg, M.; Regnström, K.; Sjöberg, B.-M.; 
Eklund, H. Structure 1997, 5, 1077. 
 10. Seyedsayamdost, M. R.; Stubbe, J. J. Am. Chem. Soc. 2006, 128, 2522. 
 11. Seyedsayamdost, M. R.; Stubbe, J. J. Am. Chem. Soc. 2007, 129, 2226. 
 12.  Seyedsayamdost, M. R.; Reece, S. Y.; Nocera, D. G.; Stubbe, J. J. Am. Chem. Soc. 
2006, 128, 1562. 
 13. Seyedsayamdost, M. R.; Reece, S. Y.; Nocera, D. G.; Stubbe, J. J. Am. Chem. Soc.2006, 
128, 1569. 
 14. Reece, S. Y.; Nocera, D. G. J. Am. Chem. Soc. 2005, 127, 9448. 
 15. Steeper, J. R.; Steuart, C. D. Anal. Biochem. 1970, 34, 123. 
 16. Booker, S.; Licht, S.; Broderick, J.; Stubbe, J. Biochemistry 1994, 33, 12676. 
 
 212
 
 17. Yee, C.S.; Seyedsayamdost, M. R.; Chang, M. C. Y.; Nocera, D. G.; Stubbe, J. 
Biochemistry 2003, 42, 14541. 
 18. Salowe, S.; Bollinger, J. M., Jr.; Ator, M.; Stubbe, J.; McCraken, J.; Peisach, J.; 
Samano, M. C.; Robins, M. J. Biochemistry 1993, 32, 12749. 
 19. Salowe, S.; Stubbe, J. J. Bacteriol. 1986, 165, 363. 
 20. Mao, S. S.; Yu, G. X.; Chalfoun, D.; Stubbe, J. Biochemistry 1992, 31, 9752. 
 21. Booker, S.; Licht, S.; Broderick, J.; Stubbe, J. Biochemistry 1994, 33, 12676. 
 22. Van Holde, K. E. Physical Biochemistry, 2nd Ed.; Prentice Hall: Englewood Cliffs, N.J., 
1985; p 64. 
 23. Damrauer, N. H.; Hodgkiss, J. M.; Rosenthal, J.; Nocera, D. G. J. Phys. Chem. B 2004, 
108, 6315. 
 24. Loh, Z.-H.; Miller, S. E.; Chang, C. J.; Carpenter, S. D.; Nocera, D. G. J. Phys. Chem. A 
2002, 106, 11700. 
 Chapter X 
 
 
Towards Photoactive β2 Subunits  
 
 
 
 
 
 
 
 
 
 
 213
10.1 Motivation 
The results of Chapter IX suggest that observation of radical transport from •Y356 on the 
R2C19 peptide into α2 may be precluded by the conformational flexibility of the C-terminus 
of the peptide bound to α2. Multiple conformations of the peptide bound to α2 are evident 
from the data, and we postulate that the productive conformation supporting radical transport 
is only present at concentrations that are too low for observation with our transient 
spectroscopic methods. 
In the natural system in vitro, RNR activity is regulated by conformational triggers in the 
α2:β2 complex.1 By replacing β2 with the Y-R2C19 peptide, we may be missing some of the 
conformational triggers that enable radical transport between Y356 and C439. The 
assumption here is that the conformational trigger in the α2:β2 complex in some way affects 
the radical transport through Y356. Several lines of evidence support this assumption. First, 
the pKa of 3-NO2Y356 in the 3-NO2Y356-β2 subunit was determined to shift by almost +1 
pKa unit upon binding to α2, but only in the presence of RNR substrate and effector.2 Also, in 
the DOPA356-β2 subunit, •Y122→DOPA356 radical transport is only observed upon binding 
of DOPA356-β2 with α2 in the presence of RNR substrate and effector.3 The shift in pKa of 
Y356 upon binding to α2 predict a change in the thermodynamics of oxidation of this residue, 
while the result with DOPA356-β2 shows that the kinetics of •Y356 formation change upon 
subunit interaction. 
Thus, in order to observe radical transport in a photochemical RNR, replacement of the Y-
R2C19 peptide with the entire β2 subunit that is functionalized for photochemical •Y356 
generation may be a fruitful endeavor. These constructs may capture RNR in a conformation 
appropriate for radical transport, which can be initiated by a laser pulse. Binding of met-β2 
(β2 with •Y122 reduced) with reduced α2 should shift the enzyme conformation to favor 
product formation (also favoring forward radical propagation). In such cases, phototriggering 
•Y356 formation halfway along the radical transport pathway in RNR may allow for 
visualization of the •Y356→Y731 radical transport step. This chapter presents the first 
attempts towards preparing chromophore-functionalized β2 subunits for application to 
photochemical RNRs based on the α2:β2 complex. 
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10.2 [Re]-β2 
10.2.1 Background 
One potential method of generating a photoactive β2 subunit involves synthesis of a 
photoactive Y-R2C19 peptide that can be attached to the truncated β2 subunit by well 
established protein intein ligation methods.2 This semisynthetic method relies on the 
generation of the C-terminal peptide tail of R2 via solid-phase peptide synthesis (SPPS). The 
peptide must contain an N-terminal cysteine residue that can then be ligated to a truncated, 
thioester-terminated recombinant R2 subunit via thiotransesterfication. By directly 
incorporating the photo-oxidant into the C-terminal peptide during SPPS, we have synthetic 
control over the location of the chromophore with respect to Y356.The modified protein can 
then be used to study reverse radical transport in β2, as well as forward radical transport in the 
α2:β2 complex. Based on the work presented in the foregoing chapters, [Re] is the excited 
state radical initiator of choice with 3,5-F2Y at position 356.  
Figure 10.1 depicts the design plan that was implemented for studying the reverse radical 
transport: 
The basic design can be summarized as: (1) Excitation of the [Re] chromophore covalently 
attached to 3,5-F2Y356-β2 at position 355 will generate the [Re0]-3,5-F2Y• charge separated 
state. (2) A bimolecular quencher can be used at this point to oxidize [Re0] and prevent back 
electron transfer with the 3,5-F2Y• radical. (3) Once formed at the surface of met-β2, the 3,5-
F2Y• radical can then initiate reverse radical transport along the 3,5-F2Y356•→W48→Y122 
pathway, reforming the stable •Y122. This experiment seeks to provide kinetic resolution of 
 
Figure 10.1 Proposed photochemistry for [Re]-3,5-F2Y356-β2. 
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reverse radical transport in β2 and afford a method to test the hypothesis that D237 controls 
the thermodynamics W48 oxidation (see Chapter II).4 The met-[Re]-3,5-F2Y356-β2 (with 
•Y122 reduced) can also be bound to α2 in the presence of RNR substrate and effector so that 
the experiment is applicable to the study of forward radical transport in RNR. 
10.2.2 Results and Discussion 
A synthetic method utilizing solid-phase peptide synthesis (SPPS) to generate a N-
terminal Cys-peptide containing the [Re] chromophore and Y for ligation to the β2 subunit 
was developed. For this preliminary work, we focused on smaller, 4-residue peptides, rather 
than the full length R2C19. The strategy focused on utilizing an amino acid with two, 
orthogonally protected amine 
groups, such that the Re(bpy–
COOH)(CO)3CN chromophore 
could be coupled to one amine 
group and the peptide extended 
off of the other. Scheme 10.1 
shows the synthetic scheme for 
the Cys-Pro([Re])-Tyr-Leu-NH2 
peptide. 
MBHA resin was chosen, as it 
is stable to both trifluoroacetic 
acid (TFA) and piperidine. Fmoc-
Y(tBu)-OH was coupled to Fmoc-
Leu-MBHA resin using standard 
Fmoc-peptide coupling 
conditions. N-Boc-cis-4-N-Fmoc-
amino-L-proline was chosen as 
the amino acid containing two 
orthogonal protecting groups. 
After coupling this residue to Y, 
the Fmoc group was cleaved with 
piperdine and Re(bpy–COOH)(CO)3CN chromophore coupled to the free amine (Step 1 in 
 
Scheme 10.1 Synthesis of Cys-Pro([Re])-3,5-F2Y-Leu-
NH2 peptide. 
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Scheme 10.1). The Boc-protecting group was then cleaved with TFA ad peptide synthesis 
continued. Cleavage of the final product from the resin could be afforded with triflic acid. The 
resulting tetra-peptide was purified by HPLC under basic conditions (see below) and analyzed 
by MALDI-TOF mass spectrometry. The tetra-peptide was sparingly soluble under the 
conditions necessary for ligation to truncated β2.  
10.3 Y356C-BP β2 
10.3.1 Background 
The second method for developing photochemical RNRs involves site-specific labeling of 
β2 at or near position 356 in the C-terminal region of the protein with photochemical Y• 
generators. If the label is incorporated at position 356, then •Y731 may be generated directly 
if the photooxidant is in proximity to this residue in the α2:β2 complex. We chose 
benzophenone as the photooxidant for our first attempt owing to its relatively small size 
(minimal perturbance of the α2:β2 interaction) and its known ability to generate Y• upon 
excitation (see Chapter III). Furthermore, 4-acetamidobenzophenone (4-Ac-BP) has a major 
advantage for kinetics studies: the chromophore has an exceptionally large absorption cross-
section outside of the protein absorption envelope with ε (300 nm) = 23,000 M–1cm–1,5 ten 
times that of BPA at this wavelength. This chromophore thus has ample absorption cross-
section outside the protein envelope, thus allowing us to work at relatively low (~50 μM) 
concentrations of RNR. 
Labeling was 
accomplished by 
introducing a cysteine 
residue via site directed 
mutagenesis into the C-
terminus of β2. For the 
labeling to be specific to the cysteine of choice, the two surface accessible Cys residues of R2, 
C268 and C305, must also be mutated to Ser. The Stubbe lab has constructed the triple 
mutant: C268S, C305S, Y356C-R2 for these studies. Commercially available 4-
(iodoacetamido)-benzophenone (BPIA, Scheme 10.2) was used to label the Y356C residue, as 
previously described for other protein derived Cys residues.6  
 
Scheme 10.2 Labeling of β2 with benzophenone derivative. 
 217
 
Figure 10.2 TA spectra recorded after  photolysis of 100 μM solutions of 4-Ac-BP in the 
absence (left) and presence (right) of 10 mM L-tyrosine methyl ester with 320 nm pulsed 
laser light. Spectra in the left panel were recorded 100, 200 ns, 1, 2, and 5 μs after the laser 
pulse (top to bottom). Spectra in the right panel were recorded 200 ns, 1, and 5 μs after the 
laser pulse (top to bottom). 
10.3.2 Results and Discussion 
4-Ac-BP was used as a control compound for comparison to the benzophenone-labeled β2 
subunit. Figure 10.2 plots the TA spectra recorded upon photolysis of solutions of 4-Ac-BP 
(20 mM Tris, pH 7.5) with 320 nm nanosecond-pulsed laser light in the absence (left panel) 
and presence (right panel) of 10 mM L-tyrosine methyl ester. The spectra in the left panel are 
broad with a peak at ~490 nm and decay on the microsecond timescale. Photolysis of the 
same sample in the presence of L-tyrosine methyl ester (right panel), produces spectra with 
the characteristic double hump feature (λmax = 410 nm) corresponding to Y• (see Chapter III) 
along with a sharp peak at 348 nm and a broad peak with λmax ~ 570 nm. The latter two 
features resemble that of the ketyl radical of BPA, reported in Chapter III, red-shifted 15-20 
nm. We therefore attribute these features to that of the ketyl radical of 4-
acetamidobenzophenone (4-Ac-BP•). From these data, it is clear that the excited state of 4-
Ac-BP is a competent photooxidant of tyrosine. 
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Figure 10.3 plots the TA spectra recorded upon photolysis of solutions containing 
Y356C(BP)-β2 with 320 nm laser light. Note that photolysis of wt-β2 or α2 subunits alone at 
this wavelength produces no observable transient signals on the nanosecond timescale. Panel 
A of Figure 10.5 plots the spectra observed following excitation of a 50 μM solution of met-
Y356C(BP)-β2 (•Y122 reduced) with 15 mM MgSO4, 1 mM CDP, and 3 mM ATP (pH 7.5). 
The spectra contain a sharp peak at 360 nm and a broad feature with λmax ~ 455 nm that decay 
on the microsecond timescale. In the presence of 70 μM α2 (panel B) and for 50 μM 
Y356C(BP) with 70 μM α2 (panel C), the peak at 360 nm is maintained, but the broad feature 
at 455 nm has decreased in intensity. The feature at 360 nm is reminiscent of the spectrum of 
4-Ac-BP• which exhibits a sharp peak at 348 nm (see above). We would expect the thioether 
 
Figure 10.3 TA spectra recorded after 320 nm photolysis of 50 μM solutions of met-
Y356C(BP)-β2 in the absence (A) and presence (B) of 70 μM α2, and 50 μM 
Y356C(BP)-β2 with 70 μM α2 (C). Spectra were recorded 150, 300 ns, 1 and 5 μs 
after the laser flash (top to bottom). Conditions: 50 mM Tris (pH 7.5), 15 mM MgSO4, 
1 mM CDP, and 3 mM ATP. 
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modification of the 4-acetamido group in Y356C(BP) to perturb the spectrum of the 4-Ac-BP• 
radical. We therefore tentatively assign the 360 nm feature to the ketyl radical of 4-
acetamidobenzophenone attached to β2 Y356C(BP•). Based on this assignment, we can 
conclude that the excited state of the BP chromophore has oxidized some residue in either the 
β2 or α2 subunit. The spectrum recorded at 150 ns in panel B contains a weak feature at 410 
nm, which may correspond to a tyrosyl radical.  
10.4 Conclusions 
We have developed a synthetic strategy in Section 10.2 to generate β2 C-terminal peptides 
containing the [Re] chromophore for ligation to the truncated β2 subunit. The solubility 
problems of the tetra peptide should be resolved upon synthesis of the full length peptide, 
which contains multiple Asp and Glu residues (the [Re]-Y-R2C19 peptide is soluble at neutral 
pH). Using the synthetic methodology described here and the previously established peptide-
protein ligation methods for the β2 subunit,2 we may be able to generate semi-synthetic β2 
subunits containing covalently attached [Re] photooxidants for study of the PCET of radical 
transport in RNR. Time resolved emission and absorption spectroscopies should be used to 
verify Y• formation on the full length peptide. If the proline linkage does not afford the 
appropriate photochemistry, other orthogonally protected, bis-amine containing amino acids 
can be used, such as Boc-3-(Fmoc-amino)-L-alanine. 
The results reported in Section 10.3 represent initial attempts to characterize the excited 
state chemistry of the 4-Ac-BP chromophore, both free in solution and covalently attached to 
the β2 subunit via a thioether linkage. The data show that this chromophore is a competent 
photooxidant of tyrosine, and TA spectra corresponding to 4-Ac-BP• and Y• in the charge 
separated state have been characterized. The spectra obtained for the “control” experiment in 
left panel of Figure 10.2 do not resemble the spectra for the control experiment in panel A of 
Figure 10.3. Perhaps the thioether linked 4-Ac-BP chromophore would provide a better 
control. Synthesis of this compound could be accomplished by allowing benzophenone-4-
iodoacetamide to react with cysteine.  
The peak at 410 nm in the spectrum recorded at 150 ns in panel B may indeed be due to a 
tyrosine radical in α2. To confirm this interpretation, flash photolysis of met-Y356C(BP)-β2 
and Y356C(BP)-β2 should also be carried out with the Y730F-α2 and C439S- α2 variants to 
trap any tyrosyl radicals generated along the transport pathway in α2. Similar experiments 
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with the Y731F-α2 should result in no Y• production if •Y731 is indeed the observed radical. 
Photochemical assays should also be carried out with the Y356C(BP)-β2 subunit and α2 to 
confirm light initiated turnover.  
10.5 Experimental Section 
Materials. Boc-Leu-MBHA resin, 1-hydroxybenzotriazole (HOBt), N-α-Fmoc-S-trityl-L-
cysteine (Fmoc-Cys(Trt)-OH), Benzotriazole-1-yl-oxy-tris(dimethylamino)-phosphonium 
hexafluorophosphate (BOP) (Novabiochem), O-(1,1-dimethylethyl)-N-[(9H-fluoren-9-
ylmethoxy)carbonyl]-L-tyrosine (Fmoc-Y(tBu)-OH), O-(7-Azobenzotriazol-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate (HATU) (Applied Biosystems), (2S,4S)-N-tert-
butoxycarbonyl-4-N-(9-fluorenylmethoxycarbonyl)aminopyrrolidine-2-carboxylic acid (N-
Boc-cis-4-N-Fmoc-amino-L-proline), triflic acid, trifluoroacetic acid (TFA), piperidine, 
diisopropylethylamine (DIPEA), triisopropylsilane (TIS), thioanisole, N-methylmorpholine 
(NMM), 1,2-ethanedithiol and dimethylformamide (DMF) (Sigma Aldrich) were used as 
received. Re(bpy-COOH)(CO)3CN7 was prepared as previously described. Y356C(BP)–β2 
was prepared by Lars Plate in the Stubbe Lab by labeling the Y356C–β2 mutant with 
benzophenone-4-iodoacetamide as previously described for myosin.8 4-
Acetamidobenzophenone (4-Ac-BP) was synthesized as previously described.9 
Synthesis of Cys-Pro([Re])-Tyr-Leu-NH2. The peptide was synthesized using a 
combination of Boc and Fmoc solid-phase peptide synthesis (SPPS) strategies. Boc-Leu-
MBHA resin (250 mg, 0.54 mmol/g) was loaded into a 10 mL Bio-Rad Poly-Prep column 
containing a porous 30 μm polyethylene bed in the bottom to hold the resin. All 
reaction/washing steps were performed by shaking the resin with a FisherScientific Vortex 
Genie 2 (VWR). 
Boc-protecting groups were cleaved by shaking the resin in 2 mL of 1:1 TFA:CH2Cl2 (1 × 
1 min, 1 × 20 min) followed by neutralization of the resin with 2 mL of 10% NMM in CH2Cl2 
(2 × 5 min). Fmoc-protecting groups were cleaved with 2 mL of 20 % Piperidine/DMF (3 × 7 
min). Trt-protecting groups were cleaved with 94:1:5 CH2Cl2:TFA:TIS. Amino acid (Fmoc-
Y(tBu)-OH,  N-Boc-cis-4-N-Fmoc-amino-L-proline, and Fmoc-Cys(Trt)-OH) coupling steps 
were achieved by combining 4 eq of the N-protected amino acid to be coupled with HATU 
(185 mg, 3.6 eq and DIPEA (188 μL) in 1.1 mL of DMF and the reaction shaken for 80 
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minutes. In between coupling and Fmoc- (Boc-) protecting group cleavage steps, the resin 
was rinsed with 4 × 2 mL of DMF (CH2Cl2). 
 Coupling of Re(bpy-COOH)(CO)3CN was achieved by combining 2 eq of the Re(I) 
complex with BOP (239 mg, 4 eq), DIPEA (188 μL) in 4 mL of DMF and the reaction 
mixture shaken overnight. Note that higher yields can be achieved with the BOP coupling 
reagent, however it should only be used if a tBu-protected form of the tyrosine phenol is used 
on the peptide. If the free phenol is employed (as with Fmoc-3,5-F2Y)10, then HATU should 
be used as the coupling reagent and the reaction run for 2 × 80 min.  
The peptide was cleaved from the resin following cleavage of the S-Trt and N-Boc 
protecting groups of the Cys residue and washing of the resin. The resin (50 mg) was placed 
in a conical vial and thioanisole (100 μL) and 1,2-ethanedithiol (50 μL) were added. The vial 
was chilled in an ice bath, TFA (1 mL) was added, the mixture stirred for 5 min. Triflic acid 
(100 μL) was then added and the vial sealed and stirred at room temperature for 3 hours. The 
reaction mixture was filtered through the Bio-Rad Poly-Prep column and the filtrate 
concentrated under a stream of nitrogen gas. The peptide was isolated by precipitation with 30 
mL of ether, followed by consolidation of the precipitate via centrifugation and canting off of 
the ether. The resulting pellet was dissolved in 10% MeCN, 0.1 M (NH4HCO3) (pH 10) for 
purification by HPLC. 
Purification and Characerization of Cys-Pro([Re])-Tyr-Leu-NH2. The title peptide 
was purified by reversed phase HPLC using the system described in Chapter VII. Samples 
were manually injected onto a preparative Waters XTerra MS C-8 column (30 × 100 mm), 
which had been previously equilibrated with 10% acetonitrile/  0.1 M ammonium bicarbonate 
buffer (pH 8). A linear gradient of 10 → 55 % acetonitrile vs. ammonium bicarbonate buffer 
over 50 min at a flow rate of 10 mL/min was used to elute the peptide. The eluant absorbance 
was monitored at 355 and 210 nm, where the [Re] chromophore and peptide amide bond 
absorb, respectively. Fractions containing the desired product were collected by hand, pooled, 
and lyophilized to dryness. MALDI-TOF mass spectrometry was used to characterize the 
peptide as described below [(M–CN)+ Calc. (Obs.) 975.25 (974.2)]. 
Physical Measurements. MALDI-TOF mass spectrometry was performed with a Brüker 
Omniflex instrument in the DCIF using α-cyano-4-hydroxycinnamic acid as the matrix. The 
instrument was calibrated in positive ion mode with a quadratic polynomial using a mixture of 
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angiotensin II (1046.5423), P14R synthetic peptide (1533.8582), and ACTH fragment 18-39 
(2465.1989) (Sigma). Transient absorption spectroscopy was carried out as described in 
Chapter IX, except that the excitation laser light was tuned to 320 nm. 
 223
 224
 
10.6 References 
 1. Ge, J.; Yu, G.; Ator, M. A.; Stubbe, J. Biochemistry 2003, 42, 10071. 
 2. Yee, C. S.; Seyedsayamdost, M. R.; Chang, M. C. Y.; Nocera, D. G.; Stubbe, J. 
Biochemistry 2003, 42, 14541. 
 3. Seyedsayamdost, M. R.; Stubbe, J. J. Am. Chem. Soc. 2006, 128, 2522. 
 4. Reece, S. Y.; Stubbe, J.; Nocera, D. G. Biochim. Biophys. Acta 2005, 1706, 232. 
 5. Musier-Forsyth, K.; Schimmel, P. Biochemistry 1994, 33, 773-779. 
 6. Sutoh, K.; Lu, R. C. Biochemistry 1987, 26, 4511-4516. 
 7. Reece, S. Y.; Nocera, D. G. J. Am. Chem. Soc. 2005, 127, 9448. 
 8. Lu, R. C.; Wong, A. Biochemistry, 1989, 28, 4826. 
 9. Gooβen, L. J.; Ghosh, K. Eur. J. Org. Chem.  2002, 3254. 
 10. Seyedsayamdost, M. R.; Reece, S. Y.; Nocera, D. G.; Stubbe, J. J. Am. Chem. Soc. 
2006, 128, 1562. 
Acknowledgements 
The work in this thesis would not have come to fruition without the support and energy of 
many people who I hold near and dear to my heart. First and foremost, I need to thank my 
parents for raising me and having the courage and insight to send me away when I was in high 
school. Thank you for challenging me, believing in me, for being a constant source of support, 
and for being my friends. Also thanks to my brothers, Shaun and Todd, for being such good 
friends over the years. Shaun, you have been and will always be my role model and Todd, you 
can be one of the funniest people I know. 
Thanks to my friends from Davidson who have kept in touch with me and kept me sane 
over the years. Graham Gravley, Diego Marquez, and Adam Kennedy, I have no doubt that 
we will be friends for life and things always pick up right where they left off. Prof. Durwin 
Striplin was my first mentor in chemistry and has now become one of my best friends. Thanks 
for giving me a chance to explore my curiosity in chemistry and helping me fall in love with 
the science. I hope I can always call you up to listen to your philosophy on life and on 
science, as they always provide a source of inspiration. 
Since joining the ranks here at MIT, many people have provided words of wisdom, 
friendship, awkward moments, or forms of entertainment all of which need recognition. 
Thanks to the laser lab crew of Niels Damrauer, Justin Hodgkiss, Zhi-Heng Loh, and Liz 
Young for teaching me how to think about my experiments, providing New Zealand puppet 
shows while tuning the regen, teaching me how to use and abuse the Infinity, and for keeping 
us all in line, respectively. Now, can someone tell me how to buy a lense? Special recognition 
go to Bart “B-Money” Bartlett and David “Mank-the-Tank” Manke, the original members of 
perhaps the first chemistry fraternity at MIT founded at 68 Beacon St. Aetna Wun provided 
the plushy interior. Adam Veige is the most destructive person I know, so thanks for helping 
me keep things in perspective, teaching me how to hail a cab properly, and for always getting 
us started on the right foot, even if you “had a bad feeling” about that night. Thanks to 
Matthew F. Shores for being so conversational and Julien Bachmann for being so Swiss. 
Becky Somers always has a smile on her face and somehow manages to deal with the rest of 
the Nocera group. Jenny Yang was a great bay-mate for so many years and always provides a 
good listening ear. Joel Rosenthal does the best Nocera impressions and keeps him from 
getting out of control.  
 225
Currently Dan has assembled a crack team of postdocs that keep the lab running. Special 
thanks go to Dino Villagrán for being a real Mexican. Thanks to Matt Kanan for introducing 
the lab to Pinnochio’s in Harvard Square, for nights at Grafton St with the X-factor, and for 
challenging me to reevaluate everything I thought I knew. Ted Betley has been the recipient 
of far too many streece melt-downs over the last year and for that I am eternally grateful. 
Without him I may not be here today. I wish him all the best at Harvard and beyond.  Up for 
another game of Guitar Hero? 
“Good luck” to the next wave of Nocera students. “Little” Emily McLaurin is a force to be 
reckoned with who can sense oxygen with one hand and spin records with the other, all while 
riding a skateboard. The photochemical hydrogen project is in the best of hands with Tim “the 
Hobbit” Cook who adds depth to the lab with his incredible artistic and Photoshop talents. 
May the force be with you, Montana, in ripping apart water to make oxygen. To Marshak, 
Yogi, and Jay, thanks for your fresh perspective on things that once seemed old to me. 
Having Arthur Esswein as a fellow classmate to share in the trials and tribulations of MIT 
has been a blessing. Arthur is a man of multiple personalities and has had many nicknames 
over the years: Little Krodel, Alfred, Artie, the Corrector, JR, Artie Bukes, little Buddy… 
Seriously though, thanks for being a good friend and for putting up with me.  
Several others outside the Nocera lab need mentioning. Leslie Murray helped me survive 
first year and has been there for me ever since. Lindsay McQuade is a great running partner 
and was always there to listen when I was freaking out. Josh Figueroa helped me through 
third year orals and always provides a unique perspective on things with his own dialect. 
Thanks to Leif Hammarström for his interest in me and his enthusiasm for my science. He has 
been a wonderful collaborator and I have learned much from our interactions. Tania Irebo 
always makes you feel welcome, whether in the lab, outside in the cold, dark winters of 
Sweden, or in the hot tub in Ventura. Much of the work in this thesis couldn’t have been 
possible without the help of Mohammad Seyedsayamdost. I have been extremely fortunate 
that he was willing to dedicate time and energy to my project. Thanks for always making me 
feel welcome in the Stubbe lab, for teaching me biochemistry, and for being a good friend. 
Thanks to Joseph Sadighi for being a wonderful thesis chair, always interested to hear 
about what I have been up to. Steve Lippard made my thesis defense a very memorable and 
rewarding experience. I feel that JoAnne Stubbe has invested enough of her time and energy 
 226
 227
in me to qualify as my co-advisor. Thank you for your commitment and enthusiasm to science 
and for being interested in the details of every experiment. I am always inspired by your 
passion for learning and determination to get the science right. 
I find it hard to express in words the appreciation I have for my advisor, Daniel G. 
Nocera. Thank you for taking a “dumb kid from a small school in the South” and molding 
him into a scientist. As a man with Italian heritage, you can’t help but be emotional, but you 
wear your heart on your sleeve and face life every day with an honesty and enthusiasm that I 
find inspiring. Thank you for teaching me to think about the importance of my science, to 
always think of a better way to explain myself, and to be fearless in following your passions. 
Also thanks for introducing me to fine dining in Boston, beers at the Muddy, the car ride back 
from the ET Gordon Conference at Salve Regina, guys night out in the North End, being my 
father from Australia at the Phoenix, taking me in after the break up, Leng Leng’s last day 
(the best day ever), ladies lunch, and all the stories from your rock star exploits. Thank you. 
 228
 229
Biographical Note 
Steven Young Reece was born on February 26, 1980 in Kinston, NC and raised there by 
his parents Sonny and Susan. He grew up the middle child with two brothers, Shaun and 
Todd, who proved to be the best friends a boy could have. Being the oldest, Shaun was the 
role model and introduced Steven to such things as music, science, and swimming. Shaun and 
Steven had the same high school chemistry teacher, Mr. David Sawyer, now a meteorologist 
in Alabama, who was the first to spark Steven’s interest in chemistry.  
Growing up, weekdays were spent at school in K-town and swimming laps with the local 
swim club, but the weekends provided a good escape to the beautiful beaches of North 
Carolina. Sneads Ferry, NC provided a quality education on combing the beach for sand 
dollars, waterskiing, pulling in flounder nets at sunrise, and trawling for shrimp at sunset. 
Always an introspective and quiet kid, he found the physical connection with the ocean a 
serene experience. 
At the age of sixteen, Steve was “shipped off” to boarding school at Phillips Exeter 
Academy in Exeter, NH. Thus began his “formal” education on life that opened his eyes to 
the complexity of the world around him. At Exeter, Steve developed a love for the 
hypnotizing music of the Great Highland bagpipe through lessons with the wonderfully 
skilled and insightful Brian Yates, a native of Winchester, MA. In 1998, Steven migrated 
south to continue education at Davidson College in Davidson, NC where he learned the value 
of persistence and the true meaning of friendship as a four-year member of the varsity swim 
team. At the end of his freshman year, he joined the lab of Prof. Durwin Striplin to try his had 
at chemical research. Without this single event this thesis probably wouldn’t be written. Dr. 
Striplin proved to be a wonderful mentor; Steve fell in love with inorganic synthesis and 
photochemistry, while gaining an appreciation for how chemistry can contribute to the search 
for renewable sources of energy.  
In 2002, Steve moved back north to continue studying chemistry at MIT in Cambridge, 
MA. He was persistent and fortunate enough to join the lab of Prof. Daniel Nocera. Through 
work in Dan’s labs and those of his collaborator, Prof. JoAnne Stubbe, Steve has been molded 
from someone with a naïve love and passion for science to a more careful, thoughtful chemist 
who appreciates the complexity of his chosen discipline. His interests have broadened to 
include bioinorganic and biophysical chemistry. In early fall 2007, Steve will leave MIT to 
continue his scientific journey as a postdoc in the labs of Prof. Michael Marletta at the 
University of California, Berkeley. 
  230
  231
Curriculum Vitae of Steven Y. Reece 
Work Address Contact Information 
Department of Chemistry, 2-301  phone (work): 617•258•7268 
Massachusetts Institute of Technology phone (cell): 617•448•1227 
77 Massachusetts Ave. FAX: 617•253•7670 
Cambridge, MA 02139-4307 e-mail: streece@mit.edu 
Education 
2002-2007  MASSACHUSETTS INSTITUTE OF TECHNOLOGY   Cambridge, MA 
Ph.D. in Inorganic Chemistry  
Thesis: “Proton-coupled electron transfer and amino acid radical hopping in class I E. coli 
ribonucleotide reductase”  
1998-2002 DAVIDSON COLLEGE Davidson, NC 
B.S. with High Honors in Chemistry • Minor in Mathematics • Cum Laude 
Honors Thesis: “Synthesis and Characterization of Oligoproline Systems Designed for 
Photoinduced Energy and Electron Transfer” 
Experience 
2007- Postdoctoral Research Fellow, Univ. of Cal., Berkeley • Michael A. Marletta, Advisor 
2002-2007 Graduate Research Assistant, MIT • Daniel G. Nocera, Advisor 
2002-2003 Teaching Assistant, MIT  
 Lecture course: Principles of Chemical Science 
 Lab course: Introduction to Experimental Chemistry  
1998-2002 Undergraduate Research Assistant • Durwin R. Striplin, Advisor 
2001-2002 Varsity Swim Team Captain 
 Team member 1998-2002 
Awards and Affiliations 
2006 Morse Travel Grant (MIT) 
2005 Travel Award, Div. of Inorg. Chem., Fall 2005 ACS National Meeting 
2002 Student Awardee of the American Institute of Chemists Foundation (AICF) 
2001 Samuel Bell Merit Scholarship (Davidson College) 
2000 Porter P. Vinson Chemistry Award (Davidson College)  
1998 Cum Laude graduate of Phillips Exeter Academy 
2002- American Chemical Society member 
Publications  
(1) Reece, S. Y.; Seyedsayamdost, M. R.; Stubbe, J.; Nocera, D. G. “Direct Observation of a Transient 
Tyrosine Radical Competent for Initiating Turnover in a Photochemical Ribonucleotide 
Reductase” submitted. 
(2) Irebo, T.; Reece, S. Y.; Sjödin, M.; Nocera, D. G.; Hammarström, L. “Proton-Coupled Electron 
Transfer of Tyrosine Oxidation: Buffer Dependence and Parallel Mechanisms” submitted. 
  232
(3) Reece, S. Y.; Seyedsayamdost, M. R.; Stubbe, J.; Nocera, D. G. “Photoactive Peptides for Light 
Initiated Tyrosyl Radical Generation and Transport into Ribonucleotide Reductase” J. Am. Chem. 
Soc. 2007, ASAP article, DOI: 10.1021/ja0704434. 
(4) Reece, S. Y.; Seyedsayamdost, M. R.; Stubbe, J.; Nocera, D. G. “Electron Transfer Reactions of 
Fluorotyrosyl Radicals.” J. Am. Chem. Soc. 2006, 128, 13654-13655. 
(5) Reece, S. Y.; Hodgkiss, J. H.; Nocera, D. G. “Proton-Coupled Electron Transfer: The Mechanistic 
Underpinning for Radical Transport and Catalysis in Biology.” Phil. Trans. Roy. Soc., B 2006, 
361, 1351-1364. 
(6) Seyedsayamdost, M. R.; Reece, S. Y.; Nocera, D. G.; Stubbe, J. “pH Rate Profiles of FnY356-R2s 
(n = 2, 3, 4) in Escherichia coli Ribonucleotide Reductase: Evidence that Y356 Is a Redox-Active 
Amino Acid along the Radical Propagation Pathway.” J. Am. Chem. Soc. 2006, 128, 1562-1568. 
(7) Seyedsayamdost, M. R.; Reece, S. Y.; Nocera, D. G.; Stubbe, J. “Mono-, Di-, Tri-, and Tetra-
Substituted Fluorotyrosines: New Probes for Enzymes That Use Tyrosyl Radicals in Catalysis.” J. 
Am. Chem. Soc. 2006, 128, 1569-1579. 
(8) Reece, S. Y.; Nocera, D. G. “Direct Tyrosine Oxidation Using the MLCT Excited States of 
Rhenium Polypyridyl Complexes.” J. Am. Chem. Soc. 2005, 127, 9448-9458. 
(9) Reece, S. Y.; Stubbe, J.; Nocera, D. G. “pH Dependance of Charge Transfer Between Tryptophan 
and Tyrosine in Dipeptides.” Biochim. Biophys. Acta 2005, 1706, 232-238. 
(10) Striplin, D. R.; Reece, S. Y.; McCafferty, D. G.; Wall, C. G.; Friesen, D. A.; Erickson, B. W.; 
Meyer, T. J. “Solvent Dependence of Intramolecular Electron Transfer in a Helical Oligoproline 
Assembly.” J. Am. Chem. Soc. 2004, 126, 5282-5291.  
 
